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PREFACE 
This thesis describes the results of research carried out in the 
Department of Biochemistry, John Curtin School of Medical Research, 
Australian National University. 
Abbreviations used in this thesis without definition include: 
kb 
bp 
mol wt 
Mr 
FAD 
Tris HCl 
EDTA 
b.p. 
SDS 
kilobase pairs 
base pairs 
molecular weight 
apparent molecular weight 
flavin-adenine dinucleotide 
tris(hydroxymethyl)aminomethane hydrochloride 
ethylenediaminetetraacetate 
boiling point 
sodium dodecyl sulphate 
The following enzyme nomenclature has been adopted: NADH 
dehydrogenase (1.6.99.1), any enzyme (complex) which catalyzes the 
oxidation of NADH by artificial electron acceptors; Respiratory NADH 
dehydrogenase, the enzyme (complex) which catalyzes the transfer of 
electrons between NADH and ubiquinone in vivo. In the case of the 
purified respiratory NADH dehydrogenase of!· coli described in this 
thesis, it is also referred to as the NADH:ubiquinone oxidoreductase 
to signify that ubiquinone-1 is used in assays as the electron 
acceptor. 
NADH oxidase refers to the activity of the intact respiratory 
chain in oxidizing NADH and reducing endogenous ubiquinone-8 present 
in E.coli membranes. Where enzymes that catalyze specific reactions 
are described, they are named according to I.U.B. rules, eg 
NADH:ubiquinone oxidoreductase (1.6.5.3), etc. 
iv. 
ABSTRACT 
The work described in this thesis is part of a 
multidisciplinary approach to the isolation and characterization of 
the respiratory NADH dehydrogenase of E.coli. 
The complete nucleotide sequence for the ndh structural gene was 
determined using the Sanger chain-termination method (Young, I.G., 
Rogers, B.L., Campbell, H.D., Jaworowski, A., and Shaw, D.C. (1981) 
Eur. J. Biochem. 116, 165-170). Analysis of the sequence revealed 
the following features: (a) A putative promoter approximately 40 bp 
upstream from the initiation codon, (b) two inverted repeats, one 
upstream from the initiation codon (covering sections of the putative 
promoter), and the other iIILmediately after the stop codon. The 
latter repeat is believed to act as an RNA transcription termination 
structure. (c) A ribosome binding site, complementary to the 16S 
ribosomal RNA immediately precedes the initiation codon. (d) UUG, 
which codes for N-formylmethionine rather than the usual leucine 
residue acts as an atypical initiation codon. 
An examination of the primary amino acid sequence led to the 
detection of internal homology within the enzyme. There are two 
large repeating units of -130 amino acids near the N-terminus of the 
protein and two smaller repeats of -20 amino acids near the C-
terminus. Comparison of the primary amino acid sequence of the 
enzyme with other proteins led to the detection of homology with the 
human glutathione reductase. By comparison with the well known 
three-dimensional structure of glutathione reductase, the two large 
N-terminal repeats of the NADH dehydrogenase can be assigned as the 
FAD and NADH binding domains. The function of the short C-terminal 
repeats is unknown. 
v. 
The catalytic activity of the purified!· coli respiratory NADH 
dehydrogenase was examined with short and long chain homologues of 
ubiquinone. The purified enzyme catalyzes the reduction of various 
ubiquinone homologues at high rates without the involvement of any 
auxilliary protein(s). The enzyme was reconstituted into 
phospholipid vesicles, after which it possesses high ubiquinone-8 
reductase activity. Results of kinetic and inhibition studies are 
consistent with the view that ubiquinone-1, ubiquinone-3 and 
ubiquinone-8 all act at the same catalytic site on the enzyme and 
that ubiquinone-8 is the irrunediate electron acceptor for the E.coli 
respiratory NADH dehydrogenase in vivo 
The reconstitution of membrane vesicles of ndh mutants by 
purified respiratory NADH dehydrogenase was investigated. The enzyme 
can readily become membrane-associated and reconstitute the NADH 
oxidase of membrane vesicles from ndh mutants. The purified enzyme 
was shown to be capable of inserting into the outer surface of the 
inner cytoplasmic membrane of ndh spheroplasts. Once assembled, the 
enzyme does not readily 'flip' across the lipid bilayer even when 
amplified to 70-fold wild type levels. The observation that the 
purified enzyme can reconstitute ndh spheroplasts suggests that there 
is no obligatory protein receptor that facilitates membrane binding. 
A novel [ 14c]-labelled photoaffinity analogue ([14c]-2'-
arylazidoubiquinone-l) of ubiquinone was synthesized in an attempt to 
probe the ubiquinone binding site of the purified enzyme. After 
photolysis the [ 14 c]-2'-arylazidoubiquinone-l was shown to be 
covalently attached (typically 0.1-0.15 mole label per mole 
polypeptide) to the purified enzyme. The labelled enzyme was cleaved 
at tryptophan residues by BNPS-skatole. The labelled polypeptides 
vi. 
produced were separated with high resolution, purified and anal yzed . 
The results suggested that the middle region of the protein appea r ed 
to be more heavily labelled than the C-terminal reg ion wh ich was mo r e 
labelled than the N-terminal region. 
With the aim of assisting with the identification of the 
ubiquinone binding site of the respiratory NADH dehydrogenase, the 
determination of the DNA sequence of the dld gene (codes for D-
lactate dehydrogenase) was initiated. The cloned ~6.9 kb DNA 
fragment which contains the dld gene was isolated and purified after 
Hindlll digestion of pIY2 (Young, I.G., Jaworowski, A., and Paulis, 
M.I. (1978) Gene~' 25-36). Although time did not permit the 
completion of the sequence, approximately 1030 bases of unique DNA 
sequence was obtained. 
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Chapter 1 
General Introduction 
1. 
The Aerobic Respiratory Chain of E.coli 
The aerobic respiratory chain of.§_. coli and mitochondria are 
similar in their basic design. Both systems possess substrate-
specific dehydrogenases which catalyze electron transfer via 
ubiquinone to a cytochrome chain and ultimately to molecular oxygen. 
There have been a number of schemes proposed for the arrangement 
of the components in the respiratory chain of E . coli (for example 
Haddock and Jones (1977), Downie and Cox (1978) and Kita, Kasahara 
and Anraku (1982)) . These schemes differ in several respects, most 
importantly in the site(s) of ubiquinone interaction and the sequence 
of the cytochromes . One such scheme, taken from Kita and Anraku 
( 1981) is presented in Figure 1-1. However, although the various 
schemes may be valuable as a stimulus for further experimentation, 
there is still no general agreement on the order of the respiratory 
components , and the involvement of iron- sulphur proteins is also 
uncertain. 
Several respiratory-chain-linked dehydrogenases have been 
purified from the inner membrane of E . coli. Some of their 
biochemical properties are listed in Table 1-1. Of the enzymes 
listed in Table 1- 1, the best characterized are the NADH 
dehydrogenase and the D-lactate dehydrogenase . 
Under conditions of vigorous aeration the maJor membrane-bound 
cytochromes are cytochromes _!:5 56 , _!:562 and o, whereas under anaerobic 
growth the major-membrane bound cytochromes are cytochromes _!:555, 
_!:558 and ~2 (cytochrome i) together with low concentrations of ~l 
(Haddock and Schairer , 1973). 
Fi gure 1- 1 . Sequence of the Cytochrome b 556 Electron-Carrying Chain 
of Aerobically Gr own E . coli 
NAOH-OH - Fe/ S --(Q ) - CyT MK 
D-LDH / 
L-LDH 
SDH 
/ 
This sequence is for aerobically grown j_. coli in the early 
e xponential phase. Abbreviations used include: NADH-DH, NADH 
dehydrogenase; SDH, succinate dehydrogenase; L-LDH, L-lactate 
dehydrogenase; D-LDH, D-lactate dehydrogenase; Fe/S, iron-sul phur 
protein; Q, ubiquinone-8; MK, menaquinone-8; c y t, c y tochrome. 
The figure is taken from Kita and Anraku (1981). 
Table 1-1. Properties of the Purified Respiratory-Chain-Linked Dehydro genases of E. coli 
Enzyme Mol Wt Prosthetic Specific Acceptor K Donor References 
. . a Ill (rnM) (monomer) Group Activity-
NADH 47000 FAD 500-600 Q-1 0.057 Jaworowski, Campbell, 
Paulis and Young (1981a); 
Jaworowski, Mayo, Shaw, 
Campbell and Young 
(1981b) 
Succinate 61000 not 0.15 not not Bragg (1980) 
dehydrogenase cited cited cited 
D-Lactate 71000 FAD 200-23# MTT 0.6-1.8 Futai (1973); Kohn and 
dehydrogenase -72000 Kaback (1973); Pratt, 
Fung, Flowers and Ho 
(1979). 
L-Lactate 43000 FMN 311 MTT 0.12 Futai and Kimura (1977) 
C dehydrogenase-
Glycerol-3-phosphate 58000 FAD 37.7 
3- 0.8 Schryvers, Lohmeier, and Fe(CN)6 
dehydrogenas~ Weiner (1978); Weiner and 
Heppel (1972) 
D-Arnino acid 55000 and FAD 3.5 DCIP 29 Olsiewski, Kaczorowski 
C dehydrogenase- 45000 27.0 Q-1 5.3 and Walsh (1980) 
(nonidentical 
subunits) 
Praline 124000 FAD 7.3 p-iodonitro 60 Scarpulla and Soffer 
C dehydrogenase- tetrazoliurn (1978 ) 
Table 1-1. (continued) 
Enzyme 
Pyruvate oxidase 
Mol Wt 
(monomer) 
66000 
Prosthetic 
Group 
FAD 
-1 -1 
a µmol (donor) min mg protein. 
Specific 
. . a Activity-
200 
Acceptor 
3-Fe (CN)6 
K Donor 
m(mM) 
10 
References 
Williams and Hagar (1966); 
O'Brien, Schrock, Russell, 
Blake and Gennis (1976) 
b Assayed by phenazine methosulphate (PMS) mediated reduction of MTT (3-(4,S-dimethylthiazolyl-2)-2, 
5-diphenyltetrazolium bromide). 
c Inducible enzyme. 
2. 
Both cytochromes ~ and d have been shown to function as terminal 
oxidases in the respiratory chain of E.coli (Caster and Chance, 
1959; Pudek and Bragg, 1974). The relative amounts of these two 
cytochromes is altered by changes in growth conditions. Thus, 
stationary phase cells have a much greater relative amount of 
cytochrome i_ to cytochrome~ compared to cells ha rveste d in the 
exponential phase of growth (Pudek and Bragg, 1974; Rice and 
Hempfling, 1978). Pudek and Bragg (1974) demonstrated that oxidation 
proceeding via cytochrome o is more sensitive to cyanide than 
cytochrome d. 
Recently, Green and Gennis (1983) reported experiments with an 
E.coli cytochrome i_ mutant (cyd) which showed that growth and oxygen 
consumption are maintained by cytochrome i in the presence of cyanide 
concentrations which inactivate cytochrome o. 
Kita et al. (1982) have purified the .!:_552-~ complex (terminal 
oxidase) and reconstituted the preparation into liposomes. 
Furthermore, they provided evidence that the cytochrome ls52-~ 
complex functions as a coupling site (ibid). They also found that 
the cytochrome lsss-i_ complex, a major terminal oxidase of E.coli 
cells in the late exponential phase of aerobic growth serves as a 
coupling site (ibid). 
Interestingly, a terminal oxidase complex which contains 
cytochrome lsss, ~land i and only two major polypeptide subunits has 
recently been purified and reported to function as a ubiquinol-8 
oxidase in reconstituted proteoliposomes (Miller, Koland, and Gennis, 
unpublished data cited in Green and Gennis, 1983). 
3 • 
Quinone Function 
Quinones are known to play an important role in a number of 
diverse and essential biological processes. Most notable is their 
role in the respiratory chain in mitochondria and bacteria (Redfearn, 
1966; Brodie and Watanabe, 1966) as well as in photosynthesis in 
plants (Crane and Henninger, 1966). 
Two major structural groups of bacterial isoprenoid quinones can 
be recognized, the naphthoquinones and benzoquinones. 
Naphthoquinones can be divided further into two main types on the 
basis of structural considerations. These are the phylloquinones 
(associated with the green part of plants and occurs less commonly in 
bacteria) and the menaquinones (Collins and Jones, 1981). E.coli is 
one of a small group of organisms containing both ubiquinone and 
menaquinone (vitamin K2 ) (Pandya and King, 1966), the structures of 
which are shown in Figure 1-2. The relative amounts of ubiquinone 
and menaquinone present in cells depends on the degree of aeration of 
the growth medium. Menaquinone has been found to be the major 
quinone in anaerobically grown cells whereas ubiquinone has been 
found to be present in amounts 20-fold that of menaquinone in 
cultures which have been vigorously aerated (Polglase, Pun and 
Withaar, 1966). 
Extraction/reactivation studies in mitochrondria demonstrated 
that ubiquinone is an obligatory redox component of the mitochondrial 
electron transport chain (Lester and Fleischer, 1959; Ernster, Lee, 
Norling and Persson, 1969a,b). In the case of E.coli, the 
obligatory role of quinones in respiration has been verified by 
experiments involving mutants unable to form ubiquinone (ubi), 
menaquinone/demethylmenaquinone (men), or both quinones (ubi men) 
Figure 1-2 . Structure of the Major Quinone Species in E. coli 
0 
0 
0 
0 
0 
I 
0 
C 3 
----~H 
8 
~H 
8 
~H 
Ubiquinone-8 
Menaquinone-8 
8 
Demethylmenaquinone-8 
4 . 
(Cox, Newton, Gibson, Snoswell and Hamilton, 1970; Newton, Cox and 
Gibson, 1972; Gibson and Cox, 1973; Wallace and Young, 1977a,b). 
The role of ubiquinone in the E. coli respiratory chain is discussed 
further in the Introduction to Chapter 3. 
Although the obligatory role of quinones in r espiration is now 
accepted, the exact mechanism(s) and sites of quinone action are 
still in dispute. The development of the chemiosmotic theory of 
oxidative and photosynthetic phosphorylation, introduced by Mitchell 
(1961,1973) and considered by many authors to be experimentally 
proved (Skulachev, 1980), has greatly stimulated interest in the 
role of ubiquinone in the generation of a transmembranous 
electrochemical gradient (~µH) which can then be utilized to form ATP 
by an H+-ATP synthetase (Harold, 1977). The electrochemical proton 
gradient can also be utilized to drive uphill transport of many ions, 
substrates and metabolites across membranes by respiration-dependent 
transport systems (Harold, 1972,1977; Mitchell, 1973; Kaback, 
1974b). 
Central to the chemiosmotic hypothesis is the view that the 
respiratory chain is an alternating sequence of hydrogen carriers and 
electron carriers, arranged across the membrane in loops. Oxidation 
of a substrate results in the translocation of protons from one side 
of the membrane to the other (Mitchell, 1973); in any one loop, two 
protons pass across (Harold, 1972). However, the stoichiometry of 
the H+ to O ratio in E. coli is subject to some dispute (Bragg, 1980) 
and little information is known about the spatial arrangement in the 
membrane of the components of the respiratory chain of E.coli. 
Mitchell (1975a,b; 1976) has put forward a general formulation 
called the "protonmotive Q cycle" describing the role of ubiquinone 
in the hypothetical redox loops. Although the protonmotive Q cycle 
5. 
hypothesis still awaits experimental verification it has stimul a ted 
interest in the biophysical behaviour of ubiquinones in both natural 
and artificial membrane systems. 
There has been much debate about whether the quinones, which are 
well in excess of electron transfer chains, are a freely mobile 
species which form a homogeneous pool (Kr8ger and Klingenberg, 
1970; 1973a,b) or whether there are several protein bound forms 
which act as the carriers of reducing equivalents in the respiratory 
chain (Yu and Yu, 1981). 
Ragan and Heron (1978) claimed that purified complex I and III 
from mitochondria, when mixed, associated in a 1:1 molar ratio to 
give a complex I-complex III unit. Furthermore, the ubiquinone 
associated with this unit does not equilibrate with other such units 
or free complex I and complex III. However, this stoichiometric 1:1 
complex could only be formed at ubiquinone and phospholipid 
concentrations well below those within mitochondrial membranes. When 
the phospholipid and ubiquinone concentrations were raised, natural 
inner mitochondrial membrane behaviour was restored to the purified 
complex I-complex III system (ie the two associated complexes 
appeared to be linked by a mobile pool of ubiquinone molecules; 
Heron, Ragan and Trumpower, 1978). Heron et al. 1978 interpreted 
these results to mean that electron transfer occurs only through 
stoichiometric complex I-complex III units which are formed and 
reformed at rates higher than the rate of electron transfer. 
Recent experiments investigating the lateral diffusion of 
integral electron transfer components have demonstrated a diffusion-
limited step in electron transfer between the inner membrane 
dehydrogenases and cytochromes bc 1 and indicates that the 
6. 
dehydrogenases, ubiquinone, and cytochromes bc 1 are independent, 
diffusible membrane oxidation-reduction components (Schneider, 
Lemasters, H8chli and Hackenbrock, 1980). Schneider et al. (1980) 
fused the inner membranes of mitochondria with exogenous soybean 
phospholipid. They demonstrated that electron transfer rates from 
NADH and succinate to cytochrome c as well as to oxygen decreased in 
proportion to the phospholipid enrichment and increased surface area 
of the membrane bilayer (examined and measured by freeze-fracture 
electron microscopy). In later experiments, the role of ubiquinone 
in this process was evaluated by fusing liposomes containing 
ubiquinone-10 or ubiquinone-6 with mitochondrial inner membranes 
(Schneider , Lemasters and Hackenbrock , 1982). In control membranes 
enriched with phospholipid only, ubiquinol-cytochrome c reductase and 
NADH- and succinate - cytochrome c reductase activities decreased 
proportionally to the increase in bilayer lipid. This effect was 
reversed by ubiquinone incorporation . The extent of recovery of 
NADH-, succinate- , and ubiquinol-cytochrome .£ reductase activity was 
related to the chain length of the newly incorporated ubiquinones 
with the shorter chain length, ubiquinone-6, giving greater 
recoveries than the longer chain length, ubiquinone-10. Since 
lateral mobility of a lipid molecule increases with decreasing chain 
length, the relationship between the chain length and activity also 
supports the view that ubiquinone mediates electron transfer by 
diffusion (Schneider et al., 1982) . Also, these results obtained by 
--
Schneider et al . (1980) are not consistent with the model outlined by 
Heron et al. (1978), and Ragan and Heron (1978). Schneider et al. 
(1980) found that as exogenous phospholipid was incorporated into the 
membrane, NADH-cytochrome c reductase activity decreased much more 
7 . 
than did NADH-ubiquinone reductase activity or ubiquinol-cytochrome c 
reductase activity. A number of schematic models pertaining to 
electron transfer between the dehydrogenases and cytochromes bc 1 are 
presented in Figure 1-3. 
Sites of Proton Translocation and Energy Coupling 
As pointed out by Hatefi (1976), the mechanisms of energy 
conservation and coupling in mitochondria are still obscure and the 
efforts of various groups in isolating coupling factors and 
reconstructing partial reactions of oxidative phosphorylation have 
not unravelled these central problems. Nonetheless, preparations of 
complex I are capable of energy coupling as shown by the 
reconstitution experiments of Ragan and Racker (1973) (referred to as 
' site I '; sites of energy coupling are shown in Figure 1-4). 
The nature and number of coupling sites in the E.coli 
respiratory chain have not been unambiguously determined . There have 
been several methods used to determine the efficiency of oxidative 
phosphorylation and the number of phosphorylation sites associated 
with the respiratory chain. One method which has been extensively 
used measures the stoichiometry of H+ extrusion from cells in the 
presence of the permeant thiocyanate ion following the addition of a 
pulse of oxygen to an anaerobic cell suspension (see Bragg, 1979, for 
review). Several reports have indicated that there are two energy 
conservation sites associated with the respiratory chain of 
aerobically grown cells of E . coli (Lawford and Haddock, 1973; Farmer 
and Jones, 1976; Jones , Brice, Downs and Drozd, 1975), 
If there are at least two coupling sites in the respiratory 
chain of E.coli, then a P/0 ratio of 2 would be the upper value 
Figur 1-3 . Diffusional Models of Electron Tran s fer betwe en 
Dehydr ogenases and Cytochromes bc 1 
a. 
b. 
c. 
(a) Dehydrogenases (DH), cytochrome bc1 complex (b c 1) , a nd ubiquinone 
(Q and QH2 ) are independently diffusing electron t r ansfer components. (b) Sarne as (a), but ubiquinone (Q) is bound to a d i f f u s i bl e quinone 
binding protein (X) as a prosthetic group. 
(c) Electron transfer through direct intera ction between d iffusible 
dehydrogenases (DH) and cytochrome bc1 c omplex ( bc1) with ubiquinone 
(Q and QH2) as a coenzyme. This figure i s t aken from Schneider et al . , 
(1980). 
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obtained for the oxidation of NADH by subcellular preparations. This 
value has not been achieved so far, and generally membrane particles 
alone have given P/0 ratios in the 0.1 -0.2 range (Bragg, 1979). 
Mitochondrial Respiratory Dehydrogenases 
The enzymes which catalyze oxidative phosphorylation in bovine 
heart mitochondria are located in the mitochondrial inner membrane 
and appear to exist as components of five enzyme complexes. 
Complexes I, II, III and IV are segments of the electron transport 
system (Hatefi, 1976). Complex Vis essentially devoid of 
respiratory-chain electron carriers and appears to be concerned with 
energy conservation and ATP synthesis (ibid.). These complexes 
represent the NADH:ubiquinone oxidoreductase (complex I), 
succinate:ubiquinone oxidoreductase (complex II), 
ubiquinol:cytochrome ~ oxidoreductase (complex III) and cytochrome c 
oxidase (complex IV) segments of the respiratory chain (see Figure 
1-4). 
The principal entry points into the mitochondrial respiratory 
chain, the respiratory NADH dehydrogenase and succinate 
dehydrogenase, have been studied intensively over the last twenty 
five years. 
Complex II (Succinate:ubiquinone Oxidoreductase) 
Succinate:ubiquinone oxidoreductase was first isolated by 
Ziegler and Doeg (1959). Preparations of complex II catalyze the 
oxidation of succinate by ubiquinone-2 or phenazine methosulphate 
(PMS) at a rate of 50 to 55 µmoles min-lmg-1 protein at 38°C 
(Baginsky and Hatefi, 1969). 
Fi gure 1 - 4 . Respiratory Chain Components Present in the Inner 
Mitochond r ial Membrane 
------Complex II -----------1 
Succinate 
Fumarate 
NADPH 
NADP 
----Complex I -------------1 
Antimycin A 
I 
~Complex Ill ---1 r- Complex IV ---i 
Sequence of electron carriers in the respiratory chain showing the 
approximate sites for coupling at the level of complexes I, III, 
IV and the apparent inhibition sites for rotenone, 
2-thenolytriluroacetone (TTFA), antimycin A, cyanide, azide and 
carbon monoxide. FeS, iron-sulphur centre. Figure is taken from 
Hate f i , ( 19 7 6 ) . 
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Davis and Hatefi (1971) purified a soluble succinate 
dehydrogenase from complex II of beef heart mitochondria by a simple 
procedure involving extraction in the presence of chaotropic agents 
(NaC10 4 ) followed by a two step ammonium sulphate fractionation of 
the extract. The succinate dehydrogenase preparation was reported to 
have a molecular weight of approximately 97000 ± 5%, and to contain 1 
mole of covalently bound flavin, 7-8 g-atoms of iron, and 7-8 moles 
of acid-labile sulphide per mole. The enzyme is composed of two 
subunits. One is a flavoprotein with a molecular weight of 
approximately 70000 ± 7%. It contains iron and labile sulphide in an 
approximate ratio of 4 g-atoms of iron and 4 moles of acid labile 
sulphide per mole of flavin. The other subunit is an iron-sulphur 
protein with a molecular weight of approximately 27000 ± 5% (Davis 
and Hatefi, 1971) . The same preparation was also shown to restore 
full activity to electron transport particles or complex II which had 
had its succinate dehydrogenase selectively destroyed at pH 9.3 
(Hanstein, Davis, Ghalambor and Hatefi, 1971). The specific activity 
for this preparation is reported to be 67-78 µmoles succinate 
oxidized min- 1mg-l protein at 38°c using PMS as an acceptor 
(Hanstein et al., 1971). This is similar to the activity observed 
for preparations of complex II (Baginsky and Hatefi, 1969). The 
activity of the purified succinate dehydrogenase with ubiquinone-2 as 
acceptor has not been reported. 
Interestingly, succinate dehydrogenases from several different 
sources have been purified and shown to possess very similar 
properties to the beef heart mitochondrial enzyme (see Table 1-2). 
Further characterization of these enzymes from diverse sources may 
provide some interesting data on the evolution of what appears to be 
a conserved enzyme system . 
Table 1-2. Properties of the Respiratory Succinate Dehyd ro genase 
Preparations Isolated from Various Sources 
Organism Flavoprotein 
M 
r 
Beef heart 70000 ±7% 
mitochondria 
Rhodospirillum rubrum 60000 
Bacillus subtilisa 65000 
b Neurospora crassa- 72000 
Micrococcus luteus 72000 
Fe-S protein Reference 
M 
r 
27000±5% Davis and Hatefi 
(1971) 
25000 Hederstedt and 
Rutberg (1981) 
28000 Hederstedt, 
Holmgren and 
Rutberg (1979) 
28000 Weiss and Kolb 
(1979) 
30000 Crowe and Owen 
(1983) 
a this preparation also contains a 19000-dalton polypeptide. 
b also contains a cytochrome b subunit (M probably 14000). 
r 
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Complex I (NADH:ubiquinone Oxidoreductase) 
In mammalian mitochondria, the respiratory NADH dehydrogenase 
(complex I) is believed to catalyze electron transfer from NADH to 
the endogenous ubiquinone-10. The primary dehydrogenase is not 
believed to catalyze electron transfer directly from NADH to 
ubiquinone-10 but a numbe~ of iron-sulphur proteins are thought to 
act as intermediate electron carriers (Hatefi and Stiggall, 1976; 
Ragan , 1976a ; Beinert and Albracht , 1982) . 
Complex I contains 1 mole of FMN , 3 moles of ubiquinone-10, 
16-18 g-atoms of iron, and 16-18 moles of acid-labile sulphide per 
6 . 5-7 x 10 5 g protein (or 8- 8.5 x 105 g protein plus lipid) (Hatefi, 
1976 ). 
Complex I catalyzes the reduction of ubiquinone-1 by NADH at a 
r a te of 27 . 6 µmoles min- 1mg - l protein at 38°c (Hatefi, Haavik and 
Griffiths , 1962) with a Km ( ubiquinone-1 as acceptor) of 44 µM 
( Ragan, 1976 a ). 
There h a s not been exact agreement on the number of polypeptides 
present in isolated preparations of complex I. One report claimed at 
l east 1 7 peptides were present , whereas another suggested the 
presence of at least 26 polypeptides (Hatefi, Galante, Stiggall and 
Ragan , 1979 ; Ragan , 1976b ; Heron, Smith and Ragan, 1979). Also, a 
number of polypeptides have been reported to occur in stoichiometric 
molar proportions (Ragan , 1976b) . However, the number of these 
proteins actively involved in the oxidation of NADH by ubiquinone and 
the coupling of this process to the translocation of protons across 
the membrane is unknown . 
The iron-sulphur protein isolated from complex I appears to be 
composed of three polypeptides with molecular weights of 75000, 53000 
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and 29000 (Ragan, 1976b). EPR spectrometry indicat es that complex I 
contains four to six iron-sulphur clusters (Ohnishi, 1979; Beinert 
and Albracht, 1982), however, the exact sequence of electron transfer 
from NADH to ubiquinone via flavin and iron-sulphur centres is 
unre solved (see Figure 1-4). 
Complex I has been successfully reconstituted into phospholipid 
vesicles by the cholate dialysis procedure (Ragan and Hinkle, 1975). 
Oxidation of NADH by ubiquinone-1 catalyzed by the reconstituted 
vesicles was coupled to proton translocation (ibid.). 
Preparations of NADH dehydrogenase from mammalian mitochondria 
may be divided into three types: (a) NADH:ubiquinone oxidoreductase 
or complex I of the electron transport system, (b) the high molecular 
weight (type I) NADH dehydrogenase, and (c) the low molecular weight 
(type II) NADH dehydrogenase (Hatefi and Stiggall, 1976). 
The type I NADH dehydrogenase (molecular weight -800000) can be 
purified by snake venom phospholipase A digestion of complex I 
followed by (NH4)2S04 fractionation (Ringler, Minakami and Singer, 
1963). Complex I and the type I NADH dehydrogenase, exemplified by 
the preparation of Ringler et al. (1963), differ primarily in that 
the latter preparation lacks phospholipid and endogenous ubiquinone 
and does not catalyze the rotenone-sensitive reduction of exogenous 
ubiquinone-1. However , the enzyme catalyzes the oxidation of NADH at 
a very high rate of 355 µmole min-lmg-1 protein at 30°C, with 
ferricyanide as acceptor (Ringler et al., 1963) . 
--
Degradation of the type I NADH dehydrog e nase by a wide variety 
of treatments causes loss of the original activities and the 
emergence of new ones, in particular, rotenone-insensitive 
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NADH:ubiquinone oxidoreductase (Ragan, 1976a). This process is 
associated with the fragmentation of the dehydrogenase into a low-
molecular-weight form (type II NADH dehydrogenase). This process can 
be achieved by treatment of the type I dehydrogenase with heat, acid 
and ethanol (Watari, Kearney and Singer, 1963) or with heat alone, 
with proteolytic enzymes or with urea (Cremona, Kearney , 
Villavicencio and Singer, 1963). It was found by Singer and his 
colleagues that the products isolated after the above mentioned 
treatments were surprisingly similar (Cremona et al., 1963). 
A type II NADH dehydrogenase has been isolated in purified, 
soluble form after resolution of complex I by chaotropic agents 
(Hatefi and Stempel, 1969; Hatefi, Stempel and Hanstein, 1969). The 
enzyme preparation is water soluble and has a molecular weight of 
69000 ± 1000 (Galante and Hatefi, 1979). It is an iron-sulphur 
flavoprotein composed of three subunits with apparent Mr values of 
51000, 24000 and 9-10000. The amino acid compositions of each of the 
isolated and purified subunits has been determined (ibid.). This 
preparation, in contrast to the isolated type I dehydrogenase which 
lacks ubiquinone-1 reductase activity, catalyzes the reduction of 
ubiquinone-1 by NADH at high rates (175 µmole NADH oxidized min-lmg-1 
protein at 38°C; Hatefi and Stempel, 1969). However, unlike the 
ubiquinone-1 reductase activity of complex I, the type II 
dehydrogenase ubiquinone-1 reductase activity is not as readily 
inhibited by rotenone, piericidin or seconal (Hatefi et al., 1969). 
Also, although the ubiquinone-1 reductase activity of complex I is 
inhibited by guanidine, the ubiquinone-1 reductase activity of the 
type II NADH dehydrogenase preparation is activated by guanidine 
(ibid.). 
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Consequently, the high ubiquinone reductase activity of the type 
II dehydrogenase preparation has been considered by some authors to 
be largely artifactual (for discussion see: Singer and Gutman, 1971; 
Ragan, 1976a; Hatefi and Stiggall, 1976). 
The controversies in the literature concerning the complex I-
derived NADH dehydrogenases (types I and II) illustrate the 
difficulties that can be encountered in the biochemical 
characterization of membrane-bound enzyme complexes. Recombinant DNA 
methods have yet to be applied to the study of the mitochondrial 
respiratory complexes. 
The recombinant DNA approach is more readily applied to those 
mitochondrial proteins encoded in the mitochondrial genome and the 
recent determination of the complete DNA sequence of the human and 
bovine mitochondrial genomes has provided a great deal of new 
information concerning this interesting energy transducing system 
(Anderson, Bankier, Barrell , de Bruijn, Coulson, Drouin, Eperon, 
Nierlich , Roe, Sanger, Schreier, Smith, Staden and Young, 1981; 
Anderson, de Bruijn , Coulson, Eperon, Sanger and Young, 1982). 
These methods have great potential and have been successfully 
utilized in some studies of the E . coli respiratory chain where the 
availability of mutants provides significant advantages. 
Bacterial Membrane-Bound NADH Dehydrogenases 
A number of bacterial membrane-bound NADH dehydrogenases have 
been purified (Table 1-3) . Only membrane-bound enzymes that are 
specific for NADH oxidation and are capable of reducing ubiquinones 
or artificial electron acceptors are included in the table. Often 
the purities of the various preparations were not given. 
Table 1-3 . Properties of Bacterial Membrane-Bound NADH Dehydrogenases 
Organism 
Escherichia coli 
Acholeplasma laidlawiiE_ 
Halophilic bacterium 
AR-1 
Photobacterium phosphoreum 
(marine bacterium) 
Bacillus stearothermophilus 
(thermophilic bacterium) 
Peptostreptococcus elsdenii 
Micrococcus lysodeikticus 
Bacillus caldotenax 
(thermophilic bacterium 
Bacillus subtilis 
Apparent 
Mol Wt 
47000 
C 
nd-
64000 
nd 
43000 
Two 
nonidentical 
subunits of 
41000 and 
33000 
lL10000 
(dimer of 
7CJOOO) 
44000 
63000 
Prosthetic 
Group 
FAD 
nd 
FAD 
FAD 
FMN 
FA~ 
FAD 
FAD 
FAD 
Specific 
Activity 
500-60~ 
23 . 2E_ 
376i 
24 . 2f 
94 . o£ 
19 . 6l 
nd 
243a 
24.7k 
Acceptor 
Ubiquinone-1 
3-Fe(CN)6 
DCIP~ 
3-Fe(CN)6 
DCIP 
DCIP 
DCIP 
DCIP 
3-(4' ,5'-dimethyl 
-thiazol-2-yl) 
-2,4-diphenyl 
tetrazolium bromide 
Reference 
Jaworowski, Campbell, 
Paulis and Young (1 981a) ; 
Jaworowski, Mayo, Shaw, 
Campbell and Young (1981b) 
Jinks and Matz (1976) 
Hockstein and Dalton (1973) 
Imagawa and Nakamura (1978) 
Mains, Power, Thomas and 
Buswell (19 80) 
Whitfield and Mayhew (1974) 
Zhukova, Kharat'yan and 
Ostrovskii (1979) 
Kawada, Takeda and Nosuh 
(1981) 
Bergsma, Van Dongen and 
Konings (1982) 
Table 1-3 . (continued) 
Organism 
Acinetobacter calcoaceticus 
Alkalophilic Bacillus 
Rhodospirillum rubrum 
(phototrophic bacterium) 
Rhodopseudomonas capsulata 
(phototrophic bacterium) 
Apparent 
Mol Wt 
34000 
Two 
identical 
subunits 
of 65000 
26000 
97000±5000 
(composed 
of six 
identical 
subunits, 
15500 
each) 
Prosthetic 
Group 
FMN 
FAD 
FMN 
nd 
µmoles NADH oxidized min-l mg-l protein at 30°C. 
Organism contains no quinones or cytochromes. 
nd = not determined. 
µmoles DCIP reduced min-1 mg-1 protein at 30°C. 
DCIP = 2,6-dichlorophenolindophenol. 
µmoles Fe(CN)i- reduced min-1 mg-1 at 25°C. 
Same as ford but at 55°C. 
Same as for a but at 37°C. 
Specific 
Activity 
0 . 43d 
74 .3i 
49 . 8 
15 . 4 
Acceptor 
DCIP 
DCIP 
Dcrpl 
DCIP 
Reference 
Borneleit and Kleber (1983) 
Hisae, Aizawa, Koyama, 
Sekiguchi and Nosoh (1983) 
Horio, Bartsch, Kakuno and 
Kamen (1969) 
Ohshima and Drews (1981) 
a 
b 
C 
d 
e 
f 
_g_ 
h 
i This unusual enzyme preparationhas 1 FAD associated with each subunit. However, the isolated protein contains 
v a rious amounts of modified flavins. 
_l_ 
k 
1 
Specific activity is defined as absorbance change of 1 min-1 mg-1 protein at A600 and 25 ° C. 
µmoles 3-(4'-5'-dimethyl-thiazol-2-yl) 2,4-diphenyltetrazolium bromide reduced min-1 mg-1 protein at 37 ° C. 
µmoles DCIP r e duced min-1 A2 80-l 
14. 
According to a maJor review of the distribution of isoprenoid 
quinone structural types in bacterial taxa (Collins and Jones, 1981) 
most of the organisms listed in Table 1-3 possess either menaquinone 
and/or ubiquinone . The exceptions are A. laidlawii which does not 
possess quinones and R_. elsdenii for which information is lacking. 
One uncertainty about the enzymes listed in Table 1-3 (except for the 
!· coli enzyme) is that although they are all membrane bound NADH 
dehydrogenases, the activities of the enzyme preparations towards 
their physiological quinone acceptor have not been determined. 
Furthermore, no other evidence is provided to prove their direct 
involvement in respiration. 
Some of the enzymes presented in Table 1-3 differ markedly in 
their subunit molecular weights which would be likely to preclude any 
close evolutionary relatedness (eg Mr 47000 for the E . coli enzyme 
versus Mr 15500 for the R. capsulata enzyme). This is not 
unexpected since a number of the enzymes in Table 1-3 have been 
purified from widely different bacterial taxa. Nonetheless, the fact 
that the respiratory succinate dehydrogenase isolated from such 
phylogenetically distant sources as beef heart mitochondria, N. 
crassa mitochondria, R. rubrum, B. subtilis and M. luteus show 
similar subunit compositions would suggest that at least some 
components of the respiratory chain have been conserved in their 
evolution . 
Eleven of the respiratory-chain-linked NADH dehydrogenases 
listed in Table 1-3 have been shown to contain or at least be 
activated by flavin (FAD or FMN). It will be interesting to observe, 
when sequence data becomes available, whether these flavoproteins 
possess a conserved flavin binding domain as has been shown for the 
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fumarate reductase of E.coli and the succinate dehydrogenas e from 
beef heart mitochondria (Cole, 1982). 
The Respiratory NADH Dehydrogenase of E.coli 
There have been a number of attempts to purify the respiratory 
NADH dehydrogenase of!· ·coli. Early reports of purification 
attempts includes those of Wosilait and Nason (1954), Bragg (1965), 
Bragg and Hou (1967a,b), and Gutman, Schejter and Avi-dor (1968). In 
these early reports the purity of the various preparations were not 
ascertained. Furthermore, the activities of the preparations with 
natural quinones, rather than artificial electron acceptors, were not 
cited. Also, frequently the isolated preparations differed markedly 
in their response to inhibitors from the NADH dehydrogenase of intact 
membrane vesicles. 
The NADH dehydrogenase of the E.coli respiratory chain has been 
identified (Dancey, Levine and Shapiro, 1976) by the following 
properties: (a) its location in membrane vesicles, (b) its 
inhibition by AMP in a fashion similar to that of the NADH oxidase, 
(c) its specificity for NADH, but not NADPH, with the same~ for 
NADH as that of the NADH oxidase (SO µMand 33 µM, respectively), and 
(d) its sensitivity to inhibition by HQNO, dicoumarol and rotenone 
which are also inhibitors of the NADH oxidase. The NADH 
dehydrogenase of the cytosol fraction (assayed as NADH:DCIP 
oxidoreductase activity) differs substantially from the membrane-
bound activity both in substrate specificity and in the inhibitors of 
the reaction (Dancey et. al., 1976) . 
Dancey, Levine and Shapiro (1976) reported the isolation of the 
respiratory NADH dehydrogenase by solubilization of membrane vesicles 
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with Triton X-100 followed by chromatography on DEAE-cellulose, 
precipitation by 30% ethanol, and chromatography on hydroxylapatite 
and DEAE-agarose. The preparation was shown to catalyze the 
3-
reduction of Fe(CN) 6 , DCIP and menadione. However, activity with 
natural ubiquinone homologues was not reported. Also, the specific 
activity with DCIP as electron acceptor was very low (0.32 µmole DCIP 
reduced min- 1mg- 1 protein) . It is noteworthy that although HQNO (at 
10 µM concentration) inhibits the respiratory NADH dehydrogenase it 
is ineffective as an inhibitor of the NADH:DCIP oxidoreductase 
isolated by Dancey et. al . (1976). 
Electrophoresis on SDS-polyacrylamide gels showed one band of 
mol wt 38000 which in the best preparations accounted for 75% of the 
protein on the gel (ibid . ). 
Dancey and Shapiro (1976) characterized the 38000 mol wt 
preparation further and demonstrated that the enzyme contains no 
flavin but has an absolute requirement for added flavin for activity. 
An antibody preparation elicited against the purified enzyme was 
demonstrated to be effective as an inhibitor of the membrane-bound 
NADH dehydrogenase and the NADH oxidase activities (ibid.). This 
antibody preparation produced two major precipitates when used to 
examine solubilized membrane preparations . 
Thompson and Shapiro (1981) purified an NADH:ubiquinone 
oxidoreductase from Triton X-100 solubilized E.coli membranes. The 
enzyme was purified 100-fold after solubilization by chromatography 
on AMP-Sepharose, DEAE-Sephacel and Bio-GelA-1.SM 1n Triton X-100 
containing buffers . The described NADH:ubiquinone oxidoreductase has 
an Mr of 46000 as determined by SDS-polyacrylamide gel 
electrophoresis. However, a protein of Mr 37000 was present 1n 
every preparation and sometimes appeared as a doublet. 
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Thompson and Shapiro (1981) concluded from atomic absorption 
spectroscopy data that there is about 1 mole of Fe/46000 daltons of 
protein. However, only small amounts of quinone reductase were used 
in these measurements (5 µg mL-1). 
The purification protocol developed by Thompson and Shapiro 
(1981) gave a low yield of 0.32 mg purified enzyme from 300 g wet 
weight of cells. Nonetheless, this enzyme preparation was active 
with ubiquinone-3, DCIP and Fe(CN)~- as electron acceptors. The 
specific activity with ubiquinone-3 as acceptor was 50 µmole of NADH 
oxidized min-lmg-1 protein with a calculated apparent~ of 40 µM. 
Thompson and Shapiro (1981) showed that antiserum prepared 
against the purified NADH:DCIP oxidoreductase (Dancey and Shapiro, 
1976) inhibits the NADH oxidase activity of the intact membranes as 
well as the purified NADH:ubiquinone oxidoreductase. Furthermore, 
the antiserum immunoprecipitated both the Mr 46000 polypeptide and 
the Mr 37000 polypeptide that is present in all preparations at 5-
30% of the amount of Mr 46000. As pointed out by Thompson and 
Shapiro (1981), one explanation for the antigenic cross-reactivity of 
the Mr 46000 and the Mr 37000 polypeptides is that the smaller 
may be a proteolytic cleavage product of the larger . However, 
although the data was not shown, Thompson and Shapiro (1981) stated 
that the two polypeptides produce distinct peptide patterns when 
digested with either Staphylococcus aureus VS protease or trypsin. 
They concluded that it is unlikely that one protein is a cleavage 
product of the other. 
Young and Wallace (1976) isolated a strain of E . coli carrying a 
point mutation affecting the respiratory NADH dehydrogenase complex . 
The evidence for the genetic lesion in this strain (AN589; Hfr; metB 
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ndh-401) being in the respiratory NADH dehydrogenase complex 
includes: (a) electron transport to oxygen from succinate and D-
lactate is not impaired whereas the NADH oxidase is (2% of wild type 
levels, (b) comparison of the quinone levels of AN589 and a wild-type 
strain indicate that the ndh strain is not affected in the synthesis 
of ubiquinone or menaquinone, and (c) the kinetics of reduction of 
cytochrome b with NADH as substrate are consistent with the lesion in 
the electron transport system of the ndh strain being prior to 
cytochrome b. 
The phenotype used for scoring strains lacking NADH oxidase in 
genetic experiments is growth on glucose plus succinate but not on 
mannitol as sole carbon source. The inability to grow with mannitol 
as sole carbon source may be because the conversion of mannitol-1-
phosphate to fructose-6-phosphate generates one molecule of NADH 
which is not reoxidized in the subsequent metabolism of fructose to 
lactate and which is presumably oxidized via NADH oxidase in the wild 
type cell (Young and Wallace, 1976). 
The gene coding for the respiratory NADH dehydrogenase of E. 
coli has been cloned (Young, Jaworowski and Poulis, 1978). Young et 
al. (1978) used the restriction endonuclease EcoRI to cleave a 
preparation of the E.coli chromosomal DNA and the fragments produced 
were ligated into EcoRI digested pSF2124 (So, Gill and Falkow, 1975). 
The ligated hybrid plasmids were transformed into an F+ derivative of 
strain C600. Transformed cells were selected by growth in medium 
containing ampicillin. These cells were grown in the presence of the 
recipient IY12 (F-, ndh rpsL) and the hybrid plasmids were 
transferred by F-mobilization (Young et al., 1978). The cells were 
then selected for the complementation of ndh (growth on mannitol; 
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Young and Wallace, 1976) . Young et al. (1978) isolated a strain 
(IY35) which possesses the hybrid plasmid pIYl carrying the ndh gene. 
Electrophoresis of the EcoRI digested pIYl on an agarose gel 
indicated that it carries a 1.6 Mdal (~2.5 kb) DNA fragment which 
possesses the ndh gene . Cells containing the plasmid are found to 
possess 8-10 times the normal level of NADH:ubiquinone oxidoreductase 
in their membranes. Moreover, when the cells were treated with 
chloramphenicol to increase the plasmid copy number, the level of 
NADH dehydrogenase 1n the membrane can be increased to 50-60 times 
the level in the wild type (Young et al., 1978). 
The aforementioned genetic amplification method has been 
successfully utilized 1n the purification protocol of the respiratory 
NADH dehydrogenase of E . coli reported by Jaworowski, Campbell, 
Poulis and Young (1981a). However , as well as the IY35 strain a 
newly constructed strain , IY85, was also described. IY85 carries the 
plasmid pIY9 , which i s derived fr om the vector pSF2124 and carries a 
double lac promoter inserted adjacent to the ndh fragment of pIYl 
(Jaworowski et al ., 1981a). 
--
The NADH:ubiquinone oxidoreductase was purified to homogeneity 
by hydroxylapatite chromatography following potassium cholate 
solubilization of membrane vesicles. The use of multicopy plasmid 
vectors carrying the ndh gene facilitated the genetic amplification 
of strains which enabled the enzyme to be purified 800- to 1000-fold 
relative to the activity in wild-type membranes. The use of a large 
scale purification procedure enables 50-100 mg of protein with a 
specific activity of 500-600 µmole of NADH oxidized rnin-lrng-1 protein 
with ubiquinone-1 as electron acceptor to be obtained . SDS-
polyacrylarnide gel electrophoresis demonstrated that the purified 
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enzyme consists of a single polypeptide with a reported Mr of 47000 
(Jaworowski et al . , 198la,b). 
The purification protocol developed by Jaworowski et al . 
(1981a) produces a similar preparation to that reported by Thompson 
and Shapiro (1981) , although it gives considerably greater quantities 
of enzyme . The purified ADH : ubiquinone oxidoreductase has been 
further characterized by Jaworowski, Mayo , Shaw, Campbell and Young 
(1981b) . They showed that the enzyme preparation contains 70% (w/w) 
lipid , predominantly phosphatidylethanolamine and one mole of 
noncovalently bound FAD/mole of enzyme subunit. Interestingly, 
Jaworowski et al. (1981b) repo r ted that the concentrated pure enzyme 
had 0 . 13 mole of Fe/mole of enzyme subun i t, contradicting the 1:1 
stoichiometry cited by Thompson and Shapiro (1981) . More recently 
Campbell (unpublished) examined the metal content of the pure enzyme 
and demonstrated by ne utron activation analysis the absence of 35 
tr ace elements including Fe , Se , Zn , Mn , Co , Wand Cu . 
The purified enzyme has also been demonstrated to reconstitute 
NADH oxidase activity when added to membrane vesicles prepared from 
ndh st r ains (Jaworowski et al ., 1981b) . 
The genetic methods utilized by Young et al . (1978) and 
Jaworowski et al . (1981a) offer several important advantages over the 
more traditional biochemical approaches used by their predecessors. 
Firstly, the genetic cloning and amplification of a gene encoding a 
membrane protein, present as a minor component of the inner membrane, 
allows high - yield purification methods to be devised. Secondly, the 
cloning of the gene provides the opportunity for the rapid 
determination of the DA sequence . This is in contrast to 
traditional protein sequencing methods which can encounter 
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difficulties with regards to membrane proteins. Thirdly, the 
sequence of the structural gene can potentially lead to the discovery 
of hitherto unknown genetic mechanisms (for example, the extreme 
economy of the genes and atypical codon usage in the human 
mitochondrial genome; Anderson et al . , 1981) . 
Research Presented in this Thesis 
The work described in this thesis is part of a multidisciplinary 
approach to the isolation and molecular characterization of the 
respiratory NADH dehydrogenase of E . coli. Chapter 2 describes the 
determination and analysis of the DNA sequence of the structural gene 
coding for this enzyme. This work led to the identification of UUG 
as an initiation codon. The DNA sequencing work also yielded the 
complete amino acid sequence of the protein and showed that no signal 
peptide was present. Comparative sequence analysis enabled two 
nucleotide binding sites to be identified and demonstrated 
significant homology between the! · coli enzyme and human glutathione 
reductase . Detailed comparisons with the latter enzyme suggested 
similar domain structure for the FAD and NADH domains of the NADH 
dehydrogenase and human glutathione reductase. The remainder of the 
thesis concerns different aspects of the membrane biology of the NADH 
dehydrogenase . This difficult area represents the major gap in the 
characterization of this enzyme. Most of the approaches were carried 
out with the ultimate goal of correlating the observed biological 
properties with features of the amino acid sequence. In Chapter 3, 
evidence is provided to demonstrate that the membrane bound 
respiratory coenzyme ubiquinone-8 is the physiological electron 
acceptor for the NADH dehydrogenase in vivo . Chapter 4 des cribes 
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experiments on the reconstitution of the NADH dehydrogenase into 
natural and artificial membranes and also attempts to define the 
membrane sector(s) of the enzyme by limited proteolysis. The use of 
photoaffinity labelling to study the ubiquinone binding site is 
described in Chapter 5 . In Chapter 6 the partial DNA sequence for 
the respiratory D- lactate dehydrogenase of E.coli is described. 
This membrane bound enzyme also appears to use ubiquinone-8 as an 
electron acceptor in vivo . Although time did not permit the 
completion of this sequence it is anticipated that future comparison 
of the sequences of the two enzymes could yield interesting 
information concerning membrane interactions and ubiquinone 
cata l ysis . 
Chapter 2 
Nucleotide Sequence Coding for the ..Ncth Gene 
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INTRODUCTION 
Rapid DNA Sequencing Methods 
Over the last five years there has been dramatic progress in the 
development of methods used to determine primary nucleotide sequences 
(for reviews see: Wu, 1978; Sanger, 1981; Gilbert, 1981; Davies, 
1982). This introduction confines itself to a discussion of the 
chain termination method since this method is used in the work 
described in this Chapter . 
Sanger, Nicklen and Coulson (1977), in a pioneering work, 
described a method of DNA sequencing with chain-terminating 
inhibitors. The principle of this method is briefly described below. 
A primer and template are incubated with DNA polymerase in the 
presence of a mixture of deoxynucleoside triphosphates (dATP, dGTP, 
dCTP and dTTP), one of which has a radioactive [a-32p] phosphate, 
allowing the newly synthesized DNA to be labelled. In each of the 
four dNTP reaction mixes a 2' ,3'-dideoxynucleoside triphosphate 
(ddATP, ddGTP , ddCTP or ddTTP) is also added. Because the ddNTPs 
contain no ]'-hydroxyl group, the chain cannot be extended further, 
so that termination occurs at positions where the ddNTPs are 
incorporated. The relative concentrations of dNTPs and ddNTPs are 
adjusted so that only a partial incorporation of the dideoxy analogue 
occurs at each possible site . Thus, by adding one of the dideoxy 
analogues to each of four separate incubations, four different groups 
of fragments ending at a particular base are produced. The other end 
of all fragments is identical, so that parallel size fractionation of 
the denatured fragments by analytical polyacrylamide gel 
electrophoresis allows the sequence to be deduced. Sanger et al. 
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(1977) also described the use of another chain-terminating analogue, 
the arabinonucleosides. Subsequently, this analogue has not be e n as 
extensively used as the dideoxynucleotides and hence it will not be 
discussed further. 
In the publications by Sanger et al. (1977) and Sanger and 
Coulson (1978) the primer~ used in the sequencing reactions were 
purified restriction fragments from the double stranded replicative 
form of 0Xl74. The template used was single-stranded 0Xl74 DNA 
(ibid.). Since most DNA's are not readily available in a single-
stranded form this approach was not widely applicable and methods 
such as the exonuclease method of Smith (1979) were developed to 
generate single stranded templates. 
A major advance in sequencing methodology came as a direct 
result of the construction of an Ml3 cloning vehicle (designated 
Ml3mpl) by Messing, Gronenborn, Mliller-Hill and Hofschneider 
(1977). Messing et al. (1977) inserted into a nonessential region of 
Ml3 a Hindll restriction fragment comprising the E.coli lac 
regulatory region and the genetic information for the a peptide of S-
galactosidase. Gronenborn and Messing (1978) modified the previously 
described Ml3mpl by introducing by mutagenesis a unique EcoRI site 
into the lac region (the new derivative was designated Ml3mp2) . They 
also confirmed that insertion of EcoRI fragments into Ml3mp2 leads to 
the inactivation of the a-complementation by the vector. 
The use of the Ml3 derivatives described by Messing et al. 
(1977) and Gronenborn and Messing (1978) offered several maJor 
advantages over other vectors of that time. These advantages 
include: (a) upon infection, phage DNA is converted into a double 
stranded supercoiled replicative form (RF) and amplified to about 
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300 copies per cell, and the phage-producing cells do not l y z e but 
continue to replicate, (b) because bacterial growth is sli ghtly 
retarded by infection, infected bacteria can be detected by 'turbid-
plaque' formation and no selective pr e ssure (eg drug resistance 
factors) would be necessary to detect bacteria transfected by Ml3 
DNA, and (c) insertion of DNA fragments at the unique EcoRI site 
results in a decrease in a-complementation allowing the 
identification of recombinant stages in an appropriate host on 
indicator plates (Messing et al., 1977; Gronenborn and Messing, 
1978). 
The single stranded Ml3mp2 proved to be suitable for use as a 
template in the Sanger chain-terminating sequence procedure (Schreier 
and Cortese, 1979; Sanger, Coulson, Barrell, Smith and Roe, 1980; 
Heidecker, Messing and Gronenborn, 1980). Sanger et al. (1980) and 
Heidecker et al. (1980) produced a major change in strategy in that 
the same primer is used on different templates, whereas in the 
previously reported dideoxy method (Sanger et al., 1977) different 
primers were used on one template. This approach is based on the 
cloning of small fragments of DNA into Ml3mp2 using a linker 
oligonucleotide. A specific primer which hybridizes close to the 
insertion site is used to determine the nucleotide sequence of each 
inserted fragment (Sanger et al., 1980). 
A number of specific primers have been described which hybridize 
to the S-galactosidase gene flanking the EcoRI site of Ml3mp2. 
Schreier and Cortese (1979) described the use of a 96 bp EcoRI 
restriction fragment which hybridized to the DNA sequence 
corresponding to amino acid 7 to 35 of the S-galactosidase gene. 
Heidecker et al. (1980) described the use of a similar primer 
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(EcoRI/Alul restriction fragment) which extended from bp 13 to 1 06 o f 
the lacZ gene. However, the disadvantage of both of th es e prime r s is 
their excessive length, approximately four times longer than is 
necessary for a stable specific interaction with the template. 
Hence, a shorter primer, a 26 bp EcoRI/BamHI fragment was synthe s ize d 
and cloned (Anderson, Gait, Mayol and Young, 1980). 
The development of methods for the rapid synthesis of 
oligodeoxyribonucleotides has enabled specific, single-stranded, 
heptadecamers to be synthesized and used as primers in the Ml3mp2 (or 
its derivatives) DNA sequencing system (Duckworth, Gait, Goelet, 
Hong, Singh and Titmas, 1981). Subsequently, several 
oligodeoxyribonucleotide primers have become commercially available 
and they will not be discussed further here. The ability to 
synthesize specific single stranded primers should, in theory, allow 
DNA sequencing of fragments cloned into normal plasmid vectors and 
several reports have been published recently demonstrating the 
validity of this approach (Wallace, Johnson, Suggs, Miyoshi, Bhatt 
and Itakura, 1981; Vieira and Messing, 1982). 
A series of different derivatives of Ml3mp2 (Gronenborn and 
Messing, 1978) have been produced by the introduction of new cloning 
sites by the insertion of synthetic DNA into the S-galactosidase 
gene. The most notable derivatives include: Ml3mp5 (Messing, 1979), 
Ml3mp7 (Messing, Crea and Seeburg, 1981), and Ml3mp8 and Ml3mp9 
(Messing and Vieira, 1982). 
The development of the Ml3mp2 derivatives with a multipurpose 
cloning site has led to the use of the 'shotgun' system of DNA 
sequencing (Messing et al., 1981). Hence, large quantities of DNA 
can be cleaved with an assortment of restriction endonucleases 
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(single or double digests) and the DNA cloned into Ml3mp7, 8 or 9. 
Sanger and his coworkers, in a major achievement, used a n assortme nt 
of methods, including the 'shot~un' 
0 system, to determine the compl e te 
nucleotide sequence of bacteriophage A (48502 bp; Sanger, Coulson, 
Hong, Hill and Petersen, 1982). 
Essential to the execution of the 'shotgun' random sequencing 
method is the application of computer programs suited to handle DNA 
sequence data. Numerous computer programs have been reported which 
have been specifically designed for storage, editing and analysis of 
both DNA and amino acid sequences (see Nucleic Acids Research Vol 
10). In this laboratory the 'DNA programs' written by Roger Staden 
have been used (PDP FORTRAN PDP 11/45, Staden, 1977;1978;1979;1980; 
programs in FORTRAN 77 (VAX 11/780), Staden, 1982). 
This Chapter describes the determination of the nucleotide 
sequence of the gene coding for the respiratory NADH dehydrogenase of 
E.coli by the chain termination method. 
MATERIALS AND METHODS 
All chemicals used were of the highest purity commercially 
available. 
5-Bromo-4-chloro-3-indolyl-S-D-galactopyranoside (X-gal) was 
stored at 20°C as a 40 mg rnL-1 stock solution in demethylforrnamide. 
Deoxythymidine-5'-triphosphate, sodium salt (and other 
deoxynucleotides, dNTPs) were obtained from Boehringer Mannheim 
GmbH, and stored at -20°c as 20 mM stock solutions in 10 mM Tris 
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HCl, 0.1 mM EDTA, pH 7.5 buffer (T 10 E0 . 1 , pH 7.5). 2' ,3'-
Dideoxythymidine-5'-triphosphate, sodium salt (and other 
dideoxynucleotides, ddNTPs) were obtained from P-L Biochemicals 
(Milwaukee, Wis) . 
Restriction endonucleases were supplied by New England, Biolabs, 
Inc. DNA polymerase (enzyme A according to Klenow) was obtained from 
Bohringer Mannheim GmbH (Klenow, Overgaard-Hansen and Patkar, 1971). 
Deoxyadenosine-5'-[a-3 2p] triphosphate, triethylammonium salt 
([a-3 2P]dATP) was provided by The Radiochemical Centre, Amersham, 
England. The specific activity of the [a- 32 P]dATP was 2000-3000 Ci/rn 
mole (-74-111 TBq/m mole) and its radioactive concentration was 
1 mCi/mL (37 MBq/mL). 
Bacterial Strains and Plasmids 
Young, Jaworowski and Poulis (1978) described the construction 
of a plasmid, pIYl, which contains a 1.6 Mdal (-2.5 kb) fragment 
inserted into the EcoRI site of the cloning vector pSF2124 (So, Gill 
and Falkow, 1975). The 1.6 Mdal insert contained the ndh structural 
gene which was obtained from an EcoRI digest of the chromosomal DNA 
of the E.coli Kl2 strain AN595 (thi his ilv trp rpsL) (Young and 
--------
Wallace, 1976). E. coli Kl2 71-18 (6[lac, pro], F'lac IqZ6Ml5 
-- --
pro+) was used as a host for Ml3 (Messing et al., 1977; Gronenborn 
and Messing, 1978). The single stranded phage vectors Ml3mp2 
(Gronenborn and Messing, 1978; Sanger et al., 1980) and Ml3mWJ22 
(Rothstein, Lall, Bahl, Narang and Wu, 1980) were used as cloning 
vectors. 
Strain IY35, derived from IY12 (thi his ilv trp rpsL ndh) (Young 
and Wallace, 1976), which possesses the hybrid plasmid pIYl carrying 
ndh was used for the isolation of plasmid DNA . For the isolation 
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of plasmid DNA 1 L cultures were grown in glucose-minimal salts 
medium (Stroobant, Young and Gibson, 1972) containing 0.5 % (w/v) 
casamino acids and the plasmid DNA was amplified using 
chloramphenicol (Clewell, 1972). The cells were harvested a nd a 
cleared lysate prepared according to the method of Clewell and 
Helinski (1969) except that 0.3% w/v Triton X-100 was used inst e ad of 
brij and deoxycholate. The DNA was purified using a CsCl-ethidium 
bromide density gradient (Clewell, 1972), the ethidium bromide 
removed by isopropanol extraction and the DNA dialyzed against (2 mM 
Tris HCl, 2 mM EDTA, 1 mM NaCl, pH 8.0). 
Transfection of Strain 71-18 with Ml3mp2 DNA 
Strain 71-18 cells were grown at 37°c in 20 mL YT medium (5 g 
yeast extract, 8 g tryptone, 5 g NaCl in 1 L) to a Klett reading of 
140 (Klett-Summerson colorimeter). The cells were harvested by low 
speed bench centrifugation for 5 minutes. The cells were resuspended 
in the same volume of 50 mM CaC1 2 (prechilled on ice) and mixed 
gently. The cells were pelleted and resuspended in 10 mL of 50 mM 
CaC1 2 , mixed gently and held on ice for 15 minutes. The cells were 
pelleted and then resuspended to 1 mL volume in 50 mM CaC1
2
. 
Transfection DNA (eg ligation mixture), about 10 ng per 200 µL of 
cell suspension, was added to the cell mix. The cells were held on 
ice for 30 minutes. The cells were then placed at 42°C for 3 
minutes and then added to a soft agar overlay preparation containing 
isopropyl-B-D-thio-galactopyranoside (IPTG) and X-gal. 
Titration of Ml3mp2: Detection of Recombinant Plaques 
3 mL of 0.7% agar in YT medium was autoclaved and cooled to 
42°c. 20 µL of X-gal stock solution (40 mg mL- 1 in 
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demethylformamide) and 20 µL of IPTG stock solution (20 mg mL- 1 ) were 
added. The agar was mixed and then 200 µL of Ml3mp2 transfected 
71-18 cells was added and mixed and the soft agar quickly poured onto 
a pre-warmed (37°C) YT plate. The plates were incubated for 24 
hours at 37°c. 
Strain 71-18, in which the entire lac operon is deleted, 
harbours an F episome which carries a deletion in the operator 
proximal region of the S-galactosidase gene (Messing et al., 1977; 
Gronenborn and Messing, 1978). Ml3mp2 has a HindII insert which 
codes for the lac regulatory region and the base sequence for the 
first 145 amino acids of the S-galactosidase (ibid.). It has been 
shown that the peptide produced by this fragment complements the 
episome encoded protein and consequently, strain 71-18 cells that are 
infected with Ml3mp2 can be detected by their blue colour on IPTG/X-
gal indicator plates (ibid.). Furthermore, the insertion of cloned 
DNA into the cloning site of Ml3mp2 leads to a loss of the a-
complementation and therefore the plaques produced are white (Sanger 
et al., 1980). 
--
Restriction Endonuclease Digestion of DNA 
Ten times concentration stock solutions (sterile) of restriction 
endonuclease buffers were prepared. The compositions of the buffers 
was as outlined for the assay conditions in the New England, Biolabs, 
Inc. chemical catalogue. One tenth volume of stock solution was 
added to the DNA solution and restriction endonuclease was added to 
give a ratio of -0.5 units enzyme per 1 µg DNA (one unit is defined 
as the amount of enzyme required to produce a complete digest of 1.0 
µg of A DNA in 60 minutes in a volume of 0.05 mL). The restriction 
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endonuclease reaction mix was routinely incubated at 37°C (or 
67°C in the case of Taql) for 1 hour. 
Preparation of Single Stranded Ml3mp2 Template 
cells were 
Ml3mp2 plaques were picked from an agar-overlay plate and~grown 
to stationary phase at 37°C in 1.5 mL of twice strength YT medium. 
The cells were placed into 1.5 mL capped Eppendorf tubes and 
centrifuged for 5 minutes. 0.8 mL of the supernatants was removed 
and placed into a tube containing 200 µL of buffer (2.5 M NaCl, 20% 
(w/v) polyethylene glycol 6000). This solution was thoroughly mixed 
and left at room temperature for 30 minutes. The solution was then 
centrifuged for 10 minutes in an Eppendorf centrifuge. The 
supernatant was poured out and any remaining supernatant was 
carefully removed using a drawn out capillary. A small white pellet 
was visible. The pellet was dissolved in 100 µL T10 E0 . 1 , pH 7.5. 
Neutralized phenol (50 µL) was added and the solution was vortexed 
for 10 seconds, left for 10 minutes, vortexed again and then 
centrifuged for 1 minute. The aqueous layer was removed and 
transferred to another Eppendorf tube. The phenol wa~ removed by 
three extractions with two volumes of diethyl ether. The DNA in the 
aqueous layer was ethanol precipitated by the sequential addition of 
0.1 volume of 5 M NaCl and two volumes of ethanol. The solution was 
mixed, placed in a bath of cardice-ethanol for one hour and then 
centrifuged for 10 minutes. The supernatant was removed and the tube 
dried in vacuo for 5 minutes. The dried pellet was dissolved in 50 
µL T10Eo.1, pH 7.5. Purified single stranded phage was analyzed by 
electrophoresis on a 0.8% (w/v) agarose gel and detected by staining 
with ethidium bromide as described below. 
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Analytical Agarose Gel Electrophoresis 
Electrophoresis was carried out on 3 mm thick 0 . 8% agarose gels 
using a horizontal slab gel apparatus. Gels were prepared in TEA 
buffer (40 mM Tris HCl, 1 mM EDTA, 16 mM sodium acetate; pH adjusted 
to 7.8 with glacial acetic acid). DNA samples (5 µL) were mixed with 
15 µL of sample buffer (14.5% sucrose, 0.045% bromophenol blue, 50 mM 
EDTA) and then loaded into each well by layering under 
electrophoresis buffer. The nucleic acid was subjected to 
electrophoresis at room temperature until the bromophenol blue had 
migrated to the end of the gel. The DNA bands were stained for 15 
minutes in 1 µg mL- 1 ethidium bromide and visualized with ultraviolet 
light using a transilluminator (Ultra-violet Products, San Gabriel, 
CA, USA). The gels were photographed using a Polaroid (Model 545) 
camera and film (high speed type 57). Standard size markers of A cut 
with Hindlll were included where required. 
Preparative Agarose Gel Electrophoresis: Preparation of Purified DNA 
Fragments Using Hydroxylapatite 
Pur ified pIYl (Young et al., 1978) with a concentration of ~500 
µg m1-l was digested with EcoRI restriction endonuclease. The 
digested DNA was electrophoresed and the gel stained with ethidium 
bromide. The plasmid vector (pSF2124) band and the insert band (~1.6 
Mdal) were visualized using a hand held shortwave ultraviolet lamp . 
The band containing the cloned fragment was cut out of the gel with a 
razor blade and the DNA recovered by electroelution onto 
hydroxylapatite (Bernardi, 1971). The hydroxylapatite was 
transferred to a 5 mL sterile plastic syringe. The DNA was eluted 
from the hydroxylapatite using 0 .4 M sodium phosphate, pH 7.0 buffer 
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containing 1 µg mL-1 ethidium bromide. Fractions containing DNA we re 
pooled and the ethidium bromide was removed by 5 extractions with an 
equal volume of isopropanol and the phosphate buffer removed by 
dialysis against two changes of STE buffer (2 mM Tris HCl, 2 mM EDTA, 
1 mM NaCl, pH 7.5). The DNA concentration was estimated by 
measurement of ultraviolet absorbance at 260 and 280 nm~ 
Internal primers used for sequencing the ndh gene were generated 
by restriction endonuclease digestion and purified using the same 
method as described above. 
Protocol for DNA Sequencing 
The primers used were the 26 bp EcoRI/BamHI fragment prepared 
from a double digest of pSP14 according to the procedure outlined in 
Anderson et al. (1980) and the internal primers described in the 
text. The single stranded templates were prepared from Ml3 clones as 
described in the previous sections. The sequencing procedure used is 
outlined below: 
(a) A primer/template mix was prepared for hybridization and 
was composed of: 
5 µL Ml3 template (=0.4 µg DNA) 
2 µL primer 
1 µL Hin (lOx) buffer (0.1 M Tris HCl, 0.1 M MgC1 2 , 0.5 M 
NaCl, 10 mM dithiothreitol, pH 7.5) 
2 µL sterile distilled water. 
Each component of the primer/template mix was added to a 
capillary, mixed and the capillary sealed. The capillary was then 
added to a bath of boiling water for three minutes and slowly cooled 
to 30°c. 
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(b) The capillary was opened and 2 µL aliquots of the 
primer/template were each added to four siliconized glass tubes. To 
each of the four tubes 1 µL of the following solutions was added: 
A tube; (5 µL of 0.7 mM ddATP, 1 µL Hin (lOx), 1 µL of 
0.02 mM dATP and 1 µL [a-32 P]dATP). 
The other tubes had the same additions except the ddNTPS added were 
of the following concentrations: 1.5 mM ddGTP, 1 mM ddCTP and 2 mM 
ddTTP. The solution was mixed by repeatedly taking up the solution 
and expelling it from the capillary into a siliconized tube. 
(c) dNTP mixes were prepared from stocks of 20 mM dNTP (in 
T10Eo.1, pH 7.5). The 0.5 mM working stocks were made fresh. The 
composition of the dNTP mixes were as follows: 
dTTP dCTP dGTP dATP 
0.5 mM dTTP 1 µL 20 µL 20 µL 20 µL 
0.5 mM dCTP 20 µL 1 µL 20 µL 20 µL 
0.5 mM dGTP 20 µL 20 µL 1 µL 20 µL 
50 mM Tris HCl, 
1 mM EDTA, pH 7.5 5 µL 5 µL 5 µL 5 µL 
To 4 µL of each dNTP0 mix was added 0.8 µL of Klenow (DNA-
polymerase, enzyme according to Klenow, Boehringer-Mannheim, 125 
units/SO µL). This solution was mixed and 1.2 µL was immediately 
added to each reaction capillary and incubated for 15 minutes at room 
temperature. 
(d) To each reaction capillary was added 1 µL dATP (0.5 mM) 
solution which was a 'chase'. The solutions were mixed and then the 
capillaries incubated for 15 minutes at room temperature. 
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(e) 5 µL of formamide dye mix (100 mL deionized formamide , 
0.3 g xylene cyanol FF, 0.3 g bromophenol blue and 20 mM EDTA) was 
added to each reaction tube. The dye was mixed with the contents of 
the capillary and expelled into the siliconized tube. The tubes were 
then placed into a boiling water bath for 5 minutes. In the case of 
experiments in which the primer was cleaved, endonuclease was added 
and the mixture was incubated for 30 minutes at 37°C prior to the 
addition of dye mix. Approximately 2 µL was added to each track of a 
denaturing polyacrylamide gel. 
Polyacrylamide Gel Electrophoresis 
Thin acrylamide gels used for DNA sequencing were prepared 
according to the methods outlined in Sanger and Coulson (1978). The 
urea/acrylamide stock solution used for the gels was prepared as 
follows: 288 g of urea, 1.8 g bisacrylamide and 34.2 g acrylamide 
were dissolved at 45°c in distilled water to give a volume of 500 
mL . 20 g of amberlite MB-1 resin was added and gently stirred for 30 
minutes. The solution was then filtered twice through Whatman No 1 
filter papers, 60 mL of ten times strength TBE buffer (1.12 M Tris 
HCl , 0.89 M boric acid, 0.025 M EDTA, pH 8.3) was added and the 
volume made up to 600 mL with distilled water. The final composition 
of the stock solution was (8 M urea, 6% (w/v) acrylamide, 0.11 M Tris 
HCl, 0.09 M boric acid, 2.5 mM EDTA, pH 8.3). 
The gels were formed between two 20 x 38 x 0.4 cm glass plates 
(0.4 mm spacers between them), one with a notch 16.5 x 2 cm cut out 
from the top to allow contact between the gel and the upper 
compartment of the apparatus (Sanger and Coulson, 1978). 
Usually 2 µL of the sequencing reaction mixture in dye mix was 
loaded onto each of two polyacrylamide gels which were 
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electrophoresed at 1500 volts for 2.2 and 4.5 hours respectively, and 
the glass plates separated. The gel was covered with Saran wrap and 
autoradiographed using Kodak X-omat H film. In the early experiments 
autoradiography was performed at -60°C but in later work the gels 
were fixed in 10% (v/v) acetic acid in water prior to autoradiography 
at room temperature. 
RESULTS AND DISCUSSION 
In early 1979 the project for the sequencing of the cloned ndh 
gene (Young et al., 1978) was initiated. At that time one of the 
strategies used for sequencing was to use double stranded restriction 
fragments as primers and a single stranded template. This strategy 
had been successfully employed for the sequencing of bacteriophage 
0Xl74 where single stranded template is readily available (Sanger, 
Air, Barrell, Brown, Coulson, Fiddes, Hutchison, Slocombe and Smith, 
1977). With the development of the Ml3 cloning vector Ml3mp2 this 
approach could be extended to other DNA's and it was utilized in the 
present work. It soon became clear, however, that high quality 
sequence data could be obtained more easily by randomly cloning 
restriction fragments into Ml3 vectors and using a 'universal' 
flanking primer to initiate chain extension across the cloned 
fragment. This approach because of its random nature requires 
adequate computer programs to search for overlaps and to enable a 
complete sequence to be assembled. The lack of suitable computer 
facilities precluded the use of this approach at that time in this 
laboratory. Sequencing experiments of this type were carried out in 
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Cambridge U.K. in early 1980 by Dr I.G. Young whilst on study leave 
in Dr F . Sanger's laboratory. 
The sequencing strategy for the ndh gene using internal primers 
is outlined below. Plasmid pIYl (Young et al., 1978), which carries 
the cloned ndh fragment (designated as fragment 1-1), and the double-
stranded RF of Ml3mp2 were digested separately with EcoRI 
endonuclease, ligated together, and transfected into strain 71-18 
(Messing et al., 1977; Sanger et al., 1980). Plaques which were 
white on indicator plates containing X-gal were propagated, and the 
replicative forms of the hybrid phages isolated. Two hybrid phages 
carrying the ndh fragment cloned in opposite orientations (designated 
A and B) were obtained. Since mature Ml3 virus carries single 
stranded DNA, the two different hybrid phages provided a source of 
both complementary strands of the ndh gene. 
During subsequent cultivation, the size of the DNA of the 
progeny phages was monitored by agarose gel electrophoresis to detect 
the presence of deleted forms . It was found that the two different 
hybrid phages differed in stability . Only one orientation of the 
cloned fragment resulted in instability of the hybrid phage 
(orient ation B), suggesting that the sequence of the insert may be 
important in determining the stabili ty of hybrid phages. Both phages 
could be grown without significant deletion if plaque-purified before 
use, and if grown on a small scale. 
The cloned fragment containing the ndh gene (fragment 1-1) was 
purified by hydroxylapatite chromatography as described in the 
Materials and Methods section . Using different restriction 
endonucleases a preliminary restriction map was constructed (Figure 
2-1). Purified fragment 1-1 was digested with a series of 
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restriction endonucleases with 5 or 6 base recognition sites (eg Taql 
Pvull, Mboll, Sall, Pvul and Hinfl). The order of the fragments was 
established by double digestions with these enzymes. Taql digestion 
of purified fragment 1-1 gave 6 major fragments which were purified 
by agarose gel electrophoresis and hydroxylapatite chromatography. 
The order of the Taql digestion fragments (numbered 1-2 to 1-7) was 
determined by using double digests with the restriction endonucleases 
listed above. To produce small restriction fragments for use as 
primers, restriction endonucleases with 4 base recognition sites were 
used to cleave each of the purified Taql fragments. The restriction 
fragments produced by these digestions were each given a numerical 
designation (1-n) and their respective nucleotide chain lengths were 
calculated by polyacrylamide gel electrophoresis (Maniatis, Jeffrey 
and deSande, 1975) . 0Xl74 and pBR322 DNA which had been digested 
with Haelll endonuclease were used as size standards. Primers 1-67, 
1-68 and 1-33 are shown as an example in Figure 2-2. 
A summary of the sequence data obtained using internal primers 
is illustrated in Figure 2-3 . All the primers were cleaved with 
restriction endonuclease prior to polyacrylamide electrophoresis, as 
shown in the restriction map (Figure 2-1), except the very short 
primers (1-52, 1-58 , 1-45, 1-61 and 1-62). 
The 'internal' primer sequencing method using primers described 
above proved difficult to apply in practice. The sequence data 
obtained generally showed a higher level of ambiguity than expected, 
and long sequence readings were not obtained. Later developments 
indicated that the problems were probably due to impure primers 
leading to inhibition of the copying of the t emp late by the DNA 
polymerase I. 
Figure 2-1. Restriction Endonuclea se Map of the Cloned Fragment 1-1 Containing the Ndh Structural Gene 
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The restriction map was determined as described in the text. Endonuclease recognition sites are indicated by vertical 
bars. The ~I fragments, numbered 1-2 to 1-7, were purified and further cleaved to produce the fragments listed at 
the bottom of the figure. These fragments were purified as described in the Materials and Methods section and used 
as internal primers in sequencing experiments. 
Figure 2-2. Analytical Polyacrylamide Gel Electrophoresis of 
Endonuclease Digested Fragment 1-4: Production of 
Internal Primers 
1-67 
(Taql/ Mboll} 
-......______ 
+
1-33 
1-68 
(Mboll/Taql} 
1-68 
(M bo 11 / Pvu 11)-......______ 
1-33 
(Pvu II /Taq I} 
1 2 
Base pairs 
---
--
587 
540 
504 
458 
434 
267 
234 
213 
192 
184 
124 
104 
Samples: (1) MboII and PvuII digested fragment 1-4 (see restriction 
map in Figure 2-1), (2) HaeIII digested pBR322. The fragments 
produced from the digestion of fragment 1-4 include: 1-67, 1-68, 
1-33 and the partial digestion fragment composed of 1-68 and 1-33. 
DNA sequence derived from the use of purified fragments 1-33 and 
1-67 as internal primers is shown in Figures 2-3, 2-4 and 2-5. The 
primers were purified as described in the Materials and Methods 
section. 
Figure 2-3. Summary of Sequence Data Obtained Using Internal Primers 
and Ml3 Clones Car r ying the Whole Ndh Fragment as 
Template 
Base Pairs 
1-68 
Strand A 
1- 67 
1-69 
Strand B 
Consensus 
Sequence 
1-,4 
Start 
t 
500 
1-33 , 
1-52 
1-58 
1-58 
1-52 
ndh 
---- ----------· 
1000 
1- 29 
1-,45 
gene 
·---
1500 
_I 
1- 7 
1-63 
1-61 
Stop 
t 
1-5 
1- 5 
---· ·----
2000 
1- 62 
·---· 
The reg ions where sequence data was obtained are r epresented by 
dotted lines . Some primers were cleaved with endonucleases prior 
to electrophoresis . The endonucleases used are shown in the 
rest riction map in Figure 2-1. See text and Materials and Methods 
section for more details . 
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The sequence data obtained using internal primers was examined 
for sequences corresponding to the N-terminal coding sequence of the 
protein which was determined in this laboratory by automated Edman 
degradation by Drs H.D. Campbell, A. Jaworowski and D.C. Shaw. 
One region of the cloned fragment for which good DNA sequence 
data was obtained is shown in Figure 2-4. The internal primers 1-67 
and 1-33 were used in these experiments (Figure 2-1, 2-2 and 2-3). 
Each sequencing experiment was performed twice and the sequences were 
determined on separate complementary strands (designated A and Bin 
Figure 2-4). Autoradiographs of two of the gel readings are shown in 
Figure 2-5 with their deduced DNA and amino acid sequence. 
The first 19 residues of the N-terminal sequence of the purified 
NADH dehydrogenase is presented below: 
Thr-Thr-Pro-Leu-Lys-Lys-Ile-Val-Ile-Val-Gly-Gly-Gly-
Ala 
-Gly-Gly-Leu-Glx-Met Ser 
The 19-residue N-terminal sequence was in complete agreement with the 
DNA sequence (Figure 2-4 and 2-5). The overall yield in the spinning 
cup for the first residue (threonine) was approximately 70%, which is 
close to the expected maximum yield of -80%. This indicates that the 
initiating formylmethionine has been largely or completely removed by 
post-translational processing. 
One puzzling feature of the DNA sequence at this time was the 
absence of a suitable initiation codon. There were no suitable AUG 
or GUG codons upstream from the N-terminal sequence. This ruled out 
the possibility that the dehydrogenase used a signal peptide for 
membrane assembly and suggested that post-translational processing 
probably involved the removal of formylmethionine. This indicated 
that the initiation codon would be UUG which had not previously been 
Figure 2-4. The DNA Sequence of the Region Encoding the 
N-terminus of the NQh Protein 
The direction of the gel readings are indicated by arrows . 
The consensus sequence is in large type . The initiation 
codon UUG is underlined as is the ribosome binding site. 
The letters A and B indicate the complementary strands of 
the cloned ndh fragment. Examples of some gel reading 
autoradiographs covering this region are shown in 
Figure 2-5. 
1-67 B 
-. A T G T T A A T A A C C A T T A A T T A A C A A T T G G T T 
A K G N T A A T A A C C A T T A A T T ~ ~ C A A T T G G T T ~ 
T G T T A A T A A C C A T T A A T T A A C A A T T G G T T .,___ 
P. T GT TA AT A AC CATT A ATTA AC A AT T G GT T 
1-67 B 
--+G NC AC GT T GA CT AC G 
A A T A A A T T T A A G G G G G T C A C G T T G A C T A C G 
A A T A A A T T T A A G G G G G T C A C G T T G A C T A C G ....__ 
A A T A A A T N T A A G G G G G T C A C G T T G A C T A C G .._ 
Met Thr Thr 
AATAAATTTAAGGGGGTCACGTTGACTACG 
___. C C A T T G A A A A A G A T T G T G A T T G T C G G C G G C 
_. C C A T T G A A A A A G A T T G T G A T T G T C G G C G G C 
C C A T T G A A A A A G A T T 1 T G * T T G ~ C G G ~ G G C .,__ 
C C A T T G A A A A A G A T T G T G A T T G T C G +- 1-33 A 
Pro Leu Lys Lys Ile Val Ile Val Gly Gl y 
C C A T T G A A A A A G A T T G T G A T T G T C G G C G G C 
~ G G T G N T G G T G G G C T G G A A 
---.. G G T G C T G G T G G G C T 
AG G T G C T G G T G G G C T .,__ 1-33 _A T T 
Gly Ala Gl y Gly Leu Glu 
G G T G C T G G T G G G C T G G A A 
Figure 2-5. Autoradiographs of Acrylamide Gel Electrophoresis from Experiments which Identified the N-terminal 
Coding Region 
Gel A 
A A T A A A T T T A A G G G G G T C A C G T T G A C T A C G C 
Gel B 
primer 1-33 
Met Thr Thr Pro Leu Lys Lys Ile Val Ile Val Gly Gly 
Pvull A 
G T C A C G T T G A C T A C G C C A T T G A A A A A G A T T G T G A T T G T C G G C G G C 
primer 1-67 Mboll B 
TT TTT 
II 111 
I 
A 
TT CC CCC T C CT T C 
II 11111 1 I II I I 
111 
AAA II I 11 II I I AG G AA GA G G 
T 
C 
G 
A 
C C CT TT T TT 
I I II II I II 
II II I II I 11111111 GG GG G AG G AGAAAAAG 
TT CC C TC TT C CT 
I I II I II I I I II 
I; 
- ~-"- . 
I I I II f I I 
A G A AG GA G 
The initiation codon and the ribosome binding site are underlined. The letters A and I indicate the complementary 
strands of the cloned ndh fragment. The primers used, 1-33 and 1-67, are described in the text and in Figures 
2-1, 2-2 and 2-3. The endonucleases PvuII and MboII were used to cleave the primers. 
T 
C 
G 
A 
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shown to be a normal initiation codon. The presence of a ribosome 
binding site (Shine and Dalgarno, 1974;1975) four bases upstream from 
the UUG gave additional support to this hypothesis. 
Since at the time the use of UUG as an initiation codon was very 
novel, additional experiments involving in vitro transcription/ 
translation were carried out in this laboratory which verified that 
UUG does code for N-formylmethionine in this instance (Paulis, Shaw, 
Campbell and Young, 1981). 
Overall, the problem of the high level of ambiguity in the DNA 
sequence data suggested that an alternative sequencing strategy 
should be attempted. The method chosen was to randomly clone 
fragments into Ml3mp2 and to use a universal primer for sequencing 
experiments. These sequencing experiments were carried out by Dr 
I.G. Young whilst on study leave in Cambridge, U.K., where suitable 
computer facilities were available. 
Plasmid pIYl (Young et al., 1978) was digested with EcoRI 
endonuclease and the cloned ndh fragment was purified by gel 
electrophoresis using low-melting agarose (Sanger et al., 1980) . The 
' 
restriction endonucleases Sau3A and TaqI were used to generate the 
small fragments for subcloning into Ml3. Fragments derived by 
digestion with Sau3A were cloned directly into the BamHI site of the 
vector Ml3mWJ22 (Rothstein et al., 1980). BamHI linkers were used to 
clone Taql fragments into the same vector (ibid.). The chain-
termination method of Sanger et al. (1977) was used for sequencing 
the Ml3 clones . The 26 bp primer used (Anderson et al., 1980) 
--
anneals adjacent to the EcoRI site of Ml3mp2 and related vectors, and 
directs the primed synthesis into the cloned fragments. Individual 
Ml3 clones were propagated on a 1 mL scale and the template DNA was 
41 . 
prepared after precipitation of the phage using poly(ethyleneglycol) 
(Sanger et al., 1980). The Ml3 clones carrying random short 
fragments were screened initially by carrying out the normal 
sequencing reaction with only one dideoxynucleotide (usually ddT). 
In this case the positions of thymines in the DNA sequences were 
determined and used as a basis for comparison of the various clones. 
By recognizing the sequence of the vector this technique enabled the 
size of the inserts to be determined as well as their relationship 
with each other and with other sequence data. The random sequence 
data determined on both complementary strands were assembled into a 
complete sequence using the computer programs described by Staden 
(1977; 1980). A summary of the gel readings used to assemble the 
sequence is given in Figure 2-6 (taken from the reference; Young, 
Rogers, Campbell, Jaworowski and Shaw, 1981). The sequence itself is 
shown in Figure 2-7 (taken from Young et al., 1981). Examination of 
both strands of the DNA sequence showed the presence of only one 
reading frame compatible with the subunit Mr of 47000 determined 
for the purified enzyme (Jaworowski et al., 1981b). This reading 
frame is shown in Figure 2-7 and predicts a protein sequence of 434 
residues with an Mr of 47200. The amino acid analysis (performed 
by Drs H.D. Campbell, A. Jaworowski and D.C. Shaw) of the purified 
enzyme gave good overall agreement with the predicted amino acid 
composition (Young et al., 1981). In other studies (Jaworowski et 
al., 1981b) the 16-residue C-terminal cyanogen bromide peptide 
predicted from the nucleotide sequence has been isolated which 
further confirmed the reading frame. 
The nucleotide sequence presented in Table 2-7 is discussed in 
the next section of this Chapter. Since some time has elapsed from 
Figure 2-6 . Summary of DNA sequence Data Obtained from the Ml3 Clones 
~ I -»-I ~ ~ 
~ ,.. .. J · ?> · I ~ 
~------->-- ----~ ~ ,.. ~ 
Sau3A 
TaqI Sau3A Sau3 A Sau3A TaqI Sau3A Sau3A Taql ·raqI Sall 
Eco 
rI I I l Taq I I 
,.J...,_H""' "' -=•=••=rr.:.~~J ".:
3
:
3
1L,u = • 11 ..... , .. J =~ '!I = Bl II! =!==i,=i !!'l!l!II!' ·!111::!I ~ 11aa1.l 11u1 t :: ..• •a z= 200 400 600 800 1000 1200 1400 1600 1800 2000 0 
Base pai rs 
cE -E . " . -E 
~ cE ~ -E -E 
~ ~ ~ 
The restriction sites for TaqI and Sau3A in the ndh gene are shown . The lines above and below the restriction map 
indicate the v a rious gel readings obtained for the two DNA strands. The solid lines are us ed for data that was 
obtained from Ml3 carrying subfragments which were sequenced using an external primer. The dotted lines indicate 
that the data was obtained with Ml3 clones carrying the whole n<lh fragment as template . In this case, for sequences 
within the gene , internal primers were used. The minimum overlap in the gel readings used to construct the sequence 
was 17 nucleotides. 
Figure 2-7. The Nucleotide Sequence of the lkl.h Gene 
GAATTCTGTGGGTCGGATAAGGCGTCCACGCCGCATCCGACAGTCGAGCATCAATGCCTGATGCGCTTCTTATCAGGCCTACCGAACGCCCTGCATACACCCCTCACTCTATATCACTC 
10 20 30 40 50 60 70 80 90 100 110 
TCACAAATTCGCTCAAATAATAAACAATAAACTCTGTTTTTTGATCTCACCCGGTAAAGTCGCCTATCTTTTCAGCAACAAAACTTGATTAACATCAATTTTGGTATGACCAATGCACCA 
130 140 150 160 170 180 190 200 210 220 230 
~Thr TTCATGTTATTCTCAATAGCGAAGAACATTTTCATTGCTGTAACCTGTTGTTAATTAAGAGCTATGTTAATAACCATTAATTAACAATTGGTTAATAAAT'IfrAAGGGGGjrAC~CT 
250 · 260 270 280 290 300 310 320 330 340 350 
10 20 30 40 
ThrProLeuLysLysileVa1IleVa1GlyGlyGlyAlaGlyGlyLeuGluMetAlaThrGlnSeuGlyHisLysLeuGlyArgLysLysLysAlaLysileThrLeuVa1AspArgAsn 
ACGCCATTGAAAAAGATTGTGATTGTCGGCGGCGGTGCTGGTGGGCTGGAAATGGCAACACAGCTGGGGCATAAGCTGGGACGCAAGAAAAAAGCCAAAJ...TTACGCTGGTCGATCGTAAC 
370 380 390 400 4 10 420 4 30 440 450 460 470 
50 60 70 80 
HisSerHisLeuTrpLysProLeuLeuHisGluValAlaThrGlySerLeuAspGluGlyValAspAlaLeuSerTyrLeuAlaHisAlaArgAsnHisGlyPheGlnPheGlnLeuGly 
CACAGCCACCTGTGGAAACCGCTGCTGCACGAAGTGGC~ACTGGCTCGCTTGATGAAGGCGTCGATGCGTTGAGCTATCTGGCCCATGCGCGCAATCATGGTTTCCAGTTCCAGCTGGGT 
490 500 510 520 530 540 550 560 570 580 590 
90 100 110 120 
SerVa1IleAspileAspArgGluAlaLysThrileThrileAlaGluLeuArgAspGluLysGlyGluLeuLeuVa1ProGluArgLysileAlaTyrAspThrLeuVa1MetA1aLeu 
TCCGTCATTGATATTGATCGTGAAGCGAAAACAATCACTATTGCAGAACTGCGCGACGAGAAAGGTGAACTGCTGGTTCCGGAACGTAAAATCGCCTATGACACCCTGGTAATGGCGCTG 
610 620 630 640 650 660 (70 680 690 700 710 
130 140 150 160 
GlySerThrSerAsnAspPheAsnThrProGlyVa1LysGluAsnCysI1ePheLeuAspAsnProHisGlnA1aArgArgPheHisGlnGluMetLeuAsnLeuPheLeuLysTyrSer 
GGTAGCACCTCTAACGATTTCAATACGCCAGGTGTCAAAGAGAACTGCATTTTCCTCGATAACCCGCACCAGGCGCGTCGCTTCCACCAGGAGATGCTGAATTTGTTCCTGAAATACTCC 
730 740 750 760 770 780 790 800 810 820 830 
170 180 190 200 
AlaAsnLeuGlyAlaAsnGlyLysValAsnileAlaileValGlyGlyGlyAlaThrGlyValGluLeuSerAlaGluLeuHisAsnAlaValLysGlnLeuHisSerTyrGlyTyrLys 
GCCAACCTGGGCGCGAATGGCAAAGTGAACATTGCGATTGTCGGCGGCGGCGCGACGGGTGTAGAACTCTCCGCTGAATTGCACAACGCGGTCAAGCAACTGCACAGCTACGGTTACAAA 
850 860 870 880 890 900 910 920 930 940 950 
210 220 230 240 
GlyLeuThrAsnGluAlaLeuAsnValThrLeuVa1GluAlaGlyGluArgI1eLeuProAlaLeuProProArgileSerAlaAlaAlaHisAsnGluLeuThrLysLeuG1yValArg 
GGCCTGACCAACGAAGCCCTGAACGTAACGCTGGTAGAAGCGGGAGAACGTATTTTGCCTGCGTTACCGCCACGTATCTCTGCTGCGGCCCACAACGAGCTAACGAAACTTGGCGTTCGC 
970 980 990 1000 1010 1020 1030 1040 1050 1060 1070 
250 260 270 2 80 
ValLeuThrGlnThrMetVa lTh rSerAlaAspGluGlyGlyLeuHisThrLysAspGlyGluTyrileGluAlaAs p LeuMe tValTr pAlaAla GlyileLysAla ProAs p Phe Leu 
GTGCTGACGCAAACCATGGTCACCAGTGCTGATGAAGGCGGCCTGCACACTAAAGATGGCGAATATATTGAGGCTGATCTGATGGTATGGGCAGCCGGGATCAAAGCGCCAGACTTCCTG 
1090 1100 1110 1120 1130 1140 1150 1160 1170 1180 1190 
290 300 310 32 0 
LysAspI1eGlyGlyLeuGluThrAsnArgileAsnGlnLeuVa1Va1GluProThrLeuGlnThrThrArgAspProAspileTyrAlaileGlyAspCysAl a SerCy s Pr o Ar gPro 
AAAGATATCGGTGGTCTTGAAACTAACCGTATCAACCAGCTGGTGGTGGAACCGACGCTGCAAACCACCCGCGATCCAGACATTTACGCTATTGGCGACTGCGCGTCATGCCCGCGTCCG 
1210 1220 1230 1240 1250 1260 1270 1280 1290 1300 1 310 
330 340 350 360 
GluGly GlyPhe Va1ProProArgAlaGlnAlaAlaHisGlnMetAlaThrCysAlaMetAs nAsnI1e LeuAlaGlnMe tAsnGl y LysP r o LeuLysA s nTyrG 1nTyrLysAspHis 
GAAGGGGGCTTTGTTCCGCCGCGTGC~CAGGCTGCACACCAGATGGCGACTTGCGCAATGAACAACATTCTGGCGCAGAT GAACGGTAAGCCGCTGAAAAATTATCAGTATAAAGATCAT 
1330 1340 1350 1360 1370 1380 1390 140 0 1410 14 20 14 30 
370 380 39 0 400 
GlySerLeuVa1S e rLeuSerAsnPheSerThrVa1GlySerLeuMetGlyAsnLeuThrArgGlySerMetMetileGluGlyArg il e Al a ArgP heVa 1Ty r I1eSerLeuTyrArg 
GGTTCGCTGGTATCGCTGTCGAACTTCTCCACCGTCGGTAGCCTGATGGGTAACCTGACGCGCGGCTCAATGATGATTGAA GGACGAATTGCGCGCTTTGTATATATCTCGC TATACCGA 
1450 1460 1470 1480 1490 1500 1510 1520 1530 1540 1 5 50 
410 420 430 
MetHisGlnileA1 a LeuHisGlyTyrPheLysThrGlyLeuMe t MetLeuVa1GlyS e r i l e AsnAr gVa1IleArgP r o Ar g Le uLys Le uHis 
ATGCATCAGATTGCGCTGCATGGTTACTTTAAAACCGGATTAATGATGCTGGTGGGGAGTATTAACCGCGTTATCCGTCCGCGTTTGAA GTTGCAT TAATCGACGTAC ACTGGCGGATGT 
1570 1580 1590 1600 1610 1620 1630 1 6 40 16 50 1 660 1670 
~ATAAACGCCTCATCCGCCCTTGAGGAACAGCGCGATCGGCAGCCGCGTTGTATCAGGCATCCTTTCAGACTCCTCCGAATCCTTAAGTATTTCCAGCC ATTCCCGCGCTTTTCATC1 
169ir" 170 0 1710 1720 1730 1740 175 0 1760 1 770 1 780 1790 
TCTGTCTGATAGC TGCTTTTCTCCTTCGCTTGCATGATTGGCATAACTGCAAAGAAGGAGGTGTTCCCGTGAATAAA TCAATGTTGGCGGGTATCGGGATTGGTGTCGCAGCTGCGCTGG 
1810 1 820 1830 1840 1850 1860 187 G 18 80 1 890 1900 1 91 0 
GCGTAGCGGCAGTGGCCAGTCTGAACGTGTTTGAAC GGGGCCCGCAATACGCTCAGGTTGTTTCTGCAACCCCAATCAA GGAAACGGTTAAAACACCGCGTCAGGAGTGTCGCAACGTCA 
19 30 1940 1950 1960 1970 1980 199 0 2 0 00 2 01 0 2020 2030 
CAGTGACCCATC GTCGAC 
2050 
Th e region shown covers most of the ndh f r agment , s t ar t ing at the EcoRI si t e at one end and t e rminating at a uni que Sa l l 
within the f r agme nt . Two pairs of invert ed repea t s present in the nucleotide sequen ce ( 287 - 297, 316-3 26 ; 1671-1682 , 
1689-1700) are und e rlined . The possible ribosome b i nding site and UUG initiation codon are indicated by th e boxes . Tl1e 
d r e presenting deoxy and the hyphens r ep r esenting phosphodieste r linkages have been omit t ed . The prediced a min o aci d 
se que nce is aligned above the nucleot i de sequ ence . 
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the time of the publication of the sequence (mid-1981), the 
discussion has integrated subsequent work by others. 
FEATURES OF THE NUCLEOTIDE SEQUENCE 
Transcription Control Sequences 
Pribnow (1975) and Schaller, Gray and Herrmann (1975) after 
comparing a few promoter sequences noted that each contained a seven 
base pair sequence generally homologous to the sequence TATAATG, 
which was centred about 10 bp upstream from the mRNA startpoint. 
Rosenberg and Court (1979) compared the nucleotide sequences of 46 
promoter sites recognized by the!· coli RNA polymerase. They 
concluded that as judged by sequence homology alone, the conserved 
-10 region clearly extends for some 13 nucleotide pairs and the 
extent to which particular positions within the region are conserved 
appears to vary widely. 
Sequence similarity has also been noted among promoters in a 
region about 35 bp preceding the mRNA startpoint (called the -35 or 
recognition region) (Takanami, Sugimoto, Sugisaki and Okamoto, 1976). 
An idealized promoter sequence which is a composite of 112 known 
promoter sequences (Hawley and McClure, 1983) is presented in Figure 
2-8 together with a putative promoter sequence upstream from the 
initiation codon of the ndh gene. 
The gene sequence was also examined for the presence of 
inverted repeats. An 11-base inverted repeat is present in the 
promoter region (nucleotides 287-297, 316-326), the significance of 
which is unclear at present (Figure 2-7). 
Figure 2-8 . Representation of an Ideal Promoter Sequence: Comparison with a Putative Promoter Sequence of the N£ih Gene 
Ideal -30 Region -10 Region +l Region 
Sequence 
t c T T G A ( a t - - t t - t g - T A t A a T C a t 
·k ,,, '~ ,,, ,,, ,·, ,·, ;', ·;', ,... ..... ..1 .. 
... ,... '" 
Ndh T G C T G T A A C C T G A G A G C T A T G T T C A T 
Sequence t 
I I I I I I 
275 286 297 307 314 316 
The ideal consensus promoter for~- coli RNA polymerase is derived from a compilation of 112 promoter sequences (Hawley 
and McClure, 1983). Bases that occur in at least 39% of the promoters are listed . Bases that are >54% conserved are 
capitalized. An asterisk marks regions of agreement with the ndh sequence. Both of the sequences presented are of the 
sense strand . The nucleotide corresponding to the likely 5' end of the transcript (+l) is indicated by an arrow. 
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The DNA sequences of a number of sites that encode information 
for transcription termination have been determined (Biro and 
Weissman, 1979). Comparison of termination site sequences reveal 
three common features: (a) a region of hyphenated dyad symmetry 
(ie an inverted repeat sequence) precedes the termination site, (b) U 
residues are found at the terminus of the RNA transcript, and (c) G/C 
rich sequences variable in length (3 to 11 contiguous G/C base pairs) 
are found preceding the termination site (ibid.). 
The ndh gene has a 12 bp inverted repeat (nucleotides 1671-1682, 
1689-1700) which includes one mismatch, a short distance after the 
end of the reading frame (Figure 2-7). A possible RNA transcription 
termination structure at the 3' end of the ndh gene is illustrated in 
Figure 2-9. The RNA hairpin (stem and loop) structure that is 
essential for terminator function is illustrated, and is a direct 
consequence of the DNA inverted repeat sequence. However, the ndh 
gene RNA transcription termination structure does not possess a poly-
U sequence. The significance of this is unknown. 
Ribosome Binding Site S~quence 
The work of Shine and Dalgarno (1974;1975) provided a maJor 
impetus to the study of sequences involved in the initiation of 
translation. They suggested that a purine-rich sequence (ribosome 
binding site) in the mRNA preceding the translation start could base 
pair with the 3'-end of the 16S RNA of the small ribosomal subunit. 
This homology alone can be used to distinguish!· coli translational 
initiation sites from all other sites in tabulated mRNA sequence 
libraries (Stormo, Schneider, Gold and Ehrenfeucht, 1982a; Stormo, 
Schneider and Gold, 1982b). 
Figure 2-9 . A Possible RNA Transcription Termination Structure at 
the 3' End of the Nd.h Gene 
u 
A 
u 
Leu His term 
UUGCAUUAAUCGACGUACACU 
Nucleotide I 
Number 1650 
AA 
A 
C 
CG 
GC 
GC 
u 
GC 
UA 
AU 
GC 
GC 
CG 
GC 
GC 
CUUGA 
I 
1705 
The 3' end of the ndh gene has been represented as a sequence of 
ribonucleotides in a stern and loop secondary structure. The 
C-terminal histidine is followed by one nonsense codon (term). 
A G/C-rich sequence forms the stem,however there is not a U-rich 
region downstream. 
44. 
Using an!· coli mRNA sequence database, the sequence of 
nucleotides that should be present in an mRNA for optimum binding to 
the E. coli ribosome has been calculated (Scherer, Walkinshaw, Arnott 
and Morre, 1980). This sequence is compared with the ndh ribosome 
binding site as well as its complementarity to the 16S RNA sequence 
(Shine and Dalgarno, 1974) in Figure 2-10. The ndh ribosome binding 
site has considerable homology with the 'optimum' sequence proposed 
by Scherer et al., (1980). It should be noted that when the model 
sequence was compared with each of the 68 ribosome binding site 
sequences used to generate it, it showed a preference rather than an 
absolute requirement for a specific base in any given position 
(ibid.). Perhaps more importantly, their analysis suggested that 
preferences for certain bases persists along the whole length of the 
RNA within the ribosome binding domain even though nearly half of 
that length includes translated codons. However, although the ndh 
ribosome binding site matches well with the model mRNA sequence 
deduced by Scherers et al. (1980) upstream from the initiation codon, 
less homology is observed in the early translated region (not shown 
in Figure 2-10) . A comparison is listed below: 
ndh gene UUGACUACGCCAUUGAAAAAGAU 
****** *** ** 
model AUGAAAAAAAUUAAAAAACUCAA 
sequence CUC G 
Internal Sequence Repeats 
One obvious feature of the ndh DNA sequence is an internal 
sequence repeat of 15 bp at nucleotides 380-394 and 875-889 in the 
Figure 2-1 0 . The Ri.bosome Binding Site o f t he Ndh Gene 
16S Ribosomal RNA 
A u U C C u C C A Py initiation codo n HO . I . 
I I I I I i . I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I ndh I I I I I I I I I I I I I I I I I I I I ! I ! I I • . . 
Sequence A A A u u U A AGG G G G U C A C G u u G 
* * * * * * * * * * * * 
Model 
Sequ en ce 
AA A AU UAAGG A GG U A UA U UA UG 
The ] ' -terminal sequence of~- coli 16S ribosomal RNA ( Shine and Dalgarno, 1974) is shown aligned above a 
complementary region 5 ' to the UUG initiation codon of the ndh gene . Complementary base matches are indicated by 
a dotted line. Aligned below the ndh sequence is a model sequence proposed by Scherer et al . ( 1980) that 
represents an mRNA which exhibits optimum binding to the~- coli ribosome . Agreement with the ndh sequence 
is shown by an asterisk . 
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ndh structural gene (Figure 2-11). The homology is even more 
striking when degene rate codons and conservative amino acid 
substitutions are considered. The amino acid sequence homology is 
described below: 
Residue 
Number 7 16 
Lys-Ile-Val-Ile-Val-Gly-Gly-Gly-Ala-Gly 
* * * * * * * 
Asn-Ile-Ala-Ile-Val-Gly-Gly-Gly-Ala-The 
172 181 
These two regions have subsequently been identified as part of 
the two nucleotide binding sites possessed by this enzyme and are 
discussed in a later section of this Chapter. 
Initiation Codon Sequences 
Early studies by Ghosh, S811 and Khorana (1967) established 
that AUG, GUG and UUG trinucleotides were capable of binding fmet-
tRNA to ribosomes. Furthermore, the two forms of E.coli tRNA frnet 
responded similarly in the ribosome binding assay to the triplets 
AUG, GUG and UUG, in decreasing order of effectiveness (Cory, Dube, 
Clark and Marker, 1968; Weiss, Pearson and Kelmers, 1968). 
Subsequently, AUG has become well established as the usual initiation 
codon in vivo (Gold, Pribnow, Schneider, Shinedling, Singer and 
Stormo , 19 81 ) . 
In the sequence compilation of Gold et al. (1981) four of the 
--
124 translational initiation sequences have GUG rather than the far 
more prevalent AUG initiator (see also Stormo et al., 1982b). The 
reason why GUG is occasionally used as an initiation codon is as yet 
Figur e 2-11 . An Internal Sequence Repeat at Nucleotides 380-394 
and 875 - 889 in the Ndh Structural Gene 
380 390 400 
A A G A T T G T G A T T G T C G G C G G C G G T G C T G G T 
• • • • • • • • • • • * * * * 
AACATTGCGATTGTCGGCGGCGGCGCGACG 
870 880 890 
15bp internal repeat 
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unexplained. A list of E.coli genes that have been r e ported to use 
GUG as an initiation codon is given in Table 2-1. The mRNAs that use 
GUG as an initiation codon encode proteins that have no obvious 
similarity. It should be noted that in some of the reports in Table 
2-1, protein chemical data was not provided and hence GUG has not 
been unequivocally demonstrated to code for N-formylmethionine in 
these cases. 
The first report of the use of UUG as a normal initiation codon 
was made by Young, Rogers, Campbell, Jaworowski and Shaw (1981). 
Thus, the codon UUG has a dual function in protein synthesis in that, 
in addition to coding for internal leucine residues, it can also 
signify the start of protein synthesis. This is analogous to the 
dual function hitherto demonstrated for AUG and GUG. Confirmation 
that the initiating codon UUG codes for methionine in the ndh gene 
has come from studies in which the NADH:ubiquinone oxidoreductase has 
been synthesized in vitro using a transcription/translation system, 
under conditions where the post-translational processing is 
considerably reduced (Poulis et al., 1981). The results indicated 
that the first residue of the unprocessed NADH dehydrogenase is N-
formylmethionine. 
Soon after the first report of the use of UUG as a normal 
initiation codon (Young et al., 1981) two other reports have been 
published. Mackie (1981) reported that the gene for ribosome protein 
S20 (rpsT) of E.coli utilized UUG as the initiation codon and 
McLaughlin, Murray and Rabinowitz (1981) reported that UUG acts as an 
initiation codon for the Staphylococcus aureus S-lactamase gene. As 
with some of the reports listed in Table 2-1, the evidence presented 
by Mackie (1981) for the use of UUG as the initiation codon is an in-
Ta ble 2-1. E . col i and Coliphage mR As t ha t have been r eported to use 
GUG as t he Initiat ion Codon in vivo 
Protein 
coliphage MS2 
A-protein 
lactose repres sor 
minor capsid protein of 
bacteriophage FD and 
Ml3 
elongation factor 
Tu 
ribosomal protein 
Sl3 
S' subunit of 
RNA polymerase 
coliphage T7 
protein 2.8 
alkaline 
phosphatase 
flavoprotein subunit 
of fumarate reductase 
protein-b of the F0 
component of the 
ATP- synthase 
histidyl-tRNA 
synthetase 
resistence transfer 
factor 
a histidine transport-
protein 
Gene 
lacI 
geneIII 
tufA 
rspM 
rpoC 
phoA 
frdA 
gene 4 of the 
unc operon 
hiss 
repAl 
hisM 
Reference 
Fiers (1979) 
Steege (1 977); 
Farabaugh (197 8) 
Beck et al. (19 78); 
Wesenbeek and 
Schoenma kers (1979) 
Yokota, Sugisaki, 
Takanami and Kaziro 
(1980) 
Post, Arfsten, Davis 
and Nomura (1980) 
Ovchinnikov et al. 
--(1981) 
Dunn and Studier 
(1981) 
Kikuchi, Yoda, Yamasaki 
and Tamura (1981) 
Cole (1982) 
Gay and Walker (1981) 
Eisenbeis and Parker 
(1982) 
Brawner and Jaskunas 
(1982) 
Higgins, Haag, Nika ido, 
Ardeshir, Garcia and 
Ames (1982) 
a Membrane component of the histidine transport operon of 
Salmonella typhimurium . 
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phase reading frame of the appropriate length preceded by a Shine -
Dalgarno ribosome binding sequence an d a putative promoter s e quence. 
McLaughlin et al. (1981), using [ 35 s]-methionine, [ 3H]-leucine and 
[3H]-lysine coupled with automated amino acid sequence analysis, 
demonstrated that the UUG initiation codon codes for me thionine at 
the N-terminus of the leader sequence of the S-lactamase. 
More recently, AUU has been reported to act as an initiation 
codon for the initiation factor IF3 (infC gene) of!· coli (Sacerdot, 
Fayat, Dessen, Springer, Plumbridge, Grunberg-Manago and Blanquet, 
1982). The evidence provided for the use of AUU as an initiation 
codon included an open reading frame of the appropriate length 
preceded by a ribosome binding site sequence (ibid.). Unfortunately, 
no protein sequence data was provided to demonstrate that AUU codes 
for N-formyl methionine. 
Hence, AUG, UUG and GUG have all been shown to act as initiation 
codons in vivo with the only invariable nucleotide base (thus far) 
being the conserved central U (AUU has also been suggested). 
Codon Usage 
The accumulation of extensive sequence data has led to the 
detection of a genetic control mechanism mediated via codon usage. 
The use of a mRNA sequence database has established that the genetic 
code is used differently by different species and each type of genome 
has a particular coding strategy, that is, choices among degenerate 
bases are consistently similar for all genes therein (Grantham, 
Gautier and Gouy, 1980a; Grantham, Gautier, Gouy, Mercier and Pave, 
1980b). Contrary claims have been made suggesting that the 
preferential use of degenerate codons is gene specific (Wain-Hobson, 
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Nussinov, Brown and Sussman, 1981). Nonetheless, in E. coli it has 
been established that codon usage is markedly different in highly 
expressed genes compared with genes coding for rare proteins like 
repressors (Grantham, Gautier , Gouy, Jacobzone and Mercier, 1981; 
Gouy and Gautier , 1982; Grosjean and Fiers, 1982) . 
The codon usage and codon composition of the ndh structural gene 
of E .coli is shown in Table 2-2. The ndh gene is fairly similar to 
the!· coli genome in its use of the following codons: (a) 
preference for CUC in coding for leucine (this unexplained preference 
occurs also in animals as well as in bacteria), (b) CCC is the 
favoured codon for praline, and Cc) the following codons are not 
favoured: CGG, AGA, AGG, (arg); CCC, CCU, (pro); AUA, (ile). The ndh 
gene is atypical in that it utilizes UCG Cser) relatively more often 
than highly expressed! · coli genes (12 versus O codons per 1000, 
respectively; see Gouy and Gautier, 1982). 
Gouy and Gautier (1982) have developed an interesting strategy 
enabling the confirmation of the correlation of codon usage with gene 
expressivity (rate of synthesis of a protein and the total amount of 
it made; defined in Grantham et al. , 1980b). Gouy and Gautier (1982) 
have quantified the influence of tRNA availability based on a model 
of protein synthesis dynamics (Pl index= average number tRNA 
discriminations per elongation cycle). They also characterized each 
messenger in their sequence bank (83 E. coli sequences) by the 
frequencies of the choices between the pyrimidines among codons 
beginning with AA, AU, UA, UU, CC, CG, GC or GG (called the P2 
index). The relationship between highly expressed genes in E.coli 
as well as the ndh gene (called ECONDH) with these two calculated 
indices (Pl and P2) is shown in Figure 2-12. The respiratory NADH 
Table 2-2. Tabulation of t he Codon Usage and Codon Composition of 
the J'hlh Structural Gene of E. Co li 
Amino Codon Codon Codonb 
Amino Codon Codon 
. . a Acid C . . a Acid Composition- Usage- omposition-
Arg CGA 5 2 Val GUA 16 
CGC 21 9 GUC 21 
CGG 0 0 GUG 16 
CGU 25 11 GUU 9 
AGA 0 0 
AGG 0 0 Lys AAA 44 
AAG 14 
Leu CUA 5 2 
CUC 5 2 Asn AAC 42 
CUG 81 35 AAU 12 
cuu 7 3 
UUA 5 2 Gln CAA 7 
.J. 
UUG 16 8 " CAG 25 
Ser UCA 5 2 His CAC 23 
ucc 9 4 CAU 16 
UCG 12 5 
ucu 5 2 Glu GAA 42 
AGC 12 5 GAG 12 
AGU 5 2 
Asp GAC 12 
Thr ACA 5 2 GAU 30 
ACC 21 9 
ACG 21 9 Tyr UAC 14 
ACU 14 6 UAU 14 
Pro CCA 12 5 Cys UGC 9 
CCC 0 0 UGU 0 
CCG 25 11 
CCU 2 1 Phe uuc 18 
uuu 7 
Ala GCA 12 5 
GCC 16 7 Ile AUA 0 
GCG 44 19 AUC 18 
GCU 18 8 AUU 42 
Gly GGA 9 4 Met AUG 32 
GGC 39 17 
GGG 12 5 Trp UGG 5 
GGU 37 16 
Codonb 
Us a ge-
7 
9 
7 
4 
19 
6 
18 
5 
3 
11 
10 
7 
18 
5 
5 
13 
6 
6 
4 
0 
8 
3 
0 
8 
18 
14 
2 
a Codon compositions are expres sed per 1000 and both initia tor and -
stop codons are excluded from the data (Taken from Gouy and 
Gautier, 1982). 
b Codon usage is expressed as the number of codons represented in 
the ndh structural gene (434 codons). The table lists the atypical 
initiator UUG codon as encoding Leu not Met ( *) . 
Figure 2-12 . Characterization of Bacterial Gene Codon Usage by umber 
of on-Specific tRNA Discriminations During Translation 
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and Pyrimidine use in Codon Position III 
ECOLPP 
ECOSl ECOUNC) 
EAMLPP ECOS I I 
SHALPP 
ECOOHPA ECOSl2 
ECOS-20~- --
EC0712 ECOTUf8 
- - ECOTUfA 
ECOLII ECOSJO 
-- ECOL) 
ECORECA ECOEFG 
ECOL I ECORP08 ECOUNCA 
ECOUNCD 
ECOEFTS ECORPOC 
ECOS4 
ECOL JO 
ECORPOD 
ECOUNC4 
ECOS7 
ECOALRS 
ECONDH ECORPOA 
ANANLFH 
ECOUNC2 
ECO!LVG 
ECOUNCC ECOLEXA 
ECOUNCG 
HALRHO 
SHI RA2 
ECOTNAA ECOLLVE ECOASNA 
STYTRPD 
SHI RAJ EC0903K ECOTN)L ECOTRPL 
ECOTHRL 
30 
STYHISJ ECOTRP8 RHINIFH 
KPNNIFH 
ECOUNCS ECOFOL 
SHATRPG 
STYTRP8 
ECOTRPE ECOTHRA 
ECOTRPC ECOLACY 
STYTRPA 
ECOPHOA 
8Ll PEN 
ECOAMPC ECOTN 3T 
CLO!HMU 
ECOTN )R ECOARAC 
ECOTN9 SDYTRPD 
ECOTRPA 
ECOTRPD ECPFOL 
STYTRPE ECOAROH 
STYARGT 
ECOTRPR 
ECOILVL STYILVL 
SALH!N 
KAETRPA 
JS 
ECOLACI 
SAULRER 
40 
STYTRPL ECOHISL 
STYHISL 
4S 50 
ECORIHE 
RI PORL I 
RIPORI2 
STYLEUL 
CLOH 
60 
ECOR I EN 
ECOLTA 
SAURERY 
Pl index: AVERAGE NUH8ER OF tRNA DISCRIMINATIONS PER ELONGATION CYCLE 
Genes for the most abundant proteins a re underlined and the ndh gene 
is arrowed. Symbols with a dashed underline are hypothetical genes. 
The Pl and P2 indices are defined in the text and are taken from 
Gouy and Gautier (1982). 
ECOPHO. 
6 
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dehydrogenase is a rather minor component of the cytoplasmic membrane 
of E.coli and this is reflected in the co-ordinates of the ndh gene 
(ECONDH) in Figure 2-12. The ECONDH co-ordinates are quite separate 
from the cluster of highly expressed genes (underlined). 
FEATURES OF THE AMINO ACID SEQUENCE 
Amino Acid Sequences and their Relationship to Membrane Association 
The primary structure of the NADH:ubiquinone oxidoreductase 
represents the first complete sequence of a respiratory NADH 
dehydrogenase. The amino acid composition of the enzyme is similar 
to an 'average'!· coli protein calculated from data presented in 
Grantham et al., (1981). The amino acid composition and the 
--
comparison is presented in Table 2-3. Also, although the enzyme is 
membrane-bound it is not particularly hydrophobic since its polarity 
(43.4%) is not unusually low (Capaldi and Vanderkooi, 1972). 
The average hydrophobicity index of the NADH dehydrogenase is 
fairly low (l.95 kJ/mole residue) (calculated according to the method 
described by Heijne (1980), with modifications for the tyrosine and 
cysteine residues as recommended by Gilson, Higgins, Hofnung, Ames 
and Nikaido (1982a)). A comparison between the average 
hydrophobicity index of the NADH dehydrogenase (not including N-
terminal methionine) and some other proteins from~- coli and 
Salmonella typhimurium is presented in Figure 2-13. This figure is 
adapted from one presented in Gilson et al. (1982a) where the 
references and proteins are defined. In Figure 2-13 it is clear that 
the NADH dehydrogenase (ndh) has a low average hydrophobicity index 
Table 2-3 . Amino Acid Compositions of the dh Gene Product and 
'Average' E. coli Proteins 
Amino Amino Mol % in: 
Acid Acid Ndha Average (E. coli) 
C . . a omposition-
Asp 18 4.2 5. 2 
Asn 23 5.3 3.5 
Thr 26 6.0 5.8 
Ser 20 4 . 6 6.3 
Glu 23 5.3 5.5 
Gln 14 3.2 4.2 
Pro 17 3.9 3.5 
Gly 42 9.7 7.2 
Ala 39 9.0 11.1 
Val 27 6.2 7.5 
Met 14 3.2 2.2 
Ile 26 6.0 6.1 
Leu 51 11.8 7. 9 
Tyr 12 2.8 2.6 
Phe 11 2.5 3.6 
Lys 25 5.8 6.4 
His 17 3.9 2.5 
Arg 22 5.0 6.6 
Cys 4 0.9 1.1 
Trp 2 0.5 1.2 
a Calculated from sequence and does not include N-terminal Met. 
b Calculated from data presented in Grantham et al., (1981). 
Figure 2-1 3. Aver age Hydrophobicity Index of Some Proteins from 
.E_. col i and~ - Typhimuriurn : Compar ison with the 
Hydrophobic ity I ndex o f NADH Dehdyrogenase (Ndh) 
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• TrpB 
• TrpG 
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• Ndh 
• HisP 
Fl COAT• LacY • 
F0 -a • 
F0 -c. 
• HisM • HisQ 
0 2 3 4 5 6 7 8 
AVERAGE HYDROPHOBICITY ( kJ/ MOL RESIDUE) 
See text fo r details. This figure is ada p t ed from one presen ted in 
Gilson et al. (1982a) where the references a nd proteins a re def i n ed . 
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among the inne r-membrane proteins and is similar to thos e of the mo r e 
hydrophobic members of soluble prot e ins of E.coli and 
S. typhimurium. 
The enzyme possesses a number of stre tches of uncharged amino 
acids. A schematic representation of the primary amino acid sequence 
of the enzyme is presented in Figure 2-14. Uncharged stre tches of 10 
or more amino acids are underlined. Although the protein ha s s everal 
stretches of 10 or more uncharged amino acids, they are not more 
hydrophobic than those of water-soluble proteins (Segrest and 
Feldmann, 1974). There is also a region of high positive charge 
starting at residue 30 and having the sequence Arg-Lys-Lys-Lys-Ala-
Lys (dashed line in Figure 2-14). 
Overall, the protein itself is somewhat basic with a calculat e d 
pl of 9-10. Two other inner-membrane proteins, the lactose permease 
(Blichel, Gronenborn and Mliller-Hill, 1980) and the hisP gene 
product (Higgins et al., 1982), are also basic, their basic character 
possibly being related to their need to interact with the negatively 
charged phospholipids of the membrane. The bulk of E.coli cell 
proteins (-90%) have pl values of 7 or less as estimated by two-
dimensional gel electrophoresis of total cell protein (O'Farrell, 
1975). 
In a list of the membrane-penetrating segments compiled by 
Heijne (1981), the length of each membrane-associated segment was 
approximately 20 residues of which none possessed a charged residue 
(arg, lys, glu or asp) or a pro residue. Using these two criteria, a 
length of at least 20 consecutive uncharged amino acids and the 
absence of a pro residue (a strong helix breaker; Chou and Fasman, 
1978) there are only two possible candidates for transmembrane 
segments in the NADH dehydrogenase sequence. These are the two 
Figure 2-14 . Schema tic Rep r esentation of the Primary Amino Acid 
Seque n c e o f the _g_h Gene 
Residue Number 
1 100 
.11 .. ll ........... l .. 1, .. ll .. ~IU., .. ll,l1l .. l ... ll .. 1.1.ll .. l .. , .. . l.l1l .. 1.1 .. 1 .. l.lll.l1.1 .. I.I 
1.86 1.54 
101 
200 
. . . 
111. I.,,, 111.,, I I,,,,,, I I I I I. I I,,, 11 I,,,, I I, I I,, I I I., I,,, I. I, I,,, I, I. I,,,,,,,, I,, I. I, I. I I,, I I, 11,, 
1.09 1.54 
201 
300 
. . . . . . . 
, , I., I, I., I, I, I., II,,,,,,, I. I,,, I I I. I I.,, I., I 1'1,, I I. I/,,, I I II, I., I. I.,,,,,,, I., I., 11.,,, /III. I I,,, I. 
1.30 
301 400 
I, I I I II' I.'''' I.' I'' I. I.''''' I. I'' I,.' I''' I I''''' I' I.' I I' I' II I. I'' I' I I' I I' ' I''' I' I I. I''' I. I.' I.''' I' 0.52 1.14 
401 434 
.I.Ii. .. I ... 11. .. "" I, 1 I .. I. I. I. I 
2.25 1.68 
Each amino acid in the ndh sequence is represented as a bar. The 
different residues are represented in the one letter amino acid 
abbreviations as follows: small bar, M,P,L,I,V,G,A,F,Y,C a nd W; 
half bar, Q,T,S,N; full bar, H; full bar with two dots, K,R and 
full bar with one dot, D,E. Stretches of 10 or more uncharged amino 
acids are underlined and a region of high positive charge starting 
at residue 30 is indicated by the dashed line. The hydrophobic 
index (Segrest and Feldmann, 1974) is listed underneath e a ch uncharged 
sequence stretch. 
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uncharged 21 amino acid stretches spanning residue numb e rs 331-351 
and 362-382. A comparison of the amino acid distribution of these 
two sequence segments and the observed distribution for a sample of 
membrane-penetrating segments is presented in Table 2-4. The stretch 
of residues 331-351 differs from the observed distribution more than 
the stretch of residues 362-382 especially at residues Gln, Met and 
Asn. This comparison would suggest that residue stretch 362-382 is 
the best candidate for a transmembranous orientation. This is 
consistent with the observation that residues 362-382 have a higher 
hydrophobicity index (1.14) than that for residues 331-351 (0.52; see 
Figure 2-14). However, it should be added that the calculated 
hydrophobicity index of the composite observed sequence (Table 2-4) 
is 2.42, somewhat higher than for either of the two uncharged 
stretches. 
Internal Repeats in the Primary Amino Acid Sequence of the _Nd_h 
Protein 
The detection of an obvious 15 bp internal repeat in the ndh 
structural gene (Figure 2-11) gave impetus to a more thorough search 
for further internal homology. Using visual inspection (Dr H.D. 
Campbell) and the Staden (1977) program SEQFIT two large repeats of 
approximately 130 amino acids in the first ~300 residues and two 
smaller repeats of ~20 amino acids near the C-terminus were detected 
(Campbell, Rogers and Young, 1982). The probabilities of these 
repeats arising by chance, as assessed by the computer program ALIGN 
(Dayhoff, 1978) are <10- 15 and 10- 10 , respectively (Campbell, Rogers, 
Young, Yeh and Dayhoff, 1983). These findings are indicative of a 
primordial gene duplication. The segments with the best homologies 
are listed in Figure 2-15. 
Table 2-4. Observed Amino Acid Distribution for a Sample of 
Membrane-Penetrating Segments: Comparison with 
Amino 
Two Long (21 residues) Uncharged Amino Acid Stretches 
in the .NQh Sequence 
Number of Residues 
Acid a Observed- b 331-351-- b 362-383-
Leu 
Ala 
Val 
Phe 
Ser 
Ile 
Pro 
Gly 
Cys 
Met 
Thr 
Tyr 
Gln 
Trp 
Asn 
His 
a 
b 
3.9 1 4 
2.3 6 0 
2.2 0 2 
1.8 0 I 
1.8 0 5 
2.5 1 0 
0 0 0 
1.5 1 3 
1.2 1 0 
0.9 3 1 
1.3 1 2 
0.4 0 0 
0.1 3 0 
0.1 0 0 
0 3 2 
0 1 1 
Total 20.0 21 21 
Number of residues/20 amino acids; derived from a composite of 
10 known membrane-penetrating sequences (Heijne, 1981) 
Residue numbering taken from sequence . 
Figure 2-15 . Regions of Internal Sequence Homology in the E. coli Respiratory NADH Dehdyrogenase 
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Residue numbering is t aken from sequence (see Figure 2-7). 
Identical residues are indicated by an asterisk. 
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Sequence Homology Between the NADH Dehydrogenase and Other Enzymes 
Evolutionary relationships between dehydrogenases (Rossman, 
Liljas, Br~nden and Banaszak, 1975; J8rnvall, 1980) and pyridine 
nucleotide disulphide oxidoreductases (Holmgren, 1980) have been 
subjected to scrutiny in recent years. 
With the aim of elucidating the evolutionary relatedness of the 
NADH dehydrogenase to other proteins a small protein sequence 
database was compiled and protein sequences were subjected to 
sequence comparisons using the program SEQFIT (Staden, 1977). 
Special attention was given to oxidoreductases and respiratory 
enzymes. A number of proteins were found to have some sequence 
homology with the E.coli respiratory NADH dehydrogenase. 
One enzyme which was shown to possess homology with the NADH 
dehydrogenase was the human erythrocyte glutathione reductase 
(Krauth-Siegel, Blatterspiel , Saleh, Schiltz, Schirmer and 
Untucht-Grau, 1982) . The glutathione reductase subunit (mol wt 
50000) consists of three structural domains corresponding to binding 
of FAD and NADPH and a flat interface domain where glutathione 
disulphide is bound (Holmgren, 1980; Schulz, Schirmer, Sachsenheimer 
and Pai, 1978) . The two nucleotide-binding domains of the flavo-
enzyme have similar chain folds and are believed to have arisen by 
gene duplication (Schulz, 1980) . The enzyme is well characterized 
and its three dimensional structure (Thieme, Pai, Schirmer and 
Schulz, 1981) and complete sequence is known (Krauth-Siegel et al., 
1982; Untucht - Grau, Schirmer, Schirmer and Krauth-Siegel, 1981). 
Amino acid sequence homology studies suggest that lipoamide 
dehydrogenase, thioredoxin and glutathione reductase are all 
evolutionarily related (Holmgren, 1980). More recently, it has been 
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shown that the chain-fold of the FAD-binding domain of 
p-hydroxybenzoate hydroxylase resembles the chain folds of the two 
nucleotide-binding domains of glutathione reductase (Wierenga, Drenth 
and Schulz, 1983) . 
Upon comparing the sequences of the! · coli NADH dehydrogenase 
and the human erythrocyte glutathione reductase, a striking section 
of sequence homology between the duplicated regions was observed 
(Figure 2-16). The probability of the sequence homology being due to 
chance, as assessed by the computer program ALIGN (Dayhoff, 1978) is 
<10-9 (Campbell et al., 1983). 
The internal sequence homologies within the NADH dehydrogenase, 
by analogy with the two known glutathione reductase domains, allow 
the assignment of a particular function to each of the repeated 
internal sequence homologies. Consequently, it is concluded that the 
internal sequence repeats ( regions defined as A, B, C, D and E, and 
A', B', C', D' and E' in Figure 2-15) can be assigned as the FAD and 
NADH nucleotide binding domains, respectively. The NADH 
dehydrogenase sequence is compared with the known sequence and 
correlated with the known three-dimensional structure of glutathione 
reductase in Table 2-5. 
It should not be implied from this data that all pyridine 
nucleotide binding domains are homologous. For example, structural 
studies suggest that all of the following enzymes have NADPH-binding 
domains that are different from one another in their chain folds and 
are not homologous:_!:. casei dihydrofolate reductase, spinach 
ferredoxin reductase, Ps. fluoescens p-hydroxybenzoate hydroxylase 
and liver 6-phosphogluconate dehydrogenase (Krauth-Siegal et al., 
1982). 
Figure 2-16 . Sequence Homology between Duplicate Regions in the 
Human Glutathione Reductase and the E.coli Respiratory 
NADH Dehdyrogenase 
-L V I ,..., G G s G G L A s A \..:1 1: RR A A E - LG AR 
2: GIL SA - LG SK V I V GGG y I A V E M A 
-3: 
4 : 
V I V G G G A G G L E M A T Q L G H K L G A K 
- -A I V G G G A T G V E L s A E L H N A V K Q L 
1: Glutathione Reductase,residues 24-45 
2: Glutathione Reductase,residues 191-212 
3: NADH Dehydrogenase,residues 9-31 
4: NADH Dehydrogenase,residues 174-196 
The residue numbering is as described in Krauth-Siegel 
et al. (1982) and Figure 2-7, respectively. 
Table 2-5. The N-terminal S-Sheet Strand and the Subsequent 
Pyrophosphate - Binding Loop in FAD-Dependent Enzymes 
and in Flavodoxin 
P . C rotein-
p-Hydroxybenzoate 
hydroxylase (Ps. fluroescens) 
D-amino acid oxidas~ (pig) 
b Glutathione reductase (man)-
FAD-binding domain 
a NADH dehydrogenase - (E. coli) 
Flavodoxin (Clostridium MP) 
Adenylate kinase (pig, man)i 
a Lipoamide dehydrogenase- (pig) 
Glutathione reductasei 
NADPH-binding domain (man) 
a d NADH dehydrogenase-'- (E. coli) 
Sheet 
st r and 
Phosphate 
loop 
-Val 5-A-I-I-G-A- G-P - S 
-Val 3-V-V-I-G-A-G-V-I 
-Ty r 23-L-V-I-G-G-G-S-G 
-Ile 8-V-I-V-G-G-G-A-G 
-Val 4-Y-W-S-G-T-G-N-T 
-Ile 11-F-V-V-G-G-P-G-S 
-Val 9-X-V-I-G-S-G-P-G 
-Ser 190-V-I-V-G-A-G-Y-I 
-Ile 173-A-l-V-G-G-G-A-T 
a Tertiary structures are unknown; for these flavoenzymes the 
alignment is based on sequence. 
b 
C 
d 
As indicated by the position numbers (Val-5, Val-3, etc), the 
strand sheet which is located in the protein's interior is 
very close to the N-terminus. The special case of the long 
N-terminal extension is discussed in Untucht-Grau et al., (1981). 
References defined in Untucht-Grau et al ., (1981). 
Adenylate kinase and the NADPH-domain of glutathione reductase 
which do not bind FAD nor FMN represent numerous other 
nucleotide binding structures . NADH dehydrogenase binds 
NADH not NADPH . 
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Interestingly, the frdA gene product sequence and the beef heart 
succinate dehydrogenase share nine consecutive residues at their 
flavin binding site (Cole, 1982). The FAD cofactor is believed to be 
covalently bound to a histidyl residue (residue 45 in the frdA 
protein, Cole, 1982; Weiner and Dickie, 1979). The NADH 
dehydrogenase also has a histidine at position 45, however there is 
no discernible sequence homology in the vicinity of the histidyl 
residue. 
Another member of the disulphide reductase class of 
flavoproteins, mercuric reductase, which possesses striking 
spectroscopic similarities to the lipoamide dehydrogenase and 
glutathione reductase has recently been purified and characterized 
(Fox and Walsh, 1982). In contrast to the three disulphide 
reductases, mercuric reductase catalyzes no net reduction of a 
substrate disulphide but rather the more unusual two-electron 
reduction of inorganic Hg 2+. It will be interesting to see when 
sequence data becomes available, whether this enzyme shares homology 
with the NADH dehydrogenase. 
The two smaller repeats of approximately 20 amino acids near the 
C-terminus (probabilities of these repeats arising by chance <10-10; 
Campbell et al., 1983) are not related to any section of sequence 
from glutathione reductase. The function of the short C-terminal 
repeats (assigned as F/F' in Figure 2-15) is unknown. One 
possibility is that they are involved in ubiquinone reduction. If 
this is so, the ubiquinone 'domain' may have come about by a gene 
fusion event as has occurred in the evolution of other dehydrogenases 
(Rossman et al., 1975). 
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The complete nucleotide sequence of the malK gene product of E. 
coli has recently been published (Gilson, Nikaido and Hofnung, 
(1982b). Gilson et al., (1982b) claim to have found significant 
homology between the sequence of the malK protein and that of the 
respiratory NADH dehydrogenase of_§_. coli. However, the homology 
itself is marginal and Gilson et al. (1982b) admitted difficulty in 
assigning any functional significance to the putative homology. 
SUMMARY 
The complete nucleotide sequence for the ndh structural gene has 
been determined using the Sanger chain-termination method (Sanger, 
1981). This represents the first respiratory dehydrogenase to be 
sequenced (Young et al., 1981). Analysis of the sequence has 
revealed the following features: (a) A putative promoter 
approximately 40 bp upstream from the initiation codon, (b) two 
inverted repeats, one upstream from the initiation codon (covering 
sections of the putative promoter), and the other immediately after 
the stop codon. The latter repeat is believed to act as an RNA 
transcription termination structure. (c) A ribosome binding site, 
complementary to the 16S ribosomal RNA immediately precedes the 
initiation codon. (d) UUG, which codes for N-formylmethionine rather 
than the usual leucine residue, acts as an atypical initiation codon. 
The ndh structural gene codon composition and codon usage is 
consistent with the NADH dehydrogenase being only a minor component 
of the total E. coli protein . 
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The amino acid composition of the NADH dehydrogenas e is 
indistinguishable from an 'average' composite E.coli prot e in deduc e d 
from a sequence database. The enzyme is not particularly hydrophobic 
as the following parameters indicate: polarity= 43.4% 
(Capaldi and Vanderkooi, 1972) and the average hydrophobicity index= 
1.95 kJ/mole residue as calculated according to Heijne (1980) and 
Gilson et al., (1982a). 
There are nine stretches of ten or more uncharged residues in 
the NADH dehydrogenase amino acid sequence. The hydrophobic 
stretches tend to be more prevalent in the last 100 residues of the 
enzyme. Calculation of the hydrophobicity indices (Segrest and 
Feldmann, 1974) of the uncharged stretches showed that none were 
distinguishable from uncharged stretches present in known soluble 
proteins. Using sequence comparisons between a composite membrane-
penetrating sequence (Heijne, 1981) it was deduced that only one 
amino acid stretch (residues 362-382) is likely to be 
transmembranous. 
An examination of the primary amino acid sequence, both by 
manual inspection (Dr H.D. Campbell) and the use of the computer 
program SEQFIT (Staden, 1977) led to the detection of internal 
homology within the enzyme. There are two large repeating units of 
-130 amino acids near the N-terminus of the protein and two smaller 
repeats of -20 amino acids near the C-terminus. The probabilities of 
these repeats arising by chance, as assessed by the computer 
programme ALIGN, are 10-15 and 10-lO, respectively (Campbell et al., 
1983). 
Comparison of the primary amino acid sequence of the enzyme with 
other proteins led to the detection of homology with glutathione 
57. 
reductase (P<lo-9). By comparison with the well known three-
dimensional structure of glutathione reductase , the two large N-
terminal repeats of the NADH dehydrogenase can be assigned as the FAD 
and NADH binding domains . The function of the short C- terminal 
repeats is unknown . One possibility is that they are involved in 
ub i quinone reduction . 
Chapter 3 
Catalytic Activity of Purified and Reconstituted E.coli 
NADH Dehydrogenase with different Ubiquinone Homologues 
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INTRODUCTION 
The Role of Ubiquinone in Electron Transport 
Ubiquinone was first postulated to be a member of the electron 
transport chain primarily because this ubiquitous, neutral lipid
 is 
capable of oxidation-reduction and is present in mitochondria (Crane, 
Hatefi, Lester and Widmer, 1957). Some twenty years after this 
proposal, ubiquinone is now well established as an obligatory r
edox 
component of the electron transport chain of mitochondria and s
ome 
bacteria (Trumpower and Katki, 1979). Some of the most compelling 
evidence for its obligatory role comes from extraction and 
reactivation studies in mitochondria (Lester and Fleischer, 1959; 
Ernster et al., 1969a,b) and studies with ubiquinone-deficient 
mutants of E.coli (Cox et al., 1970; Wallace and Young, 1977a,b) and 
Saccharomyces cerevisiae (De Kok and Slater, 1975). The mechanism of 
ubiquinone function and the number of sites at which it acts, 
however, remains less well understood. 
The mobile carrier hypothesis states that there is a single, 
homogeneous pool of ubiquinone which diffuses between the prima
ry 
electron transport complexes in the phospholipid continuum of t
he 
membrane and that there are specific sites for oxidation-reduct
ion of 
ubiquinone located in the lipoprotein domains of the dehydrogen
ase 
complexes and the bc 1 complex (in the case of mitochon
dria). 
Kr8ger and Klingenberg (1970;1973a,b) have investigated the mobile 
carrier hypothesis and have shown that the kinetics of oxidatio
n-
reduction and the steady state redox characteristics of ubiquino
ne 
are consistent with a model in which 80-90% of the ubiquinone ex
ists 
as a functionally homogeneous pool and there are not separate 
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compartments of ubiquinone for the different substrates such as ADH 
and succinate. 
More recently, Zhu, Berden, De Vries and Slater (1982) have 
suggested that free mobile ubiquinone is not necessarily required for 
apparent pool-function behaviour and that both direct interaction 
between ubiquinone-loaded enzymes and diffusion of ubiquinone and 
ubiquinol are involved in the electron transfer from the 
dehydrogenases to the ubiquinol:cytochrome ~ oxidoreductase. 
Studies involving electron paramagnetic resonance (EPR) 
spectrometry have indicated the existence of ubisemiquinones in the 
electron transport chain of mitochondria (Ingledew, Salerno and 
Ohnishi, 1976; Ruzicka, Beinert, Schepler, Dunham and Sands, 1975). 
As pointed out by Ingledew et al. (1976) the ubisemiquinones must be 
located in an ubiquinone-protein complex and could not be free to 
diffuse because this would lead to disproportionation and subsequent 
loss of EPR signals . However, the percentage of ubiquinone which is 
present as ubisemiquinone is calculated to be very small in the 
mitochondrial membrane (~1%; Crane, 1977) and in the inner-membrane 
of E . coli (<2%; Cox et al . , 1970). The role of ubisemiquinone in 
electron transfer is still uncertain. 
Hence, the view that the bulk of the ubiquinone in the membrane 
functions as a mobile carrier of reducing equivalents is not 
universally accepted. It has also been proposed that the actual 
carrier is ubiquinone bound to specific ubiquinone binding proteins 
(QPs; Mr 12000-15000; Yu, Yu and King, 1977; Yu and Yu, 1980a). 
Furthermore, it has been asserted that there is a ubiquinone binding 
protein functioning in the mitochondrial NADH:ubiquinone 
oxidoreductase (Yu and Yu, 1981) . However, to date the most pure QP 
preparation contains at least 10% impurities including detectable 
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cytochrome E._ (Yu and Yu, 1981). Also, Hatefi and Galante (1980) 
demonstrated that purified cytochrome E..SGO (two peptides of Mr 
13500 and 15000) of Complex II is able to r econstitute the succinate : 
ubiquinone r e ductase complex when added to purified succinate 
dehydrogenase. It is not clear at present whether the QPs isolated 
by Yu et al. (1977) and the cytochrome E..sso preparation of Hatefi and 
Galante (1980) are related. 
Recent work by Schneider et al. (1980;1982) has provided further 
experimental evidence to support the earlier proposals by Green and 
Wharton (1963) and Kr8ger and Klingenberg (1973a,b) that ubiquinone 
is a mobile electron carrier which functions as a homogeneous pool 
during the transfer of electrons between dehydrogenases and the 
cytochrome bc 1 complex. Schneider et al. (1980) e xami ned the rates 
of specific catalytic events in the mitochondrial inner membrane 
after enriching the membrane bilayer with exogenous phospholipid. 
From this data, they concluded that a diffusion-limited step was 
involved in the transfer of reducing equivalents from the 
dehydrogenases to cytochromes bc 1 in the native membrane. Similar 
experiments by Schneider et al. (1982) gave results which did not 
support proposals in which ubiquinone functions as a protein-bound 
electron carrier (for further discussion see Chapter 1). 
The chemiosmotic hypothesis formulated by Mitchell (1961;1973) 
has greatly contributed to our knowledge of the role of the 
'protonmotive force' in bioenergetics and the nature of the 
electrochemical proton gradient. The proton-motive ubiquinone cycle, 
proposed by Mitchell (1975a,b;l976) suggested a direct role for 
ubiquinone in the generation of the electrochemical proton gradient. 
The view that lipophilic quinones can be used to establish 
transmembrane proton gradients is supported by studies of 
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nonenzymatic ubiquinone oxidation in a model lipid-bilayer system , 
which showed that autooxidation of ubiquinol-6 formed by addition of 
NADH on one side of the lipid-bilayer caused the formation of a 
proton gradient across the membrane (Yaguzhinsky, Boguslavsky and 
Ismailov, 1974). 
The Role of Ubiquinone in E.coli 
Studies by Cox et al. (1970) on the role of ubiquinone in E. 
coli detected the existence of ubisemiquinone by EPR spectrometry. 
They proposed a scheme in which ubisemiquinone, complexed to an 
electron carrier, functions in the electron-transport sequence. 
Further studies by Downie and Cox (1978) on the amount s of 
cytochromes reduced during aerobic steady-state conditions suggested 
that ubiquinone functions at two sites, one site being betwee n the 
dehydrogenases and cytochromes and the second site being after 
cytochromes ~ 562 and ~ 556 but before cytochromes ~ 558 , _i and o. 
However, due to difficulties involved in the measurement of the 
amount of cytochrome ~ 562 reduced, the exact position of the firs
t 
ubiquinone site is in doubt (Downie and Cox, 1978). 
Wallace and Young (1977b) used a double quinone mutant of E. 
coli, ubiA menA, to examine the role of quinones in electron 
transport to oxygen and nitrate. They demonstrated that each of the 
four oxidases examined (NADH, D-lactate, a-glycerophosphat e and 
succinate) requires a quinone for activity. Furthermore, ubiquinone 
is active in each oxidase system while menaquinone gives full 
activity in a-glycerophosphate oxidase, partial activity in D-lactate 
oxidase but is inactive in NADH and succinate oxidation 
(Wallace and Young, 1977b; see electron transport scheme in Chapter 
1 ) . 
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Wallace and Young (1977 b ) conclud e d t ha t t he quinones se r ve t o 
link the various dehydro genases with th e termina l el ec tron t r a n sport 
systems to ox yge n and nitrate and that the d e h ydroge n ase s pos ses s a 
d eg ree of selectivity with respect to the quinone a c ce p to rs. 
Howe v e r, Wallace & Young , (1977a,b) did not e xcl ude t h e possib i lit y 
that ubiquinone functions at other sites in the respirat ory cha in. 
Experiments with other ubiquinone mutants of!· c o li ( ub iE, 
ubiF and ubiG mutants) indicated that certain substituents of the 
benzoquinone ring of ubiquinone-8 are important in d e termining 
whether or not the quinone can interact with e ach of the various 
dehydrogenases involved in electron transport (Wallace and Young , 
1977a). These results provided further support for the conc e pt that 
each dehydrogenase has specific structural requirements for quinone 
acceptors. In contrast to the ring substituents, the leng th of the 
isoprenoid side chain is a less critical feature of the ubiquinone-8 
molecule for activity in the four oxidases tested. As shown by 
Wallace and Young (1977b), when ubiquinone-3 was a dded to ubiA menA 
membranes the rates of oxidation of NADH, D-lactate, 
a-glycerophosphate and succinate were approximately equal to those 
found in men membranes. Moreover, electron transport promot e d by 
ubiquinone-3 was found to be coupled to phosphorylation. 
Inhibitors of Electron Transfer Mediated by Ubiquinone 
Inhibitors have played a vital role in the elucidation of the 
function of various components of the respiratory chain. Inh ibi t ors 
have especially contributed to the detection of artifactual 
activities, such as the ubiquinone reductase of the type II 
mitochondrial NADH dehydrogenase. Hatefi and Stiggall (1976) po i n t e d 
out that not only does the type I and type II NADH d ehydroge nas e 
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preparations differ in molecular weight, substrate reductase 
activities and iron-sulphur content but piericidin A, which is the 
most potent inhibitor known for ubiquinone reduction by complex I and 
submitochondrial particles, is ineffective on ubiquinone reduction by 
the soluble enzyme (type II dehydrogenase). Furthermore, substantial 
inhibition of NADH:ubiquinone-1 reductase activity of the soluble, 
low molecular weight enzyme requires more than 100-fold as much 
rotenone as is necessary for a comparable degree of inhibition of 
complex I. Both rotenone and piericidin are believed to act at the 
same site (Ragan, 1976a). 3-It is interesting that the Fe(CN)
6 
reductase of the type I dehydrogenase (Singer et al., 1973) and 
complex I (Hatefi and Stiggall, 1976) is not appreciably inhibited by 
rotenone. 
Schatz and Racker (1966) described experiments involving various 
electron acceptors that suggest that oxidative phosphorylation at the 
first phosphorylation site is only observed if electrons passed 
through the rotenone-sensitive site in submitochrondrial particles. 
In the same report, a rotenone-insensitive 'group' in the NADH 
dehydrogenase which reduces ubiquinone-1 was described (Schatz and 
Racker, 1966). Singer et al. (1973) also noted that in experiments 
with different electron transport particle preparations, inhibition 
by rotenone and piericidin was 'leaky', a small fraction of NADH 
oxidase remains. Wan , Williams and Folkers (1975) corroborated these 
reports when they demonstrated that 5-7% of the NADH:ubiquinone-1 
oxidoreductase activity of electron transport particles still 
remained in the presence of rotenone (2 µM concentration). 
Inhibitors of the electron transport chain of .E'...· coli have also 
been reported. Early studies by Jones (1967) verified that the NADH 
oxidase activity of E.coli W was inhibited (~85%) by HQNO at a 
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concentration of 60 µM. Bragg and Hou (1967a) also found that the 
NADH oxidase of E.coli was sensitive to inhibition by HQNO (62% and 
81% inhibition with HQNO at concentrations of 16 µMand 32 µM, 
respectively). Cox et al. (1970) found that the extent of HQNO 
inhibition of the E. coli NADH oxidase was similar to that previously 
reported by Jones (1967), and Bragg and Hou (1967a) but they also 
demonstrated that the inhibition was reversed by the addition of 
ubiquinone-1 . 
Ubiquinone Reductase Activity of Purified E. coli NADH Dehydrogenase 
Many experimental approaches have been used in attempts to 
elucidate the role of ubiquinone in electron transfer. One major 
shortfall is that these experiments have generally been performed on 
very complex preparations composed of many proteins, a large number 
of which are poorly characterized. The purification of the E.coli 
respiratory NADH dehydrogenase, which is composed of a single 
polypeptide (Jaworowski et al., 1981a) of known amino acid sequence 
(Young et al., 1981) provides a unique opportunity to investigate the 
properties of ubiquinone reduction by one polypeptide uncomplicated 
by the complexity of an entire respiratory chain. 
Ubiquinone-8 has been established as the in vivo substrate for 
the! · coli respiratory NADH dehydrogenase (Wallace and Young, 
1977a,b). However, the solubility of this compound in aqueous 
solution is low and this led to the rejection of ubiquinone-8 as a 
substrate for routine use. 
Previous work in this laboratory on the solubilization and 
purification of the!· coli NADH dehydrogenase used ubiquinone-1, a 
water-soluble short chain homologue of ubiquinone, as acceptor 
(Jaworowski et al., 1981a) . Ubiquinone-1 can reconstitute NADH 
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oxidase activity 1n ubi men membrane vesicles (Cox et al., 1970; 
Young, unpublished results) and can act as a soluble substrate for 
both purified enzyme and native E. coli membrane vesicles (Jaworowski 
et al., 1981a). 
Since for routine assays ubiquinone-1 is employed as substrate, 
whereas the in vivo substrate 1s ubiquinone-8, verification that the 
purified enzyme is capable of reducing long chain isoprenoid 
ubiquinones is required. 
In the present study the catalytic activity of the purified E. 
coli NADH dehydrogenase has been examined with short and long chain 
homologues of ubiquinone. The purified enzyme has been reconstituted 
into soybean phospholipid (neutral lipid free) vesicles and 
alterations in the biochemical properties of the enzyme have been 
examined. 
MATERIALS AND METHODS 
Chemicals 
Ubiquinone-1 was kindly supplied by Dr 0. Isler (F. Hoffman-La 
Roche and Co. Basel, Switzerland). NADH was from P-L Biochemicals 
(Milwaukee, WI), and FAD was from Sigma Chemical Co. (St. Louis, MO). 
N-Tris (hydroxymethyl) methyl-2-aminoethanesulphonic acid, sodium 
salt (Tes), was obtained from Calbiochem (La Jolla, CA). 2-n-
heptyl-4-hydroxyquinoline N-oxide (HQNO) was obtained from Sigma 
Chemical Company (St. Louis, MO) . Purified cholic acid was kindly 
supplied by Dr H.D. Campbell and was twice recrystallized from 50% 
(v/v) aqueous ethanol by a procedure similar to that of Hatefi 
(1978). Stock 20% (w/v) solutions of potassium cholate, pH 7.5, were 
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prepared by suspending 20 g of cholic acid in -so mL of H2 0 and 
titrating the mixture to pH 7.5 over several hours with concentrated 
KOH. The completely colourless solution was then made up to 100 mL, 
filtered, and stored at room temperature. K3Fe(CN) 6 used for NADH: 
3-
Fe(CN)6 oxidoreductase activity measurements was of analytical 
reagent grade (BDH (Australia) Pty Ltd, Sydney). KCN used as an 
inhibitor of the terminal oxidase of the respiratory chain was 
analytical reagent grade (BDH (Australia) Pty Ltd, Sydney). All 
organic solvents were of analytical reagent grade. 
Preparation of Ubiquinone-8 
Up to 30 g (wet weight) of cells were placed into an extraction 
thimble and then extracted with acetone (150 mL) in a Soxhlet 
extraction apparatus for 4 hours. The acetone extract was evaporated 
to dryness on a steam bath, the residue extracted three times with 
50 mL light petroleum (b.p. 60-80°C) and the extract concentrated. 
The combined extract was chromatographed on a GF254 (Merck) silica 
gel plate (0.5 mm thick, 18 x 20 cm). The chromatograms were 
developed in CHC1 3 :petroleum spirit (b.p. 60-80°C), 7:3 (v/v) and 
the dark yellow ubiquinone band (Rf= 0.3), was removed from the 
silica plate and eluted six times with 2 mL redistilled absolute 
ethanol (Merck, AnalR). 
The ubiquinone-8 concentration was determined 
spectrophotometrically by measuring the difference in absorbance at 
275 nm after reduction (5 minutes) with solid NaBH
4 
(Sigma, 
Analytical Reagent) and using 6E = 12500 M-1 cm-1 (Crane and Barr, 
1971). 
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Assays 
Routine assays were performed using a Varian 634 series 
spectrophotometer. Ultraviolet and visible absorption spectra were 
obtained using a Cary 118 spectrophotometer. 
NADH:ubiquinone oxidoreductase activity was measured at 30°c 
by following ubiquinone dependent NADH oxidation at 340 nm in a 1 mL 
reaction mixture containing 50 mM Tes buffer, pH 7.5, 250 µM NADH, 40 
µM FAD, enzyme and 50 µM ubiquinone-1. The reaction was started by 
the addition of enzyme and rates were calculated by using ~E = 6810 
M-1 cm-1 (Schatz and Racker, 1966). NADH oxidase activity was also 
measured spectrophotometrically by using the system described above, 
except that ubiquinone was not added and the rates were calculated 
using ~t = 6220 M- 1 cm-1. The oxidase here refers to the activity of 
the intact respiratory chain in oxidizing NADH and reducing 
endogenous ubiquinone-8 present in E. coli membranes at 2.2 nmole 
mg-1 protein (Wallace and Young, 1977b). Electrons are transported 
through the respiratory chain until they reach the KCN inhibitable 
terminal oxidase (the site of oxygen reduction). The mechanism of 
the oxidase in the respiratory chain is distinct from the oxidase 
observed with the purified enzyme. In the case of IY13 membranes the 
NADH oxidase to NADH:ubiquinone-1 oxidoreductase activity ratio is 
about 0.4-1.0 whereas with the purified enzyme the ratio is ~0.01. 
With the purified enzyme the exact mechanism whereby the enzyme and 
NADH and oxygen interact to oxidize NADH is unknown although FAD 
involvement is postulated. 
Stock ubiquinone-1 (Q-1), ubiquinone-3 (Q-3) and ubiquinone-8 
(Q-8) solutions of 20 mM concentration in redistilled absolute 
ethanol were prepared and standardized spectrophotometrically as 
described previously (Crane and Barr, 1971). 
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3-NADH:Fe(CN)6 oxidoreductase activity was measured at 4 20 nm and 
30°c, using ~E = 1000 M- 1 cm- 1 . The 1 mL reaction mixture 
contained 50 mM Tes buffer, pH 7.5, 250 µM NADH , 40 µM FAD, enzyme 
and 1 mM K3Fe(CN) 6 . The reaction was started by the addition of the 
electron acceptor . When membranes were assayed for either 
. 3-
NADH:ubiquinone or NADH:Fe(CN) 6 oxidoreductase activity, 3 mM KCN 
was incubated for 3 minutes at 30°C with the membranes prior to the 
addition of electron acceptor. This resulted in )90% inhibition of 
the NADH oxidase activity. 
Because of potential turbidity problems, NADH:ubiquinone-8 
oxidoreductase activity assays involving reconstituted vesicles were 
performed using an Aminco Chance DW2 dual wavelength 
spectrophotometer. The assays with the Aminco spectrophotometer were 
monitored in the dual wavelength mode at sample and reference 
wavelengths of 340 nm and 395 nm respectively and a spectral bandpass 
of 3 nm. The reference wavelength was chosen because this was the 
closest wavelength to the sample wavelength that did not undergo a 
significant change in absorbance upon NADH oxidation. Assays that 
were done in the presence of DMK-1 (demethylmenaquinone-1) diazide 
used a reference wavelength of 410 nm to avoid the strong absorption 
peak at 385 nm (E = 28400 M-1 cm-1, see Figure 3-1 and 3-2 for 
spectra) with this compound. 
DMK-1 diazide, final concentration 150 µM, was incubated at 
various times in the assay buffer in the presence of NADH and enzyme 
and the reaction was initiated by the addition of ubiquinone. In the 
case of the inhibition results presented in the tables in this 
chapter, DMK-1 diazide was preincubated with the enzyme for 5 minutes 
and HQNO, final concentration 12 µM , was preincubated for 3 minutes . 
Figure 3-1. Ultraviolet Absorption Spectrum of DMK-1 Diazicte 
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Spectrum of DMK-1 diazide at 50 µM concentration in absolute ethanol. 
Figure 3-2 . Visible Absorption Spectrum of DMK-1 Diazide 
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Spectrum of DMK-1 diazide at SO µM concentration in absolute ethanol . 
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All assays for the Lineweaver-Burk plots were done in duplicate 
and the points for each determination were averaged. The K 
m 
(Michaelis-Menten constant) and V (maximal velocity) were 
m 
calculated using a linear regression computer program kindly provided 
by Dr S. Stone. 
The method used to determine the stoichiometry of NADH oxidized 
to NAD+ and the reduction of ubiquinone to ubiquinol was as follows: 
IY13 membrane vesicles were added to a 1 mL assay mix and inhibited 
)95% with 3 mM KCN. The reference and sample cell absorbance 
difference reading was adjusted to A340 = 1.0. Ubiquinone was added 
to give a final concentration of 50 µMand the reaction course was 
monitored on a chart recorder . After approximately 4 minutes the 
rate of NADH oxidation had declined to a constant basal rate. This 
constant basal rate was extrapolated to the origin (time of reaction 
= 0). From the record chart the extrapolated A340 reading was 
subtracted from 1.0. The difference in absorbance at 340 nm enabled 
the amount of NADH oxidized to be calculated using 6E = 6810 M-1 
cm-
1
. This method of calculation assumes that the basal rate of 
oxidation occurs at a constant rate even during the more rapid 
oxidation of NADH mediated via ubiquinone reduction. 
Although the reported specific activity of the purified enzyme 
(Jaworowski et al ., 1981a) is 500-600 units mg-1 protein, this can 
vary greatly (100-600 units mg-1 protein) between different purified 
enzyme preparations. 
One unit of activity in the spectrophotometric assay is defined 
as the amount of enzyme catalyzing the oxidation of 1 µmole of NADH 
min- 1 . Specific activity is defined as units per mg of protein. 
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Protein Estimation 
Protein concentrations were determined by the method of Lowry, 
Rosebrough, Farr and Randall (1951) using defatted bovine serum 
albumin (BSA) as standard. BSA stock solutions, nominally 10 mg 
mL-1, were standardized spectrophotometrically using A~~m' 280 nm= 
6 . 7 . 
Synthesis of DMK-1 diazide 
DMK-1 diazide was kindly supplied by Dr H.D. Campbell. It was 
synthesized according to the method of Reid and Dietrich (1961). Tne 
DMK-1 diazide was purified by thin layer chromatography before use. 
Solutions of the purified compound in redistilled ethanol were stored 
at -20°c. No changes in the ultraviolet and visible spectra of the 
compound were observed after storage over several months (Figures 3-1 
and 3-2). 
Preparation of Membranes 
Membranes were prepared at 4°c. Cells were harvested by 
centrifugation and washed once with STM buffer (0.25 M sucrose, 0.1 M 
Tes, 0.02 M magnesium acetate, pH 7.5). The cells were resuspended 
in buffer at 1 g wet weight/3 mL STM buffer and disrupted using a 
Ribi cell fractionator at 20000 lb/inch 2 • The cell smash was 
centrifuged at 15000 rpm for 1 hour in a Sorvall SS-34 rotor. The 
supernatant was centrifuged for 2 hours at 60000 rpm in a Spinco 60Ti 
rotor. The pellet, containing crude membranes was resuspended to a 
protein concentration of -40 mg mL-1. The resuspended membrane 
vesicles were centrifuged as before and the pelleted membrane 
vesicles were resuspended to a protein concentration of approximately 
35 mg mL-1. 
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Membrane vesicles were snap frozen using liquid nitrogen and stored 
at -20°c. 
Bacterial Strains 
The ndh mutant strain IY12 (thi his ilv trp rpsL ndh), a 
derivative of E.coli Kl2, has been described previously (Young et 
a 1 . , 1 9 7 8 ) . I Y 13 ( th i h i s i 1 v t r p rps L) i s an i so gen i c t rans formant 
of IY12. 
RESULTS AND DISCUSSION 
The Stoichiometry of Ubiquinone Reduction 
The stoichiometry of NADH oxidized to NAD+ and the corresponding 
amount of ubiquinone reduced to ubiquinol was determined with 
purified enzyme and IY13 membrane vesicles (Table 3-1). It was found 
to be ~1:1 for ubiquinone-1 with pure enzyme, and for ubiquinone-1 
and ubiquinone-3 with IY13 membrane vesicles (terminal oxidase 
inhibited with KCN). The 1:1 stoichiometry is as e xpected for the 
oxidation of NADH to NAD+ and the concomitant reduction of ubiquinone 
to ubiquinol. However, it does not preclude the involvemen t of 
ubisemiquinone as an intermediate since the disproportionation 
reaction would be extremely rapid (Kr8ger and Klingenberg, 1973a). 
Michaelis Constants for Different Ubiquinone Homologues 
Little is known about the mechanism of the reaction catalyzed by 
the respiratory NADH dehydrogenase. The stereospecificity of the 
reaction has been examined and it has been shown that hydride 
Table 3-1. + Stoichiometry for the Oxidation of NADH to AD and 
the Concomitant Reduction of Ubiquinone to Ubiquinol 
Ubiquinone 
Substrate 
nmol NADH oxidized 
nmol Q reduced 
Preparation 
Q-1 1.0 
Q-1 1.1 
Q-3 1.1 
purified 
enzyme 
IY13 
membranes 
IY13 
membranes 
The stoichiometric determinations were performed as 
described in the Materials and Methods . 47 µg protein 
of membrane vesicles were added in each assay. 
Purified enzyme (O. 32 1-1g was assayed in the same 
manner except that the addition of KCN was omitted. 
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transfer occurs from the 4B position of the nicotinamide ring of NADH 
(Campbell, unpublished). At the present time no further information 
is available concerning the mechanism of FAD reduction or the 
mechanism of electron transfer to ubiquinone. 
If the respiratory NADH dehydrogenase possesses a specific 
ubiquinone binding site then the reduction of ubiquinone should 
follow a hyperbolic kinetic course. However, if ubiquinone interacts 
in a non-specific manner, ie random collision, then ubiquinone 
reduction should follow a linear kinetic course. It was shown that 
the purified enzyme has a linear Lineweaver-Burk plot for the 
reduction of ubiquinone-1 (Figure 3-3). The apparent Michaelis 
constant for NADH oxidation by purified NADH:ubiquinone 
oxidoreductase under the assay conditions used was previously 
estimated to be -57 µM from Lineweaver-Burk plots over the range 7-
150 µmole NADH (Jaworowski et al., 1981a). The NADH oxidase activity 
--
of IY13 membrane vesicles exhibited an apparent Km for NADH of 
-55 µM, similar to the value obtained for the purified enzyme 
(Jaworowski et al., 1981a). In the present experiments NADH was used 
at 250 µM concentration to ensure saturation . 
It is clear from Figure 3-3, that the purified enzyme has a 
specific ubiquinone binding site and high catalytic activity. The 
reported specific activity of the E . coli NADH:ubiquinone 
oxidoreductase is considerably greater than that of complex I, 500-
600 versus 16 µmole NADH oxidized min-1 mg-1 protein (Jaworowski et 
al., 1981a; Ragan , 1976a) . However, the specific activity of 
different purified E. coli enzyme preparations can vary greatly (100-
600 units rng-l min- 1). The apparent Km for ubiquinone - 1 reduction 
by!· coli purified enzyme (8 .2 µM) is lower than that recorded for 
complex I (44 µM; Ragan, 1976a) . 
Figure 3-3 . Lineweaver-Burk Plot for the Reduction of Ubiquinone-1 
by Purified NADH :ubiquinone Oxidoreductase 
r-------,,------,. 0. 06 r----,-----.---.----,.--.----.----.---.---.,.----.. 
0.04 
1 
V 
. -1 
units mg 
0.02 
-0.1 0.1 0.2 0.3 
1 
Q-1 
-1 
77 units mg 
0.4 
-1 (µM) 
Assays of NADH:ubiquinone oxidoreductase activit y were performed as 
described in the Materials and Methods. 0. 32 µg of purified enzyme 
was added to each assay. 
0.6 
73. 
In order to examine the effect of ubiquinone side c h a in l e ng th 
on the apparent~ and Vm, Lineweave r-Burk plots for the 
reduction of ubiquinone-0 and ubiquinone-3 were determined (Fi g ures 
3-4 and 3-5). The apparent K for ubiquinone-0 (130 µM) with m 
purified enzyme is greater than ten times the apparent Km f or 
ubiquinone-1 (8.2 µM) and ubiquinone-3 (9.5 µM) (Figures 3-3 and 
3-5, respectively). This suggests a minimum requirement of one 
isoprene unit for optimal binding. 
The apparent Kms for the reduction of ubiquinone-1 and 
ubiquinone-3 with native IY13 membrane vesicles were similar to those 
with purified enzyme (Figure 3-6 and 3-7 and summary in Table 3-2). 
Although the Vs for ubiquinone-1 and ubiquinone-3 reduction were m 
similar in the IY13 membranes, in the case of the purified enzyme 
there was a significant difference between the Vms (77 versus 19 
units mg-1 respectively; see Figures 3-3 and 3-5). Hence, the 
difference in isoprenoid side chain length significantly affects 
catalysis. One explanation for the difference would be that since 
ubiquinone-3 is more hydrophobic than ubiquinone-1, the reduced 
product (ubiquinol-3) may not partition as readily back into the 
aqueous phase but would remain in a position on the enzyme which 
slows down the free passage of unreacted substrate to the active 
site . Attempts were also made to determine these parame ters for the 
naturally occurring ubiquinone homologue (ubiquinone-8) but too great 
a variability was found presumably due to the insolubility of this 
compound. 
It is obvious that the use of hydrophobic substrates (eg 
ubiquinone long sidechain homologues) presents difficulti e s for 
assays. One possible means of increasing ubiquinone r e ductas e 
Figure 3-4 . Lineweaver -Burk Plot fo r the Reduction of Ubiquinone-0 
by Purified NADH : ubiquinone Oxidoreductase 
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Assays of NADH :ub i qu i none oxidoreductase activity were performed as 
described in the Materials and Methods . See Figure 3- 3 for further 
d e t ails . 
Figure 3-5. Lineweaver-Burk Plot for the Reduction of Ubiquinone-3 
by Purified NADH:ubiquinone Ox i doreductase 
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Assays of NADH:ubiquinone oxidoreductase activity were performed as 
described in the Materials and Methods . See Figure 3-3 for further 
details. 
Figure 3-6 . Lineweaver-Burk Plot for the Redu c tion of Ub iquinone-1 
by IY13 Membrane Vesicles 
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Assays of NADH :ubiquinone oxidoreductase activity were performed as 
described in the Mater i a 1 s a nd Methods . 4 7 }1 g pro t e in was added to 
each assay . 
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Figure 3-7. Lineweaver-Burk Plot for the Reduction of Ubiquinone-3 
by IY13 Membrane Vesicles 
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Assays of NADH :ubiquinone oxidoreductase activity were performed as 
described in the text. See Figure 3-6 for further details . 
Table 3-2. ~!<m and Vm Values Determined Using Various Ubiquinones 
as Substrates with Purified Enzyme and IY13 Membranes 
Quinone 
Homologue 
Q-0 
Q-1 
Q-3 
Purified Enzyme 
K 
m 
(µM) 
130 
8.2 
9.5 
V 
m 
(units mg-1 ) 
63 
77 
19 
IY13 Membranes 
K 
m 
(µM) 
9.0 
3.7 
V 
m 
(units mg-1) 
0.69 
0.59 
Assays were performed as described in the Materials and Methods 
and the appropriate figure legends. Lineweaver-Burk plots are 
illustrated in Figures 3-3, 4, 5, 6 and 7. 
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activity is to perform assays with detergent present which would 
increase the solubility of hydrophobic substrates. 
The effect of cholate on the ubiquinone-1 and ubiquinone-3 
oxidoreductase activities of purified enzyme and the NADH oxidase 
activity of IY13 membrane vesicles was assessed. It was clear that 
the presence of 0.5-1.0% (w/v) cholate leads to stimulation of the 
ubiquinone-3 reductase activity especially in the case of the 
purified enzyme. However, at this cholate concentration range, the 
ubiquinone-1 reductase activities of the purified enzyme and IY13 
membrane vesicles as well as the NADH oxidase of the IY13 membranes 
were inhibited (-60-80%). 
A more membrane-like microenvironment could facilitate release 
of the product and stimulate ubiquinone-3 reductase activity. In an 
attempt to test this hypothesis, pure enzyme was reconstituted into 
soybean phospholipid vesicles (neutral lipid free) according to the 
cholate dialysis method (Racker, 1979; Hokin, 1981; Eytan, 1982; see 
Chapter 4 for further details). When the reconstituted enzyme was 
assayed for ubiquinone reductase activity it was demonstrated that 
the ubiquinone-3 reductase was -70% of the observed ubiquinone-1 
reductase activity (see Table 3-5). This relationship is very 
similar to the relative Vms determined for ubiquinone-1 and 
ubiquinone-3 reduction with IY13 membranes (Table 3-2) and contrasts 
with the relatively low ubiquinone-3 reductase activity of the pure 
enzyme (Table 3-2). 
Action of Inhibitors 
It was of interest to examine the effect on the ubiquinone 
reductase activities of purified enzyme and IY13 membrane vesicles of 
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inhibitors known to inhibit electron transport. Although a number of 
inhibitors were considered, including piericidin and rotenone, 
preliminary experiments indicated that HQNO and DMK-1 diazide were 
the most promising. Both HQNO and DMK-1 diazide have structures 
which resemble the naphthoquinones (Figures 3-8). Although HQNO has 
been used as a potent inhibitor of mitochondrial NADH and succinate 
oxidase activities (Nijs, 1967; Brandon, Brocklehurst and Lee, 1972; 
Ark and Berden, 1977; Burger, 1980; Zhu et al., 1982) it has not 
been explicitly claimed that HQNO is a ubiquinone analogue or that it 
specifically acts at a ubiquinone binding site. Nonetheless, Cox et 
al . (1970) also reported that the NADH oxidase of E. coli was 
inhibited at low concentrations (16 µM) of HQNO and that inhibition 
was reversed by the addition of ubiquinone-1. 
DMK-1 diazide was designed and synthesized by Dr H.D. Campbe ll. 
The author has undertaken its preliminary characterization as an 
inhibitor of electron transfer in the E.coli respiratory chain. 
The effect of HQNO and DMK-1 diazide on the ubiquinone-1, 
ubiquinone-3 and Fe(CN)~-reductase activities of the purified enzyme 
is shown in Table 3-3. Both inhibitors gave strong inhibition of 
ubiquinone-1 reductase activity. HQNO was ineffective as an 
3-inhibitor of the NADH:Fe(CN) 6 oxidoreductase activity of the 
purified enzyme, whereas DMK-1 diazide reduced this activity to less 
than 5% of the untreated enzyme . This result infers that the site of 
action of the two inhibitors is not the same. The failure of HQNO to 
inhibit the NADH:Fe(CN)~- oxidoreductase activity of the!· coli 
enzyme while being a potent inhibitor of NADH:ubiquinone-1 
oxidoreductase activity is analogous to the action of rotenone in 
mammalian mitochondria (Hatefi and Stiggal l, 1976) . 
Figure 3-8. Structures of HQNO and DMK-1 Diazide 
DMK-1 diazide 
(demethylmenaquinone-1 diazide) 
OH 
N 
~ 
0 
HQNO 
(2-n-heptyl-4-hydroxyquinoline-N-oxide) 
Table 3-3. HQNO and DMK-1 Diazide as Inhibitors of Ubiquinone-1, 
Ubiquinone-3 and Fe(CN)i- Reductase Activities of 
Purified Enzyme 
Inhibitor 
HQNO 
DMK-1 
diazide 
Purified Enzyme 
Activity (units mg-1 ) 
Q-1 
Reductase 
270 
25 
12.8 
Q-3 
Reductase 
27 
23 
Fe(CN)g-
Reductase 
89 
91 
2.6 
Assays of NADH:ubiquinone and NADH:Fe(CN)i- oxidoreductase 
were performed as described in the Materials and Methods. 
76. 
A time course of the inhibition of NADH:ubiquinone-1 and 
3-NADH:Fe(CN)6 oxidoreductase activities of the purified enzyme by 
DMK-1 diazide is illustrated in Figure 3-9. The slope of the lines 
in Figure 3-9 differ by (10% which suggests that DMK-1 diazide 
3-affects both the NADH:ubiquinone-1 and NADH:Fe(CN) 6 oxidoreductase 
activities in the same manner. The time courses and the dependence 
on concentration of HQNO and DMK-1 diazide inhibition of 
NADH:ubiquinone-1 oxidoreductase activity were significantly 
different (Figures 3-9 and 3-10). Concentrations of HQNO greater 
than 12 µM, were incompatible with the assay conditions. However, as 
shown in Figure 3-10, at an HQNO concentration of 12 µMand after 2-4 
minutes incubation with pure enzyme or IY13 membrane vesicles, the 
extent of inhibition (~70% and 75%, respectively) reached a plateau. 
The residual 'HQNO insensitive' (~20-30%) activity is reminiscent of 
the mitochondrial rotenone insensitive portion of the NADH:ubiquinone 
oxidoreductase (see Introduction). No such effect was observed with 
DMK-1 diazide as an inhibitor of the NADH:ubiquinone-1 oxidoreductase 
activity of purified enzyme (Figure 3-9). 
When ubiquinone-3 was used as a substrate of the purified enzyme 
it was found that the extent of inhibition by HQNO was markedly 
reduced (Table 3-3) . This effect was not observed with reconstituted 
enzyme or normal membranes where the rates with ubiquinone-3 as 
substrate more closely approximated those with ubiquinone-1 (Tables 
3-4 and 3-5). 
In agreement with previous reports (Jones, 1967; Bragg and Hou, 
1967a; Cox et al., 1970) HQNO gave strong inhibition of the NADH 
oxidase activity of IY13 membrane vesicles at similar concentrations 
to those used with the purified enzyme (Table 3-4). In this case it 
Figure J-9. Inhibition of NADH:Fe(C )i- Oxidoreductase Activity 
of Purified Enzyme by DMK-1 Diazide 
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The assays were performed as described in the Materials and Methods. 
The only alteration to the procedure was that the time of incubation 
in the presence of DMK-1 diazide was varied. 
Figure 3-10. Inhibition of the NADH :ubiquinone -1 Oxidoreductase 
Activity of Purified Enzyme and IY13 Membrane Vesicles 
by HQNO : Time Course and Dependence on Concentration 
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The assays were performed as described in the Materials and Methods . 
The different symbols represent various concentrations of HQNO : 
C+) 1.2 i.i:1 , C•) 6 µM , and ( B) 12 µM. 
77. 
is possible that HQNO is also acting at sites other than the NADH 
dehydrogenase. The NADH:ubiquinone-1 and NADH:ubiquinone-3 
oxidoreductase activities of IY13 membrane vesicles and enzyme 
reconstituted into phospholipid vesicles were also strongly inhibited 
by both HQNO and DMK-1 diazide (Tables 3-4 and 3-5). DMK-1 diazide 
was also assessed as an inhibitor of the respiratory NADH 
dehydrogenase of rat liver mitochondrial vesicles (kindly supplied by 
P.H. Reinhart and prepared according to procedures described in 
Reinhart, Taylor and Bygrave, 1982). DMK-1 diazide (concentration of 
150 µM) after incubation with mitochondrial vesicles for 3 minutes in 
the presence of NADH produced 70% inhibition of the NADH oxidase 
levels. Under similar conditions DMK-1 diazide inhibited the 
NADH:ubiquinone-1 oxidoreductase to levels of 85%. HQNO 
(concentration of 12 µM) was less effective but still gave 50% 
inhibition. 
Ubiquinone-8 as a Substrate 
The purified enzyme was capable of catalyzing the reduction of 
ubiquinone-8, albeit at a reduced rate compared to the rate of 
reduction of ubiquinone-1 (4%; Table 3-6). The reconstituted enzyme, 
however, was relatively more effective than the purified enzyme in 
catalyzing the reduction of ubiquinone-8 (25%; Table 3-6). 
In wild type membranes such as those of IY13, the NADH oxidase 
activity is generally 40-80% that of the NADH:ubiquinone-1 
oxidoreductase activity. The NADH oxidase rates can be used to 
approximate the NADH:ubiquinone-8 oxidoreductase activity of the NADH 
dehydrogenase in vivo since amplification experiments indicate that 
the dehydrogenase is rate limiting in natural membranes . Thus, the 
Table 3-4. Inhibition of NADH Oxidase, NADH:ubiquinone-1 and NADH: 
ubiquinone-3 Oxidoreductase Activities of IY13 Membrane 
Vesicles by HQNO and DMK-1 diazide 
Inhibitor 
HQNO 
DMK-1 
diazide 
Assays were 
Methods. 
IY13 Membrane Vesicles 
Activity (units mg-1) 
Oxidase 
0.27 
0.01 
0.09 
performed as 
Q-1 
Reductase 
0.72 
0.15 
0.06 
described in the 
Q-3 
Reductase 
0.51 
0.18 
0.11 
Materials and 
Table 3-5. HQNO and DMK-1 Diazide as Inhibitors of NADH:ubiquinone-1 
and NADH:ubiquinone-3 Oxidoreductase Activities of 
Reconstituted Enzyme 
Inhibitor 
HQNO 
DMK-1 
diazide 
Reconstituted Enzyme 
Activity (units m1-l) 
Q-1 
Reductase 
12 
3.7 
1.5 
Q-3 
Reductase 
7.9 
4.4 
0.9 
Assays were performed as described in the Materials 
and Methods with an Aminco Chance dual wavelength 
spectrophotometer. 
Table 3-6. Effect of Ubiquinone-8 on NADH:ubiquinone-1 
Oxidoreductase Activity 
Enzyme 
Preparation 
Ubiquinone Reductase Activityg_ 
Q-1 Q-8 Q-8+Q-lb 
Purified 
Enzyme 120 4.9 25 
Reconstituted 
C Enzyme- 11 2.7 12 
a 
b 
C 
Assays were performed as described in the Materials 
and Methods using Q-1 or Q-8 as acceptor (50 µM 
concentration) . The activity figures are given in 
units mg-l protein for purified enzyme and units 
mL-1 for reconstituted enzyme. 
After the reaction was initiated by the addition of Q-8 (50 µM final); Q-1 (50 µM final) was added and the 
ubiquinone dependent NADH oxidation was recorded. 
Purified enzyme was reconstituted into phospholipid 
vesicles by the cholate dialysis method (see 
Materials and Methods Chapter 4). 
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NADH:ubiquinone-8 oxidoreductase activity measured for purified NADH 
dehydrogenase reconstituted into phospholipid vesicles is approaching 
its activity in vivo . The hypothesis put forward previously was that 
the longer chain isoprenoid ubiquinones were able to act specifically 
with the purified enzyme but solubility in the aqueous phase 
presented difficulties for release of the reduced ubiquinone. If 
this explanation is correct then ubiquinone-8 should act as an 
inhibitor of NADH : ubiquinone-1 oxidoreductase of purified enzyme but 
act as a substrate in the case of the reconstituted enzyme. This 
assumes that t he ubiquinone homologues are acting at the same active 
site. The results obtained for the use of ubiquinone-8 as an 
inhibitor of ubiquinone-1 reductase in various enzyme preparations 
are shown in Table 3- 6. The results were consistent with the 
hypothesis formulated above and furthermore, with the reconstituted 
enzyme preparation the presence of ubiquinone-8 prior to the addition 
of ubiquinone - 1 did not lead to inhibition of the ubiquinone-1 
reductase (Table 3- 6). 
SUMMARY 
The stoichiometry of NADH oxidized to NAD+ and the corresponding 
amount of ubiquinone reduced to ubiquinol was found to be 1:1 with 
purified enzyme and IY13 membrane vesicles. 
The evidence presented in the present work verifies that the 
purified respiratory NADH dehydrogenase of E . coli is capable of 
reducing ubiquinone-1 at high rates without the involvement of any 
auxilliary protein(s) . The purified enzyme catalyzes the reduction 
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of various ubiquinone homologues. Apparen t Km values for 
ubiquinone-1 and ubiquinone-3 are <10 µM with the enzyme as purified 
and in native E.coli membrane vesicles. After reconstitution into 
phospholipid vesicles, the enzyme possesses high ubiquinone-8 
reductase activity. 
Results of kinetic and inhibition studies are consistent with 
the view that ubiquinone-1, ubiquinone-3 and ubiquinone-8 (the 
naturally occurring homologue in! · coli membranes) all act at the 
same catalytic site on the enzyme. 
HQNO, a known inhibitor of mitochondrial NADH and succinate 
oxidase, has been shown to inhibit the NADH oxidase, NADH:ubiquinone-
1 and NADH:ubiquinone-3 oxidoreductase activities of IY13 membrane 
vesicles. HQNO has also been shown to inhibit the NADH:ubiquinone-1 
oxidoreductase of purified enzyme as well as the NADH:ubiquinone-1 
and NADH:ubiquinone-3 oxidoreductase activities of reconstituted 
enzyme . It is interesting to note that HQNO was ineffective as an 
3-inhibitor of the NADH:Fe(CN) 6 oxidoreductase activity of purified 
enzyme . 
A novel inhibitor of ubiquinone reductase activity, DMK-1 
diazide, was synthesized (by Dr H . D. Campbell) and its effect on 
various enzymic activities of purified enzyme and IY13 membrane 
vesicles was assessed. DMK-1 diazide was shown to inhibit both the 
E . coli NADH oxidase, NADH:ubiquinone-1 oxidoreductase and 
3-
NADH:Fe(CN)6 oxidoreductase activities as well as the rat liver 
mitochondrial NADH oxidase and NADH:ubiquinone-1 oxidoreductase 
activities . 
These results are consistent with ubiquinone-8 being the 
immediate electron acceptor for the E. coli respiratory NADH 
dehydrogenase in vivo . 
Chapter 4 
Reconstitution of the Respiratory NADH:ubiquinone Oxidoreductase 
into Natural and Artificial Membranes 
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INTRODUCTION 
The Assembly of Proteins into Biological Membranes 
A major stimulus to membrane biology came with the development 
and exposition of the signal hypothesis to explain the mechanism of 
protein transfer across membranes (Blobel and Dobberstein, 1975). 
This hypothesis was further extended to include membrane proteins in 
general (Rothman and Lenard, 1977). The signal hypothesis seeks to 
explain the widespread occurrence of hydrophobic N-terminal leader 
peptides in membrane proteins and secreted proteins. These peptides 
are 15-30 residues long and are removed rapidly during, or shortly 
after, the peptides ' passage across the membrane. The signal 
hypothesis suggests that this N-terminal region binds to a receptor 
in the bilayer and is recognized by a membrane-bound peptide 
transport system. The ribosome catalyzes the peptide's synthesis and 
passage through this specific pore. On the opposite face of the 
bilayer , the emerging leader peptide is removed by a specific 
protease . 
A large body of evidence has been accumulated in support of a 
number of the postulates outlined in the signal hypothesis of Blobel 
and Dobberstein (1975). This evidence includes: (a) the isolation of 
a large number of precursors of secreted proteins from eukaryotes 
(Kreil , 1981) and prokaryotes (Mutoh , Inokuchi and Mizushirna, 1982) 
which possess an N-terminal signal peptide which is proteolytically 
cleaved upon excretion , (b) the detection of leader peptidases in 
eukaryotes (Jackson and Blobel, 1977; Strauss, Zimmerman, Boime, 
Ashe , Mumford and Alberts, 1979) and prokaryotes (Chang, Blobel and 
Model, 1978; Mandel and Wickner, 1979; Date and Wickner, 1981), (c) 
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the detection in E. coli of specific sites in the inner membrane 
where secreted proteins share a cormnon site of localization and 
processing (Ito, Bassford and Beckwith, 1981) and (d) the detection 
of a Signal Recognition Protein in microsomal membranes of dog 
pancreas (Walter, Ibrahimi and Blobel, 1981) and a 'Docking Protein' 
(Meyer, 1982; Meyer and bobberstein, 1980). The latter two proteins 
are cytoplasmic and are involved in the mechanism of vectorial 
transfer of secreted proteins across the endoplasmic reticulum 
membrane (Meyer, 1982). 
Although the signal hypothesis has proven to be very valuable, 
it fails to address a number of important questions. Firstly, the 
hypothesis stresses the role of translation as a mechanism whereby 
the nascent peptide passes through the membrane (Blobel and 
Dobberstein, 1975). However, as pointed out by Schatz (1979), 
several proteins destined to function in mitochondria are imported 
from the cytoplasm across the mitochondrial membrane independent of 
translation. Secondly, the signal hypothesis is ostensibly a 
proposed mechanism to explain how proteins are secreted through 
membranes and hence does not adequately address the fact that a large 
number of membrane proteins are neither secreted nor proteolytically 
cleaved. How do such proteins enter their respective membranes? 
Thirdly, ovalbumin has been shown to be a secreted protein yet it 
does not possess a hydrophobic N-terminal leader sequence (Palmiter, 
Gagnon and Walsh, 1978). 
Wickner (1979) proposed an alternative scheme termed the 
membrane trigger hypothesis which placed less emphasis upon 
catalysis in membrane assembly. The central distinctions between 
this model and the signal hypothesis are the absence of a peptide 
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transport system and the proposed role of the N-terminal l e ader 
peptide. According to the membrane trigger hypothesis, the N-
terminal leader peptide plays a part in directing protein folding 
prior to, or during, interaction of the protein with the lipid 
bilayer (Wickner, 1979). It is proposed that such interaction 
triggers spontaneous folding and conformational change of the protein 
leading to its insertion into the membrane without additional 
catalysis (ibid.). Subsequently, the N-terminal leader peptide is in 
many cases removed proteolytically (ibid.). However, a number of E. 
coli inner membrane proteins have now been sequenced which do not 
possess any processed N-terminal leader sequence (Table 4-1). 
Although some of the membrane proteins listed in Table 4-1 have 
hydrophobic amino acid stretches at the N-terminus (ndh, frdA and 
lacY), several do not (hisP, malK and frdB). 
Engelman and Steitz (1981) proposed an alternative scheme called 
the helical hairpin hypothesis which differed considerably from the 
signal and membrane trigger hypotheses. They proposed that the 
initial event in the secretion of proteins across membranes and their 
insertion into membranes is the spontaneous penetration of the 
hydrophobic portion of the bilayer by a helical hairpin. 
Furthermore, they suggest that secretion and insertion of membrane 
proteins are spontaneous processes that do not require the 
participation of additional specific membrane receptors or transport 
proteins (Engelman and Steitz, 1981; Steitz, Goldman and Engelman, 
1982). The major strength of the helical hairpin hypothesis over its 
predecessors is that it attempts to explain how proteins become 
membrane bound or secreted through membranes even though they lack a 
hydrophobic N-terminus or are not proteolytically processed. 
Table 4-1. Sequenced E . coli Inner-Membrane Proteins which do not 
possess Process ed - Terminal ''Leader Sequences" 
Gene 
ndh 
lacY 
uncB 
uncF 
uncE 
frdA 
frdB 
malK 
hisP 
Protein 
Respiratory NADH dehydrogenase 
Lactose permease 
Proteins comprising the 
proton channel of ATP -
synthase 
Flavoprotein subunit of 
the fumarate reductase 
Iron-sulphur subunit of 
fumarate reductase 
Component of the maltose 
transport system 
Component of the histidine 
transport system of 
S. t yphimurium 
Reference 
Young et al ., (19 81 ) 
Ehring, Beyreuther, 
Wright a nd Overath, 
(1 980 ); Btichel, 
Gronenborn and Mtiller-
Hill, (1980) 
Gay and Walker, 
(1981) 
Cole, (1982) 
Cole et al ., (1982) 
Gilson et al., (19 82a. ) 
Higgins et al., 
(1982) 
83. 
Nonetheless, it must be stressed that the helical hairpin hypothesis 
awaits experimental verification. 
Reconstitution of Membrane Proteins into Membrane Vesicles 
In the past decade the reconstitution of purified membrane 
proteins into artificial bimolecular lipid membranes has become a 
powerful tool in understanding the various functions of membrane 
proteins especially those involving transport activity (Racker, 1979; 
Hokin, 1981; Eytan, 1982). 
Membrane proteins have been reconstituted into artificial 
membranes by a variety of procedures including: (a) cholate (or 
other detergent)-dialysis, (b) detergent dilution, (c) sonication, 
(d) freeze-thaw-sonication and (e) incorporation and reconstitution 
into planar monomolecular and bimolecular membranes. 
The cholate dialysis procedure has been widely used and will be 
the only method further discussed here. The basic procedure is to 
mix the purified protein with an excess of phospholipid and 
detergent, usually cholate, and often at high ionic strengths. The 
detergent is then removed by dialysis over a period of 1-2 days. 
During this period, liposomes containing the protein are formed 
(Hokin, 1981). One disadvantage of the cholate dialysis procedure is 
that prolonged exposure to detergent can lead to inactivation of some 
membrane proteins. Hence, each membrane protein responds differently 
to the various reconstitution procedures, and at present the approach 
is entirely empirical (Racker, 1979). 
The orientation of membrane proteins in biological membranes is 
asymmetric (Rothman and Lenard, 1977). The proteins are confined to 
a specific surface of the membrane. Transmembranous proteins span 
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the membrane unidirectionally with a specific pole always protruding 
in the same direction. However, with reconstituted membrane proteins 
unidirectional orientation has been observed in some cases while in 
other cases the proteins are orientated in both directions across the 
membrane (Eytan, 19~2). 
Approximately a decade ago Kaback and his coworkers developed 
techniques for the preparation of bacterial membrane vesicles 
(Kaback, 1971; Kaback, 1974a,b). These vesicles have been 
characterized in detail (ibid.) and exhibit the same polarity and 
configuration as the membrane of the intact cell (Owen and Kaback, 
1979a,b). 
A number of different purified membrane-bound dehydrogenases 
have been reconstituted into prepared membrane vesicles. The 
following purified membrane-bound dehydrogenases when mixed with E. 
coli membrane vesicles can spontaneously insert into the membrane: 
the D-lactate dehydrogenase (Futai, 1974; Short, Kaback and Kohn, 
1974; Halder, Olsiewski, Walsh , Kaczorowski, Bhaduri and Kaback, 
1982), the glycerol -3-phosphate dehydrogenase (Futai, 1974; 
Schryvers, Lohmeier and Weiner, 1978), the D-amino acid dehydrogenase 
(Olsiewski, Kaczorowski , Walsh and Kaback, 1981; Halder et al., 
1982), and the respiratory NADH dehydrogenase (Jaworowski et al., 
1981b). 
Interestingly, reconstitution of D-lactate-dependent transport 
and oxidase activity has been observed in membrane vesicles with 
purified D-lactate dehydrogenase bound to either surface of the 
membrane (Short et al., 1974; Halder et al., 1982). Similarly, 
-- --
reconstitution of both right-side-out and inside-out vesicles with D-
amino acid dehydrogenase has been reported (Olsiewski et al., 1981; 
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Halder et al., 1982) . Furthermore, in the pres ence of D-al a nine , 
reconstituted right-side-out and inside-out vesicl e s ge nerated 
electrochemical proton gradients of similar magnitude but opposite 
polarity, indicating that enzyme bound to either surface of the 
membrane is physiologically functional (Olsiewski et al., 1981). 
It has been demonstrated that active NADH oxidas e can be 
reconstituted from the pure NADH : ubiquinone oxidore ductase and 
membrane vesicles prepared from ndh mutant strains (Jaworowski et 
al . , 1981b) . Jaworowski et al. (1981b) demonstrated that the 
purified enzyme preparation is reconstitutively far less active after 
dialysis against low ionic buffer. The decreased ability to 
reconstitute ndh mutant membrane vesicles after dialysis against low 
ionic strength buffer is reversible , since a reconstitutively active 
preparation can be obtained by further dialysis of such 
reconstitutively inactive preparations against 1 M potassium 
phosphate buffer (ibid . ) . Therefore , it is unlikely that the loss of 
a component of the enzyme during dialysis leads to a lowered 
efficiency of reconstitution . 
The ease with which the purified NADH dehydrogenase inserted 
into mutant membrane vesicles and the reversible effect of ionic 
strength on the efficiency of reconstitution provided an interesting 
basis for further study . In the work described 1n this chapter, the 
effect of ionic strength on the efficiency of reconstitution was 
examined in more detail and reconstitution experiments were performe d 
with spheroplasts to determine whether the purified NADH 
dehydrogenase could insert into the outer surface of the E.coli 
inner membrane . Conditions were also established for 
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efficient reconstitution of the enzyme into phospholipid v es icl e s by 
the cholate dialysis procedure. Consideration of the membrane 
biology of the!· coli NADH dehydrogenase is hampered by the lack of 
information concerning the membrane sector of the enzyme. It is 
clear that a portion of the enzyme including the NADH binding site is 
accessible from the cytoplasm. However, the extent and disposition 
of the membrane sector of the enzyme is unknown. In an attempt to 
obtain further information concerning this point the approach of 
limited proteolysis was used and these experiments are also described 
in this Chapter . 
Investigation of the Membrane Topography of Membrane Proteins by 
Proteolysis 
Despite progress in different areas of structural research, 
crystallography is still the only way to determine the three 
dimensional structure of proteins to atomic resolution . 
Unfortunately , membrane proteins are inherently difficult to obtain 
in a suitable crystalline form. Only in the case of 
bacteriorhodopsin from the purple membrane of the Halobacterium 
( Michel and Oesterhelt, 1980), porin , an outer membrane protein from 
E.coli (Garavito and Rosenbusch , 1980) and the mitochondrial 
cytochrome bc 1 complex (Ozawa , Tanaka and Shimomura, 1983) has the 
cryst a lline structure been demonstrated by X-ray diffraction (review, 
Michel, 1983) . However, these crystals have not been satisfactory in 
that they have not led to the determination of the proteins' three 
dimensional structure to atomic resolution. 
For proteins that are anchored in the membrane by a short 
hydrophobic tail, the functional part can often be released intact 
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from the membrane by suitable treatment with protease(s). The part 
that is released can then be treated as a soluble protein. The 
soluble form of cytochrome ~ 5 was crystallized about 10 years ago by 
Mathews, Levine and Argo (1972). 
The aspect of cytochrome .!:_5 and its reductase which has 
generated the greatest interest is their clearly amphipathic 
structure . Both consist of a globular N-terminal domain with a 
relatively polar amino acid composition containing the haem or the 
flavin group, and a smaller distinctly non-polar C-terminal domain . 
The domains can be separated and isolated because the linking r eg ions 
are particularly susceptible to protease. Tryptic cleavage of the 
cytochrome ~ 5 molecule yields a polar fragment, containing haem, a 
hydrophobic fragment associated with lipids and a linking peptide of 
15 residues (Visser, Robinson and Tanford, 1975; Spatz and 
Strittmatter, 1971) . Similarly, cleavage by chymotrypsin converts 
the 43000 mol wt NADH:cytochrome l5 reductase protein into a core 
enzyme (mol wt 33000) and aggregated hydrophobic peptides (Spatz and 
Strittmatter, 1971; 1973). 
In some other enzyme systems limited proteolysis has also been 
used successfully as a tool to identify membrane protein topography. 
Some examples include bovine cytochrome ~S (Fleming, Dailey, Corcoran 
and Strittmatter, 1978), Torpedo acetylcholine receptor (Wennogle and 
Changeux, 1980; Strader and Raftery, 1980) and the rat renal brush-
border membrane y-glutamyltranspeptidase and aminopeptidase (Tsao and 
Curthoys, 1980). Indeed, proteolysis was an essential strategy in 
the elucidation of the structure of bacteriorhodopsin (Ovchinnikov, 
Abdulaev, Feigina, Kiselev and Lobanov, 1977; 1979). 
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With some enzymes, limited action of a particular proteolytic 
enzyme has led to the separation and purification of separa te 
domains. This procedure was successful with the bifunctional 
Saccharomyces cerevisiae flavocytochrome ~' in which the 
flavoprotein domain (carrying FMN) and cytochrome domain (with the 
haem) were able to be separately purified (Gervais and Tegoni, 1980). 
A similar approach was used with the NAD-specific glutamate 
dehydrogenase of Neurospora crassa which led to the elucidation of 
two distinct domains which possibly arose by the fusion of two 
distinct genes (Haberland, Chen and Smith, 1980). 
Proteolysis studies of both the purified NADH dehydrogenase and 
genetically amplified IY91 membrane vesicles were undertaken with the 
aim of: (a) establishing the membrane topography of the respiratory 
NADH dehydrogenase, (b) 'liberating' any soluble portion of the 
enzyme from the membrane, (c) cleaving the enzyme at an interdomain 
site producing separate domains, one or more of which may possess 
partial catalytic activity and (d) defining the membrane-embedded 
amino acid sequence(s). 
MATERIALS AND METHODS 
Media 
The mineral salts medium employed has been described elsewhere 
(Stroobant, Young and Gibson, 1972) and was used at normal strength. 
Glucose and other supplements were sterilized separately and were 
added to give the following concentrations: 30 mM glucose, 40 mM 
succinate, 0.1% Casamino acids, 0.15 mM L-histidine HCl, 0.3 mM 
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L-isoleucine, 0.3 mM L-valine, 0.2 mM L-tryptophan and 1 µM thiamine. 
The amino acids were obtained from Sigma Chemical Company (St. Louis, 
MO). Membranes were prepared as described in Chapter 3. 
Bacterial Strains and Plasmids 
The ndh mutant strain IY12 (thi his ilv trp rps ndh), a 
derivative of E.coli Kl2, has been described previously (Young et 
a 1. , 19 78) . IYl 3 ( thi his i 1 v t rp rpsL) is an i sogenic trans formant 
of IY12. 
Plasmid pIYl (Young et al., 1978) possesses the 2500 base pair 
ndh fragment cloned into the EcoRI site of pSF2124 (So et al., 1975). 
Plasmid pLJ3 (Johnsrud, 1978) carries a double lac promotor fragment 
at the EcoRI site of pMB9 (Rodriguez, Bolivar, Goodman, Boyer and 
Betlach, 1976). Plasmid pIYlO is a derivative of pMB9, carrying the 
ndh and double lac promotor fragments at the EcoRI site. Plasmid 
pIYlO was transformed into strain IY12 as described previously 
(Jaworowski et al., 1981a). Selection of transformants carrying the 
ndh gene recloned into pMB9 was made on mannitol-minimal plates 
(Young and Wallace, 1976). Viable colonies were then tested for the 
presence of hybrid plasmids containing the lac fragment by plating 
onto mannitol-minimal plates containing X-gal (Jaworowski, et al., 
198la,b). Strains with multicopy plasmids carrying the lac promotor 
produce blue colonies on this medium (Johnsrud, 1978). Membrane 
vesicles prepared from three such clones were assayed for 
NADH:ubiquinone oxidoreductase activity and the clone with the 
highest specific activity was designated IY91. 
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Reconstitution of NADH Oxidase in Membranes De rived from Ndh IY12 
Mutants 
Two methods were used to reconstitute NADH oxidase in ndh mutant 
membrane vesicles using purified NADH:ubiquinone oxidoreductase. 
In the first method , 50 µL aliquots of membrane vesicl e s were 
placed into Eppendorf tubes (1.5 mL volume) at o0 c, and varying 
amounts of pure enzyme (0-80 µL of purified enzyme in 0.65 M 
potassium phosphate buffer, pH 7.5, -30 units m1-l; or enzyme from 
pooled peaks of NADH:ubiquinone oxidoreductase activity recovered 
from sucrose density gradients, -10 units m1-l) were added and mi x ed 
thoroughly. 5 µL of the mixture was assayed for NADH oxidase in an 
assay mixture containing 1 rnL 50 mM Tes buffer, pH 7.5, 20 µM FAD and 
250 µM NADH, preincubated at 30°c. The reaction was initiated by 
the addition of reconstituted membrane vesicles and followed at 340 
nm . The rate of NADH oxidation was calculated using ~E = 6220 
M-1 -1 cm . 
In the second method, 5 µL of ndh mutant membrane vesicles or 
spheroplasts was placed into 1 mL of assay buffer in a 1 mL quartz 
cuvette and preincubated at 30°C . In the spheroplast 
reconstitution experiment the assays were done in STM buffer with 250 
µM NADH present . In STM buffer the integrity of the spheroplasts was 
maintained . Various volumes of pure enzyme (0-80 µL of purified 
enzyme in 0 . 65 M potassium phosphate, pH 7 . 5 , -30 units mL- 1 ; or 
enzyme from pooled peaks of NADH : ubiquinone oxidoreductase activity 
obtained from sucrose density gradients, -10 units mL-1) were added 
and NADH oxidation was followed as described above . 
The rates of NADH oxidation obtained in both cases were 
corrected for the NADH oxidase activities of the mutant membrane 
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vesicles and the pure enzyme, measured individually in the above 
assay system. The membrane vesicles referred to throughout this 
chapter have an inside-out orientation unless specified otherwise. 
The IY12 spheroplasts did not possess any NADH oxidase activity. The 
relationship between the NADH oxidase activity of the purified enzyme 
and added volume was linear over the range used in these 
experiments. 
Preparation of Spheroplasts from E. coli Kl2 Strains 
Spheroplasts from different strains of E. coli Kl2 were prepared 
essentially as described by Kaback, (1971). Cells were grown in 
minimal media plus supplements until late logarithmic phase c~1so 
Klett units; Klett-Summerson colorimeter fitted with a blue filter). 
Cells were harvested by centrifugation (6000 rpm, 10 minutes, GSA 
Sorvall rotor) and the wet weight was determined. 
10 g wet weight of cells were resuspended in 200 mL of 10 mM 
Tris HCl, pH 7.5, at o0 c. The cells were pelleted and resuspended 
again in the same volume of fresh buffer. The cells were then 
repelleted and resuspended in 100 mL STM buffer. The cells were 
repelleted and resuspended in the same volume of fresh STM buffer. 
Potassium EDTA, pH 7.0, and lysozyme (egg white, Sigma Chemical Co.) 
were added to give final concentrations of 10 mM and 0.5 mg mL-1, 
respectively. The cells were slowly stirred for 30 minutes at room 
temperature. The spheroplasts were pelleted, and resuspended in 100 
mL of STM buffer and then pelleted once again. The spheroplasts were 
then resuspended in a minimum volume of STM buffer (~20 mL). The 
volume of the spheroplast suspension was adjusted so that 10 µL of 
spheroplasts added to 1 mL of STM buffer gave an absorbance of 0.2 
units at a wavelength of 600 nm. 
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Reconstitution of Purified NADH:ubiquinone Oxidoreductase into 
Soybean Phospholipid Vesicles 
The procedure used to reconstitute the purified enzyme was as 
described below: 80 mg of acetone/ether extracted (ie neutral lipid 
free) phospholipids from soybean were dissolved in 2 mL CHC1 3 , dried 
under a stream of N2 and then dissolved in 2 mL diethyl ether. 2 mL 
of cholate buffer (1.0% (w/v) cholate, 5 mM potassium phosphate, 
pH 7.5, 1 mM EDTA, 1 mM 2-mercaptoethanol and 20 µM FAD) was added to 
the dried phospholipid and sonicated (3xl minutes at o0 c) until 
homogeneous. 1 mg of concentrated enzyme was added to the 
phospholipid mix and left at o0 c for 5 minutes. The enzyme had 
previously been extensively dialyzed against 5 mM potassium phosphate, 
pH 7.5, 0 . 1% cholate (w/v), 20 µM FAD, 1 mM EDTA and 1 mM 2-
mercaptoethanol. 
The enzyme - phospholipid mix was placed into a dialysis bag and 
extensively dialyzed against a buffer composed of 5 mM potassium 
phosphate, pH 7.5, 1 mM EDTA, 1 mM 2-mercaptoethanol and 20 µM FAD at 
4°c . The dialyzed mixture was then diluted with dialysis buffer to 
3 . 8 mL volume and the phospholipid vesicles were pelleted by 
ultracentrifugation (38000 rpm, 3 hours, SW56 Beckman rotor). The 
pellet was resuspended to 1 mL in dialysis buffer at 4°c. 
Sucrose Density Gradients 
Stock sucrose solutions (BDH chemicals, analytical reagent) of 
50% (w/v) sucrose 1n distilled water and 0.5 Mand 0.7 M potassium 
phosphate buffer, pH 7.5, were prepared. A two compartment perspex 
gradient mixer was used to pour a 10 mL volume 5-30% (w/v) linear 
sucrose gradient in an 11 mL capacity SW41 Beckman polyallomer 
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centrifuge tube. In all cases, 50 µL of concentrated purified enzyme 
(5.2 mg mL-1 protein) after dialysis against either 5 mM potassium 
phosphate, pH 7.5, or 0.65 M potassium phosphate, pH 7.5, (also 
including 0.1% (w/v) cholate, 20 µM FAD, 1 mM EDTA and 1 mM 2-
mercaptoethanol) was loaded onto the top of the gradient. The 
gradient was centrifuged for 14.5 hours, 40000 rpm at 0°C in an 
SW41 Beckman centrifuge. After centrifugation -80 fractions of -120 
µL volume were collected in sterile plastic trays by piercing the 
bottom of the tube with a syringe needle. Fractions were assayed 
immediately after collection. The peaks of NADH:ubiquinone 
oxidoreductase activity were pooled and snap frozen using liquid 
nitrogen. 
Both the high and low ionic strength gradients were calibrated 
with standard globular protein markers. The markers used were E. 
coli S-galactosidase (Worthington Biochemical Corporation, New 
Jersey), mol wt -540000, s20 ,w = 13.9, bovine liver catalase (Sigma 
Chemical Co., St. Louis), mol wt -225000, S = 11.3 and human 
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haemoglobin, mol wt -57000, s20 ,w = 4.3. The human haemoglobin was 
purified from packed red blood cells according to the following 
procedure. Cells were washed in 0.9% (w/v) NaCl and lyzed by shaking 
with two volumes of cold (o0 c) distilled water and 0.5 volume of 
CC1 4 • Debris was pelleted by centrifugation for 5 minutes in a bench 
MSE centrifuge. Sodium phosphate buffer, pH 6.0, was added to the 
supernatant to give a final concentration of 0.1 M. The solution was 
then recentrifuged and the supernatant removed. After purification, 
25 mL of a 50 mg mL-1 solution was obtained. 0.5 mL aliquots were 
dialyzed against 5 mM and 0.7 mM potassium phosphate buffer, pH 7.5, 
containing 0.1% (w/v) cholate. 5 µL of the dialyzed sample 
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was diluted to 50 µL with dialysis buffer and then load ed onto the 
top of the sucrose gradients. Stock solutions of B-galactosidase (5 
mg mL-1) and catalase (5 mg mL- 1 ) were dialyzed as above and 50 µL of 
each was added undiluted to the top of the sucrose gradients. 
Each standard protein was detected by measuring the absorbance 
at a wavelength of 405 nm of 50 µL of the fractions added to 1 mL of 
50 mM potassium phosphate buffer, pH 7.5. Assays of catalase and B-
galactosidase were also performed. 5 µL of fractions from the 
catalase peaks, detected by absorbance at 405 nm, were added to a 1 
mL quartz cuvette containing 1 mL of 50 mM potassium phosphate buffer, 
pH 7.5, plus 20 mM H20 2 and the change in absorbance at a wavelength 
of 240 nm was recorded. B-galactosidase was assayed by the addition 
of 5 µL from gradient fractions to a 1 mL assay mixture containing 
0.50 mg mL-1 of o-nitrophenyl-S-D-galactopyranoside in 50 mM 
potassium phosphate, pH 7.5 buffer. The change in absorbance at a 
wavelength of 405 nm was recorded. 
Proteolysis of Purified Enzyme and Membrane Vesicles 
Trypsin (bovine) which had been treated with TPCK (L-(tosyl 
amido-2-phenyl) ethyl chloromethyl ketone) to inhibit contaminating 
chymotryptic activity, was purchased from Worthington Biochemical 
Corporation, Freehold New Jersey. Chymotrypsin (bovine) was also 
from Worthington Biochemical Corporation, New Jersey and subtilisin A 
and pronase CB (B grade) were purchased from Novo Industries 
Copenhagen. Stock solutions of 4 mg mL-1 in 5 mM potassium phosphate 
buffer, pH 7.5, of the appropriate proteolytic enzyme were fr esh ly 
prepared prior to each experiment. Protease inhibitors were not 
added to the proteolysis mixture unless otherwise stated. After 
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incubation with proteolytic enzyme (2% w/w protein), samples were 
removed and derivatized in boiling (l00°C) SDS sample buffer (30 mM 
Tris HCl, pH 6.8, 5% (w/v) SDS, 5% (v/v) 2-mercaptoethanol and 5% 
(w/v) glycerol) for 5 minutes. Therefore, samples were denatured as 
quickly as possible to minimize proteolysis during derivatization. 
Comparison of samples SDS derivatized in the presence (0 minutes 
incubation) and absence of protease demonstrated that significant 
proteolysis of the sample did not occur during derivatization (see 
Figure 4-8). 
SDS-Polyacrylamide Gel Electrophoresis 
SDS-polyacrylamide gel electrophoresis was performed with 
vertical slab gels (10 x 14 cm) in which the separation gel contained 
a linear 10-25% (w/v) concentration gradient of acrylamide. The gels 
also possessed a stacking gel of 4.5% (w/v) polyacrylamide, using an 
apparatus similar to that described by Studier (1973). The 
discontinuous SDS buffer system of Laernmli (1970) was used. Gels 
were run at a constant current of 30 mA for 3-4 hours at room 
temperature. Gels were fixed at 65°c for 20 minutes in 200 mL of 
10% (w/v) trichloroacetic acid and stained with 200 mL Coomassie 
Brilliant Blue R250 (0.1% (w/v) in destainer) for 20 minutes at 
65°c then destained at room temperature using a mixture of 
ethanol/glacial acetic acid/water (25:8:67 v/v/v). 
Gels were scanned using a Schoeffel model SD3000 
spectrodensitometer at 540 nm and using a slit width of 0.5 mm and 
the relative amounts of polypeptides were estimated. For the 
determination of molecular weights the following proteins were used 
as standards: ovalbumin, catalase, lysozyme, myoglobin, cytochrome c 
and human haemoglobin (95% pure). 
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The amounts of protein loaded ont o the SDS-polyac r y lamid e ge l s 
we re -10 µg protein per lane for the purifi e d e nzyme and - 40 0 µg 
protein per lane f or the membrane vesicles. Protein conc e ntra ti on s 
were determine d as described in Chapter 3. 
Sephadex G-75 Chromatography of Purified NADH:ubiquinone 
Oxidoreductase 
0.5 mL of concentrated enzyme (3.1 mg mL- 1 , 204 units mg-1 
protein) was chromatographed on a Sephadex G-75 column (80 mL total 
volume). The column was equilibrated with a buffer composed of the 
following: 0.65 M potassi·um phosphate, pH 7.5, 0.1% (w/v) cholat e , 
1 mM EDTA and 1 mM 2-mercaptoethanol. Chromatography was p e r f orme d 
at 4°c. Fifty fractions, each of 0.86 mL volume, were colle cted 
and assayed for NADH:ubiquinone and NADH:Fe(CN)~- oxidoreductase 
activities as described in Chapter 3. 
Purified enzyme was digested with trypsin and chromatog raphed as 
described below: 0.7 mL of concentrated enzyme (3.1 mg m1-l, 204 
units mg-l protein) was incubated with 15 µL of a 4 mg m1-l solution 
of trypsin for 2.5 hours at 25°c. 25 µL of an ethanolic solution 
of phenylmethylsulphonyl fluoride (PMSF) with a concentration of 20 
mg m1-l was added and the mixture was incubated for a further 45 
minutes. After incubation, 0.5 mL of the e nzyme solution was 
chromatographed on the G-75 Sephadex column as described above and 
the remaining 0.2 mL was dialyzed at 4°c for 16 hours against a 
buffer composed of 5 mM potassium phosphate, pH 7.5, 0.1% (w/v) 
cholate. 5 µL of the dialyzed sample was derivatized in sample 
buffer and subjected to electrophoresis on an SDS-polyacrylamid e 
gel. 
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RESULTS AND DISCUSSION 
Correlation Between Aggregation State, Ionic Strength and 
Reconstitutive Activity 
The purified NADH dehydrogenase has been shown to spontaneously 
insert into membranes isolated from ndh strains of E.coli and to 
reconstitute the NADH oxidase activity (Jaworowski et al., 1981b). 
This interesting property has been reported to be largely abolished 
if the purified enzyme is dialyzed against low ionic strength buffer 
(ibid.) . The state of aggregation of the purified enzyme in response 
to ionic strength has been examined as a possible reason for the 
altered efficiency of reconstitution. 
Samples of purified NADH:ubiquinone oxidoreductase were dialyzed 
against different ionic strength buffers each having 0.1% (w/v) 
cholate present. Dialyzed enzyme samples were loaded onto 5-30% 
(w/v) linear sucrose gradients and ultracentrifuged under conditions 
described in the Materials and Methods section. Purified 
NADH:ubiquinone oxidoreductase and internal globular proteins were 
subjected to sucrose density gradient ultracentrifugation in the 
same gradient tube. The gradient profiles in high and low ionic 
strength buffers are shown in Figures 4-1 and 4-2, respectively. The 
enzyme activity peaks were as expected and the recovery of enzyme 
activity was high, being 40% for the 0.7 M potassium phosphate 
gradient and 70% for the 3.5 mM potassium phosphate gradient. 
The gradient profiles demonstrate that the purified enzyme in 
low ionic strength buffer migrates through the sucrose gradient as a 
high molecular weight species. In contrast, the purified enzyme when 
centrifuged in high ionic strength buffer migrates through the 
Figure 4-1. Sucrose Density Gradient Centrifugation of NADH:ubiquinone 
Oxidoreductase in High Ionic Strength Buffer 
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The purified enzyme was loaded onto a 5-30% (w/v) sucrose density 
gradient in 0.7 M potassium phosphate, pH 7.5 buffer, containing 
0.1% (w/v) cholate. See Materials and Metho ds for further 
details. 
Figure 4-2. Sucrose Density Gradient Centrifuga tion of NADH:ubiquinone 
Oxidoreductase in Low Ionic Strength Buffer 
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The purified enzyme was loaded onto a 5-30% (w/v) sucrose density 
gradient in 3.5 mM potassium phosphate, pH 7.5 buffer, containing 
0.1% (w/v) cholate. See Materials and Methods for further 
details. 
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sucrose gradient with an M of 80000 and an estimated S of 6.3 
r 20,w 
(Figure 4-1 and 4-3). 
Unfortunately, it is not possible to conclude whether the enzyme 
exists as a monomer or dimer in high ionic strength buffer because of 
the uncertainties relating to the amounts of bound lipid and 
detergent under the conditions of the experiment (Bont, Ernmelot and 
Vaz Diaz, 1969; Helenius and Simons, 1972). 
To correlate the aggregation state of the enzyme with 
reconstitutive activity the activity peaks from the sucrose gradients 
were pooled and aliquots were taken and used to reconstitute the NADH 
oxidase of IY12 membrane vesicles. The two different methods 
employed are described in the Materials and Methods. The results 
illustrated in Figure 4-4 (Method 2) and Figure 4-5 (Method 1) 
clearly demonstrate that the dispersed form of the enzyme isolated 
from the higher ionic strength sucrose gradient is more active in the 
reconstitution of the IY12 NADH oxidase system than the enzyme 
preparation (aggregated form) isolated from the low ionic strength 
gradient. 
From the results presented in Figures 4-4 and 4-5, the 
efficiency of reconstitution can be estimated. This is defined as 
the units of reconstituted NADH oxidase per unit of added 
NADH:ubiquinone oxidoreductase. In Figure 4-4, the efficiencies of 
reconstitution were: 3.5 mM gradient, 2.3%, 0.5 M gradient, 7.9%, 
and 0.7 M gradient, 16.9%. A similar trend was observed with the 
results presented in Figure 4-5. 
The apparent ease with which the dispersed form of the enzyme 
becomes membrane-associated suggests that such a mechanism could 
Figure 4-3. Es timated s20 w Value for NADH : ubiquinone Oxidoreductase 
in High Ionic'Strength Buffer 
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See Figure 4-1 and Materials and Methods for further details. 
Figure 4-4 . Reconstitution of NADH Oxidase in IY12 Membrane Vesicles : 
Addition of Enzyme Peaks from Suc r ose Gradients 
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5 µL of IY12 membrane vesicles plus various aliquots of NADH: 
ubiquinone oxidoreductase (Oto 60 µL) from sucrose gradients were 
mixed together in 1 mL assay buffer and assayed spectrophotome trically 
for NADH oxidase. The enzyme samples added were from the following: 
(•) 3.5 mM (10.1 units mL-1), ( ) 0.5 M (4.3 units mL-1), and(&) 
0.7 M (10.3 units mL-1) potassium phosphate sucrose gradients . The 
resulting activity was corrected for the ADH oxidase activity of 
the membrane vesicles (0.27 units mL-1) and t h e pure enzyme samples 
(0.21, 0.15 and 0.26 units mL-1 , respectively ). See Materials and 
Methods for further details. 
Figure 4-5. Reconstitution of NADH Oxidase in IY12 Membrane Vesicles : 
Addition of Enzyme Peaks from Sucrose Gradients 
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Various volumes of NADH:ubiquinone oxidoreductase (Oto 80 µL) 
were added to 50 µL of IY12 membrane vesicles (at 0°C). The 
reconstituted vesicles were assayed spectrophotometrically for 
NADH oxidase and the rate corrected for the activity of the 
pure enzyme and IY12 membrane vesicles. The samples added were 
from the following: (•) 3.5 mM (10.1 units mL-1), ( ) 0.5 M 
(4.3 units mL-1 ), and (,.._) 0.7 M (10.3 units mL-1 ) potassium 
phosphate sucrose gradients. See Figure 4-4 and Materials and 
Methods for further details. 
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operate 1n vivo. The NADH dehydrogenase synthesized on membrane-
bound ribosomes could associate or insert into the membrane after 
folding into an active conformation. 
Reconstitution of NADH Oxidase Activity 1n Spheroplasts Prepared from 
1M.h Mutants 
The experiments described above indicated that the E. coli NADH 
dehydrogenase can readily become membrane-bound when mixed with 
inside-out membrane vesicles from ndh mutants. The NADH 
dehydrogenase or at least a portion of it appears to assume its 
normal membrane orientation as it efficiently reconstitutes the NADH 
oxidase. To do this the enzyme must reduce the endogenous ubiquinone 
1n the membrane phase. 
It was of interest to see whether the purified enzyme could 
become membrane-associated and reconstitute the NADH oxidase when 
added to the outside of the cytoplasmic membrane. Spheroplasts were 
prepared from the ndh mutant strain IY12 according to the procedure 
described in the Materials and Methods section. Attempts were made 
to reconstitute the NADH oxidase in the spheroplasts using purified 
enzyme. A control experime nt was carried out at the same time with 
inside-out membrane vesicles (prepared as described in Chapter 3). 
It is clear from the results shown in Figure 4-6 that purified enzyme 
can become membrane-associated when added to the outside of 
spheroplasts and reconstitute the NADH oxidase. This would suggest 
that reconstitution is not absolutely dependent on some specific 
mechanism operating from the cytoplasmic face of the inner membrane. 
The purified D-lactate dehydrogenase and D-amino acid dehydrogenase 
have also been reported to bind to either surface of the membrane 
(Short et al., 1974; Olsiewski et al., 1981; Halder et al., 1982). 
Figure 4-6. Reconstitution of NADH Oxidase in IY12 Membrane Vesicles 
and IY12 Spheroplasts 
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5 µL. of either IY12 membrane vesicles ( ) or 5 µL of IY12 
spheroplasts ( •), plus various aliquots of NADH:ubiquinone 
oxidoreductase (Oto 60 µL; 22 units mL-1 ) were mixed together 
in 1 mL assay buffer and assayed spectrophotometrically for 
NADH oxidase. The resulting activity was corrected for the 
NADH oxidase activity of the membrane vesicles (0.31 units mL-1 ) 
and purified enzyme (0.36 units mL-1 ). The spheroplasts alone 
did not possess any NADH oxidase activity. 
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The efficiency of reconstitution of each preparation represented 
in Figure 4-6 was calculated and found to be 19% for the inside-out 
membran~ vesicles and 2.0% for the spheroplasts. The figure for the 
inside-out membrane vesicles is comparable to previous results (see 
preceding section) . The amount of spheroplast membrane added in each 
assay was approximately one half of the quantity of the inside-out 
membranes added (as calculated from the wet weight of cells). Hence, 
the relative efficiency of the spheroplast reconstitution was 
approximately 20% of that for the inside-out membranes . 
Asymmetrical Distribution of NADH:ubiquinone Oxidoreductase in Normal 
and Genetically Amplified Strains 
The above observation that E . coli NADH dehydrogenase can 
reconstitute NADH oxidase when added to the outside of spheroplasts 
indicates that the enzyme can interact with the endogenous ubiquinone 
from the outer phase of the cytoplasmic membrane. The other 
possib i lity, namely that the NADH dehydrogenase has traversed the 
membrane and assumed its normal orientation is precluded by the 
impermeability of NADH. Only the externally orientated enzyme would 
be expected to transfer electrons from NADH to ubiquinone under these 
conditions . This being the case, one can obtain an estimate of the 
amount of enzyme oriented to the inside and to the outside in normal 
and genetically amplified strains from the levels of NADH oxidase and 
NADH:ubiquinone oxidoreductase in spheroplasts and membrane 
vesicles . 
Comparison of the NADH oxidase levels in approximately equal 
quantities of spheroplasts and membrane vesicles from the wild type 
strain IY13 (Table 4-2) shows very little cyanide-sensitive NADH 
Table 4 -2 . ADH Oxidase and ADH :ubiquinone Oxidoreductase Activities 
of Membrane Vesicles and Spheroplast Preparations 
Preparation 
Spheroplas ts 
IY13 
+KCN 
IY91 
+KCN 
Membrane Vesicles 
IY13 
+KCN 
IY91 
+KCN 
NADH 
Oxidase 
0 . 18 
0 . 16 
4.8 
0 . 4 
5.7 
0.45 
30 
1 . 5 
-1 
unit s mL 
NADH : Q- 1 
Oxidoreductase 
0.22 
18.2 
13 . 3 
900 
Assays were performed as described in the 1aterials and Metho ds of 
Chapter 3. 5 pL volumes of each preparation were used per assay . 
In the case of the inside-out membrane vesicles this constituted 
the addition of -200 µg protein . The amount of spheroplast 
membranes added was estimated to be approximately equal to that 
of the inside-out membranes (calculated from the quantity of 
wet weight of cells) . 
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oxidase in spheroplasts. Similarly, very little NADH:ubiquinone-1 
oxidoreductase activity (<2%) is detectable in spheroplasts of IY13 
compared with membrane vesicles. This indicates that the vast 
majority of the enzyme is present with an orientation into the 
cytoplasm. In the case of IY91, where the NADH dehydrogenase is 
amplified -70-fold , the same situation applies. 
The maintenance of the asymmetrical distribution of the NADH 
dehydrogenase is expected since 'flipping' would involve movement of 
the hydrophilic regions of the enzyme through the membrane and this 
would be energetically very unfavourable. 
Reconstitution of the Purified NADH:ubiquinone Oxidoreductase into 
Artificial Phospholipid Vesicles 
The procedure used to reconstitute the purified enzyme was 
basically the cholate dialysis procedure described by Racker (1979) 
with minor modifications ( see Introduction and Materials and 
Methods) . The procedure is fairly efficient as shown in Figure 4-7. 
On l y 40% of the enzymic activity is lost in the high (1.0% w/v) 
concentration of cholate . 
The flow diagram illustrated in Figure 4-7 is for the 
reconstitution of purified enzyme in low ionic strength (5 mM 
potassium phosphate , see Materials and Methods). The same procedure 
was attempted in 0.65 M potassium phosphate buffer, pH 7 . 5, but it 
appeared that vesicles did not form. 
Reconstitution of the enzyme into artificial phospholipid 
vesicles allows examination of the properties of the NADH 
dehydrogenase in a phospholipid environment in the absence of other 
respiratory proteins . Such vesicles were used to study electron 
Figure 4-7 . Flow Diagram fo r the Reconstitution of NADH :ubiquinone 
Oxidoreductase with Soybean Phospholipid 
(1) Purified Enzyme 
52 units mg-l 
+ Soybean phospholipid 
+ 1% (w/v) Cholate (final) 
(2) Dialysis 
(3) Ultracentrifugation 
(4) Resuspension of Pellet 
Recovery of Activity 
100% 
58% 
36% 
Experimental details are described in the Materials and Methods 
section. 
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transfer to long chain isoprenologues of ubiquinone (Chapter 3). 
This procedure was also used in preliminary experiments in this 
laboratory aimed at testing whether the enzyme could function as a 
proton pump. To date no such activity has been detected (Campbel l 
and Jaworowski, unpublished results). 
Proteolysis as an Approach to Determining the Membrane Topography of 
the NADH:ubiquinone Oxidoreductase 
A number of different proteolytic enzymes were used in these 
studies, each having different substrate specificities. Trypsin 
hydrolyzes proteins at the carboxyl end of arginine and lysine 
residues and chymotrypsin at the carboxyl group of aromatic amino 
acid residues. Pronase and subtiliiin both have broad specificities. 
Proteolytic cleavage of the purified NADH:ubiquinone 
oxidoreductase by trypsin, chymotryps in and pronase leads to the 
production of one dominant cleavage product of Mr -37000 (see 
Figures 4-8, 4-9 and 4-10). It should be noted however that 
molecular weights of proteins derived from migration in SDS-
polyacrylamide gels are not considered more accurate than ±10%. 
The results presented in Figures 4-8, 4-9 and 4-10 were 
reminiscent of the membrane proteins, cytochrome~ and 
NADH:cytochrome ..!::s reductase. By analogy with these proteins it was 
thought that proteolysis may result in the formation of fragments 
that separately retain their original functional properties. 
Samples of the trypsin and chymotrypsin digested enzyme (from 
the experiment illustrated in Figure 4-9) were snap frozen in liquid 
nitrogen at the same times that samples were removed for SDS 
Figure 4-8. SDS-Polyacrylamide Gel Electrophoresis of NADH:ubiquinone 
Oxidoreductase after Proteolytic Digestion with Trypsin 
47K 
37K 
1 2 3 4 5 
The purified enzyme was incubated in the presence of trypsin (2% w/w) 
at 0°C. Aliquots were withdrawn at the following times: (1) 0 
hours, (2) 4 hours, (3) 8 hours, (4) 10 hours, and (5) 10 
hours (without addition of trypsin) and derivatized in SDS at 100°C. 
See Materials and Methods for further details. 
Figure 4-9. SDS-Polyacrylamide Gel Electrophoresis of NADH:ubiquinone 
Oxidoreductase after Proteolytic Digestion with Trypsin 
and Chymotrypsin 
l 2 3 4 5 6 7 
47K ___ .... 
37K • 
The purified enzyme was incubated in the presence of trypsin (2% 
w/w; samples 2-4) or chymotrypsin (2% w/w; samples 5-7) at 0°C. 
Aliquots were withdrawn at the following times: (1) 0 hours, (2) 2.5 hours, (3) 6 hours, (4) 7.5 hours, (5) 2.5 hours, (6) 6 hours (7) 7.5 hours and derivatized in SDS at 100°C. See 
Materials and Methods for further details. 
Figure 4-10. SDS-Polyacrylamide Gel Electrophoresis of NADH:ubiquinone 
Oxidoreductase after Proteolytic Digestion with Pronase 
1 2 3 4 5 6 7 8 
47K 
37K 
The purified enzyme was incubated in the presence of pronase (2% w/w) 
at 25°C. Aliquots were withdrawn at the following times: (1) 0 min, (2) 15 min, (3) 45 min, (4) 60 min, (5) 90 min, (6) 180 min, and (7) 225 min and derivatized in SDS at 100°C. See Materials and 
Methods for further details. 
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derivatization. Each was assayed for NADH:ubiquinone and NADH: 
Fe(CN)~- oxidoreductase activity. The recorded activities are 
illustrated as a percentage of undigested purified enzyme in Figure 
4-11. 
3-The ratio of activities towards ubiquinone-1 and Fe(CN)
6 
as 
acceptors are similar (4:1 respectively) for purified enzyme, wild 
type IY13 membrane vesicles and plasmid amplified IY91 membrane 
vesicles (Jaworowski et al., 1981a). It is clear from the results 
--
presented in Figure 4-11 that the ubiquinone-1 reductase and 
Fe(CN)~- reductase activities are reduced upon proteolysis. However, 
the Fe(CN)i- reductase activity is retained to a greater relative 
extent than the ubiquinone-1 reductase activity. This result is 
consistent with the hypothesis that the Mr 47000 species possesses 
both ubiquinone-1 and Fe(CN)!- reductase activities whereas the maJor 
proteolysis product(s) (the maJor species has an Mr of 37000 on a 
3-denaturing SDS-polyacrylamide gel) can transfer electrons to Fe(CN)
6 
but not to ubiquinone-1. 
This interpretation could explain the original findings of 
Shapiro and coworkers (Dancey et al., 1976; Dancey and Shapiro, 1976; 
Thompson and Shapiro, 1981; see Chapter 1). Dancey et al. (1976) and 
Dancey and Shapiro (1976) reported that their purified preparations 
of the respiratory NADH dehydrogenase from E.coli had a mol wt of 
3-38000 and possessed NADH:DCIP and NADH:Fe(CN)
6 
oxidoreductase 
activity. Although the artificial electron acceptors DCIP and 
ferricyanide were active as acceptors with the pre paration, no 
ubiquinone reductase activity was quoted. In a later publication the 
respiratory NADH dehydrogenase was once again purified but the 
reported molecular weight had increased to Mr 46000 and 
Figure 4-11. 1ADH :ubiquinone-l and NADH : Fe(C )i- Oxidoreductase 
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The purified enzyme was incubated in the presence of tryps in (2 % w/w) 
or chymotrypsin (2 % w/w) as described in Figure 4 - 9 . Aliquots were 
removed and assayed for ( •) NADH: ubiquinone and ( +) ADH : Fe ( C ) g-
oxidoreduc tase activity. The s~lcific activity for the uncleaved 
enzyme was 230 and 120 units mg , respectively . Assays were 
performed as described in the Materials and Methods (Chapter 3) . 
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ubiquinone-3 reductase activity was cited (Thompson and Shapiro, 
1981). In this account it was stated that all preparations of the 
quinone reductase (46000 mol wt) also contained a protein of 
Mr 37000. The quantity of this protein varied from 30% to less 
than 5% of that of the M 46000 protein. Antiserum to the r 
preparation of Dancey et al. (1976) precipitated both the M 37000 
-- r 
and the Mr 46000 proteins (Thompson and Shapiro, 1981). Thompson 
and Shapiro (1981) considered that the antigenic cross-reactivity 
could be because the smaller polypeptide was a proteolytic cleavage 
product of the larger. However, they reported that peptide-mapping 
experiments give distinct peptide patterns (data not shown). 
Consequently, they concluded that it was unlikely that one protein is 
a cleavage product of the other. These experiments are complicated 
by the doubtful purity of the original preparation of the 38000 mol 
wt species as shown by the imrnunochemical analysis of Owen and Kaback 
(1979a2. 
The results presented in Figures 4-8, 4-9 and 4-10 demonstrate 
that the purified enzyme with an Mr 47000 can be digested by 
proteolytic enzymes with different substrate specificities to yield a 
product of approximately Mr 37000 mol wt as assessed by SDS-
polyacrylamide gel electrophoresis. Furthermore, examination of the 
NADH:ubiquinone and NADH:ferricyanide oxidoreductase activities of 
the major proteolysis product suggest that the M 37000 species 
r 
possesses an NADH:ferricyanide oxidoreductase activity even when the 
NADH:ubiquinone oxidoreductase activity approaches zero (see Figure 
4-11). 
The results of the partial proteolysis experiments taken 
together with the results of Shapiro and colleagues suggested that it 
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is possible to generate a 37000 mol wt subfragment of the NADH 
dehydrogenase which possesses the NADH and flavin binding domains 
but has lost ubiquinone reductase activity. If such a subfragment 
arises from a single cleavage it might also be possible to isolate 
the small fragment of the enzyme which is required for the reduction 
of ubiquinone. 
To investigate this further, concentrated purified enzyme was 
digested with trypsin and then chromatographed on a Sephadex G-75 
column under conditions designed to maintain activity (see Materials 
and Methods) . The chromatograms of undigested and trypsin digested 
enzyme are shown in Figures 4-12 and 4-13, respectively. 
3-Approximately 70% of the NADH:ubiquinone and NADH:Fe(CN)
6 
oxidoreductase activity was recovered in the undigested enzyme peak. 
However , with the digested enzyme the recovered NADH:ubiquinone 
3-oxidoreductase peak was only 4% whereas the NADH:Fe(CN)
6 
oxidoreductase a c t i vity was approximately 25%. The relatively higher 
3-
recovery of the NADH : Fe(CN) 6 oxidoreductase activity is interesting 
when it is considered that the peak has been shifted to a position of 
lower mol wt as illustrated in Figure 4-13. The reason why the 
NADH:ubiquinone oxidoreductase peak is so broad in Figure 4-12 is 
unknown . A sample of each enzyme preparation was taken prior to 
Sephadex G-75 chromatography and electrophoresed on an SDS-
polyacrylamide gel (Figure 4-14). The predominant band in the 
digested enzyme preparation was the M 37000 species. 
r 
These results suggested that the NADH dehydrogenase might have a 
similar organisation to cytochrome ~Sand cytochrome~ reductase. 
According to this model the small (=8000) 'clipped off' portion would 
be at the C-terminus and would constitute a putative membrane-
Figure 4-12 . Sephadex G-75 Chromatogram of Pu rified NADH : ub i qu i none Oxidoreductase 
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Purified enzyme was chromatographed under conditions described in the Materials and Methods section. Each fraction 
was assayed for(&) NADH:ubiquinone and (a) NADH : Fe(CN)i - oxidoreductase activity as described in Chapter 3. 
Figure 4-13. Sephadex G-75 Chromatography of NADH :ubiquinone Oxidoreductase after Proteolytic Digestion with Trypsin 
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was chromatographed under conditions described in 
) NADH:ubiquinone and (l!J) NADH:Fe(CN)g-
Figure 4-14. SDS-Polyacrylamide Gel Electrophoresis of NADH:ubiquinone 
Oxidoreductase (Digested with Trypsin) prior to Sephadex 
G-75 Chromatography 
1 2 
47K 
----·-37K 
Purified enzyme samples which had been incubated in the absence 
(lane 1) and presence (lane 2) of trypsin (2% w/w) were derivatized 
in SDS and electrophoresed as described in the Materials and Methods . 
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associated tail. This portion of the protein would be required for 
the interaction with ubiquinone (see Chapter 3). 
In support of the hypothesis outlined above two aspects of the 
primary amino acid sequence can be cited. Firstly, in the region of 
amino acid residues 352-362 (see Chapter 2) there are six potential 
proteolytic cleavage sites; three lysines (trypsin) and two tyrosines 
and one histidine (chymotrypsin). A single or even multiple 
cleavages at any of these sites would produce two peptides of 
Mr -38000 and Mr -9400, respectively. There are no other 
concentrations of possible cleavage sites either from the N- or C-
terminal end which would produce the observed Mr 37000 band. 
Secondly, the N-terminus carries part of a nucleotide binding domain 
(see Chapter 2). Hence , if the N-terminus was cleaved upon 
proteolysis it is unlikely that the product would be able to transfer 
electrons to ubiquinone-1 or Fe(CN)~- at appreciable rates. Thirdly , 
uncharged r egions of the amino acid sequence would be the most likely 
candidates for membrane association. The largest uncharged stretches 
are near the C-terminal end of the protein at residues 331-351 (21 
residues), 362-382 (21 residues) , 402-412 (10 residues) and 414-424 
(10 residues) (see Chapter 2). 
In an attempt to examine the possibility that the C-terminal 
section of the enzyme is both membrane associated and the site of 
ubiquinone interaction, proteolysis studies of membrane vesicles were 
initiated. 
IY91 membrane vesicles were digested by chymotrypsin, the 
membranes pelleted by ultracentrifugation and then resuspended to 
their original volume . Aliquots were removed at each stage of the 
procedure for assay and analytical SDS-polyacrylamide gel 
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electrophoresis (Figure 4-15). One of the important features of the 
electrophoretogram is that upon chymotrypsin digestion of IY91 
membrane vesicles a major peptide is not released into the 
supernatant under the conditions used. The Mr 37000 dominant 
cleavage product is clearly still membrane-associated (see lane 3, 
Figure 4-15). The percentage of the undigested Mr 47000 species 
was calculated (adjusted for the volume of membranes loaded). Only 
23% of the original Mr 47000 species was intact and 18% was present 
as the Mr 37000 species (assuming equal staining with dye). The 
fate of the other 60% of the Mr 47000 band is unknown but 
presumably upon cleavage some of the enzyme is further cleaved to 
give multiple cleavage products which are not easily identified. 
The protein recoveries calculated from the SDS-polyacrylamide 
gel are not reflected in the amount of NADH:ubiquinone and 
3-
NADH:Fe(CN)6 oxidoreductase activities recovered in the digested 
membrane preparation. The chymotrypsin digested membrane preparation 
when assayed still maintained 65% and 61% respectively, of its 
original activities. Therefore, it must be concluded that although 
the Mr 47000 enzyme is digested )75%, the enzymic activity is 
largely maintained suggesting that in the membrane environment the 
cleaved enzyme is stabilized until disrupted by SDS derivatization. 
This result is in contrast to those obtained with purified enzyme 
(Figures 4-9 and 4-11), where the extent of proteolysis is 
proportional to the loss of enzymic activity. Possibly the membrane 
environment helps to maintain the overall enzyme configuration. 
Interestingly, Michell and Weitzman (1983) demonstrated that 
subtilisin digested Acinetobacter citrate synthase maintained its co-
operative interactions characteristic of the native enzyme even 
Figure 4-15. SDS-Polyacryl amide Gel Electrophores i s of IY91 Membr ane Vesicles after Proteoly tic Digestion with Chymotryps i n 
1 2 3 4 
47K 
---..ii.~ 
37K • 
IY91 membrane vesicles were digested with chymotrypsin (2% w/w, 0°C), the membranes pelleted by ultracentrifugation and then resuspended to their original volume (1.0 mL in STM buffer). Aliquots were removed at each stage of the procedure, SDS derivatized, and electrophoresed as described in the Materials and Methods. Samples include: (1) purified enzyme, (2) supernatant of pelleted chymotrypsin digested IY91 membranes, (3) resuspended pellet of chymotrypsin digested IY91 membranes, and (4) untreated IY91 membranes. 
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though SDS-polyacrylamide gel electrophore sis clearly revealed 
breakdown of the digested enzyme into smaller fra gments. 
Digestion of IY91 membrane vesicles by trypsin also yielded the 
M 37000 proteolytic product (Figure 4-16). Both the r 
NADH:ubiquinone and NADH:Fe(CN)~- oxidoreductase activities are ) 85% 
of the untreated IY91 membrane vesicle levels even though they are 
)50% degraded. 
The broad-specificity proteases such as pronase and subtilisin 
make short work of the enzyme leading to complete digestion and loss 
of activity of the Mr 47000 and Mr 37000 species (see Figures 
4-17 and 4-18). Possibly a significant amount of the enzyme is 
exposed (ie little is embedded in the membrane) and once digestion 1s 
initiated then proteolysis rapidly leads to the destruction of the 
enzyme. Why this should occur with the enzyme in the membrane 
(Figure 4-17) and not with the purified enzyme is puzzling (Figure 4-
10). The proteolysis experiments involving the purified enzyme 
(Figures 4-8, 4-9 and 4-10) were performed in low ionic strength 
buffer. The fact that the purified enzyme is in an aggregated state 
in this buffer (Figure 4-2) may play some part in protecting the 
enzyme from rapid and complete digestion with pronase (Figure 4-10). 
The results with the proteolysis of IY91 membranes by pronase 
and subtilisin suggest that a significant amount of the enzyme is 
exposed. This is not surprising when it is considered that a large 
proportion of the enzyme shows some homology with the soluble enzyme 
glutathione reductase (see Chapter 2). Furthermore, the enzyme mu s t 
interact in the cytoplasm with the soluble substrate NADH. 
Figure 4-16. SDS-Polyacrylamide Gel Electrophoresis of IY91 Membranes 
after Proteolytic Digestion with Trypsin 
1 2 3 5 6 7 
47K __ ... 
37K 
IY91 membrane vesicles were incubated at 25°C in the presence of 
trypsin (2% w/w). Aliquots were withdrawn and derivatized in SDS 
and electrophoresed as described in the Materials and Methods. 
Samples include: (1) 0 min, (2) 30 min, (3) 60 min, (4) 180 
min, (5) 240 min, (6) 240 min (no addition of trypsin), and 
(7) pure enzyme (no addition of trypsin). 
Figure 4-17. SDS-Polyacrylamide Gel Electrophoresis of IY91 Membranes 
after Digestion with Pronase 
1 2 3 5 6 
47K--~• 
~•--47K 
IY91 membrane vesicles were incubated at 25°C in the presence of 
pronase (2% w/w). Aliquots were withdrawn and derivatized in SDS 
and electrophoresed as described in the Materials and Methods. 
Samples include: (1) 0 min (no pronase added), (2) 30 min, 
(3) 60 min, (4) 180 min, (5) 240 min, and (6) pure enzyme (no 
pronase added). 
Figure 4-18. SDS-Polyacrylamide Gel Electrophoresis of IY91 Membranes after Proteolytic Digestion with Subtilisin 
1 2 3 4 5 6 7 8 
47K-.... •
-
- - --
IY91 membrane vesicles were incubated at 25°C in the presence of subtilisin (2% w/w). Aliquots were withdrawn and derivatized in SDS and electrophoresed as described in the Materials and Methods. Samples include: (1) 0 min (no subtilisin added), (2) 10 min, (3) 20 min, (4) 30 min, (5) 60 min, (6) 180 min, (7) 180 min (no subtilisin added), and (8) pure enzyme (no subtilisin added). 
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The proteolysis results with the purified enzyme are consistent 
with a possible ubiquinone binding domain at the C-terminus. Also 
consistent with this suggestion is the demonstration that the 
purified enzyme can reduce ubiquinone-8 (see Chapter 3) and that the 
C-terminus is the most hydrophobic region of the protein (see Chapter 
2). However, the results obtained concerning the digestion of the 
IY91 membrane vesicles do not suggest that the enzyme is attached to 
the membrane by a small anchor which is susceptible to proteolysis 
such as is the case with cytochrome _!:5 and cytochrome _!:s reductase. 
SUMMARY 
The reconstitution of membrane vesicles of ndh mutants by 
purified NADH dehydrogenase has been investigated. The enzyme can 
readily become membrane-associated and reconstitute the NADH oxidase 
of membrane vesicles from ndh mutants. Also, the purified enzyme has 
been shown to be capable of inserting into the outer surface of the 
inner cytoplasmic membrane of ndh spheroplasts. Once assembled, the 
enzyme does not readily 'flip' across the lipid bilayer even when 
ampl_ified to 70-fold wild type levels. The observation that the 
purified enzyme can reconstitute ndh spheroplasts suggests that there 
lS no obligatory protein receptor that facilitates membrane binding. 
It has been shown by sucrose density centrifugation that 1. n 
0.7 M potassium phosphate buffer the purified enzyme migrates with an 
M of 80000 and an s of 6 • 3 • In contrast to these figures, the r 20,w 
purified enzyme 1.n low ionic strength potassium phosphate buffer was 
shown to be in a highly aggregated form. The pooled activity peaks 
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from these gradients when added to ndh membrane vesicles demonstrated 
that the disaggregated enzyme preparation was si,gnificantly more 
reconstitutively active than the aggregated preparation. 
Proteolysis of the purified NADH:ubiquinone oxidoreduc tase and 
IY91 membranes has led to the partial characterization of a maJor 
proteolytic degradation product with an Mr of ~37000. Its 
NADH:ubiquinone and NADH : Fe(CN)i - oxidoreductase r e lative activities 
as well as its Mr suggest that it is the same species isolated by 
Dancey and Shapiro (1976) and Dancey et al., (1976). Proteolysis of 
the purified enzyme with either trypsin or chymotrypsin leads to a 
significant loss of NADH:ubiquinone oxidoreductase activity. 
Interestingly, there is relatively less of a reduction in the 
NADH:Fe(CN)~- oxidoreductase activity. Evidence is provided that is 
consistent with the suggestion that proteolytic cleavage occurs at 
the C-terminal region which is postulated to play a significant role 
in ubiquinone reduction. 
The Mr 37000 species is still membrane-associated after 
proteolysis of IY91 membranes with trypsin and chymotrypsin and 
maintains its functional activity. This suggests that its 
interaction with the membrane or with its membrane embedded 
segment(s) is sufficient to allow it to bind and pellet with the 
membrane in a functional conformation. Proteolysis of IY91 membranes 
with pronase and subtilisin demonstrated that a significant amount of 
the enzyme is exposed. Furthermore, the proteolysis experiments 
carried out with IY91 membranes and trypsin and chymotrypsin suggest 
that the enzyme is not anchored in the membrane by a short 
polypeptide that is susceptible to proteolytic cleavage. 
Chapter 5 
Novel Photoaffinity Analogues of Ubiquinone: Radiochemical 
Labelling of the Respiratory NADH Dehydrogenase 
111. 
INTRODUCTION 
Affinity Labelling 
An understanding of the mechanism of action of enzyme-catalyzed 
reactions requires the identification of the amino acids in the 
active site involved in binding and those more directly involved in 
catalysis. The classical approach to acquiring such information has 
been the use of general and specific reagents for chemical 
modification and ultimately identification of active site residues, 
commonly referred to as affinity labelling . * 
Another approach to chemical modification of active site 
residues has been successfully applied, that is suicide inhibition 
(for review , Rando, 1977). This method makes use of the catalytic 
function of enzymes to generate a reactive molecule in the active 
site from an inert precursor. The reactive molecule then reacts with 
nucleophilic residues of the enzyme . As pointed out by Chowdhry and 
Westheimer (1979), affinity labelling in general, and suicide 
inhibition in particular, require the presence of appropriately 
positioned reactive functional groups on the enzyme to bring about 
inactivation and labelling. 
Ideal labelling reagents should react not only with 
nucleophiles but even with the significantly less reactive but 
ubiquitous hydrophobic regions (C- H bonds) of proteins . 
Photogenerated reagents have the potential for high reacti,ity and 
also can be activated in situ . Photoaffinity labelling has become a 
major technique for studying molecular interactions in biological 
systems (for comprehensive reviews see Bayley and Knowles, 1977; 
*The field of affinity labelling has become such a powerful tool that 
a whole volume of Methods in Enzymology has been devoted to it (Vol 
XLVI , 1977, W. B. Jacobs and M. Wilchek, Academic Press) . 
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Chowdhry and Westheimer, 1979). A photolabile reagent is anchored to 
the macromolecule, when possible by a covalent bond, photolysis of 
the complex then leads to the generation of a highly reactive species 
that labels the macromolecule or specifically the active site (see 
Figure 5-1). Ideally, a very reactive reagent is generated only at 
the ligand binding site of interest, and reacts indiscriminately with 
whatever chemical groups it finds there. 
The properties desirable in a photolabile group are chemical 
stability prior to photoactivation, rapid rate of photolysis at long 
wavelength, and a very short half life for the photogenerated 
reactive species. The mechanism of labelling should not involve 
intramolecular rearrangement to a less reactive labelling species. 
Carbenes and nitrenes are the principal reagents utilized for 
photoaffinity studies in biological systems (Bayley and Knowles, 
1977) . The arylnitrene generating reagents have been suggested as 
being the most ideal photoaffinity analogues for use in the active 
sites of enzymes (Guillory, 1979). 
With the aim of constructing pyridine nucleotide photoaffinity 
analogues, Jeng and Guillory (1975) synthesized what has become a 
useful photoaffinity group, N-4-azido-2-nitrophenyl-S-alanine (ANAP), 
which can be readily linked via esterification to alcohols. Guillory 
and Jeng (1977) later described methods which would enable the 
synthesis of [ 3H]- and [14c]-labelled arylazido-nucleotide analogues. 
Subsequently, the [ 3H]-arylazido-S-alanyl NAD+ has been used to 
radiochemically label the Mr 57000 subunit of purified 
mitochondrial NADH dehydrogenase (Chen and Guillory, 1981) and to 
indicate that complex I has three distinct nucleotide reactive sites 
(Chen and Guillory, 1979; 1980). 
Figure 5-1. Schematic Rep re sentation of the Photolys i s of an Azide 
and Insertion of the Generated itrene into a C-H Bond 
azide 
Light 
·N· • • 
nitrene 
\ 
- C- H 
/ 
insertion into C-H bond 
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Quinone Photoaffinity Analogues 
Marinetti, Okamura and Feher (1979) synthesized a [ 3H]-labelled 
2-azidoanthraquinone derivative to probe reaction centres of the 
photosynthetic bacterium Rhodopseudomonas sphaeroides. The reaction 
centres are complexes of three nonidentical polypeptide chains 
denoted L, M, and H with Mrs of 21000, 24000 and 28000, 
respectively (ibid . ). 
The 2-azidoanthraquinone analogue was able to reconstitute 
photochemical activity in reaction centres which had had their 
ubiquinone removed according to the procedure described by Okamura, 
Isaacson and Feher (1975). Furthermore, upon photolysis the 
photoaffinity analogue selectively labelled the M subunit of the 
reaction centre (Marinetti et al. , 1979). Labelling of the M subunit 
was shown to be reduced when the primary quinone binding site was 
filled by ubiquinone before labelling . The extent of maximal 
labelling achieved was 7.7 ± 1 . 7 mole% as determined by liquid 
scintillation spectrometry of protein band slices after SDS-
polyacrylamide gel electrophoresis. Although the 2-azido-
anthraquinone had been shown to reconstitute photochemical activity 
in ubiquinone depleted reaction centres (Marinetti et al., 1979), it 
is noteworthy that anthraquinone had previously been shown to deviate 
from ubiquinone in low-temperature decay kinetics in the reaction 
centres (Okamura et al ., 1975). This may be due to the fact that 
anthraquinone is structurally very different from ubiquinone in that 
it has three six-membered rings rather than the benzoquinone 
structure . 
Yu and Yu (1980b; 1982) synthesized a functionally active 
arylazido-l-[1 4 c]-8-alanine-ubiquinone derivative (Q
0
c
10
NAPA) 
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in an attempt to identify the ubiquinone bind ing protein in 
ubiquinol-cytochrome c reductase preparations (see Fi g ure 5-2 for 
q0c 10 NAPA structure). 
The photoaffinity analogue, Q0c 10 NAPA, was prepared by the 
esterification of Q0 (CH2 ) 10 0H and arylazido-S-alanine (Yu and Yu, 
1982). The derivative has one notable deficiency. The 
photoactivatable azido group is very distant from the quinone ring. 
Yu and Yu (1980b) reported that the arylazido-1-[1 4 c]-S-alanine 
ubiquinone derivative labelled some specific proteins after 
photolysis although the counts incorporated were very low and no 
stoichiometry of label/protein was cited. 
Yu, Gu and Yu (1982) synthesized a further series of 
azidoubiquinone analogues which possessed the azide reporter group on 
the 2, 3 or 6 position on the quinone ring (Figure 5-2). Yu et al . 
(1982) reported that the analogues were able to act as electron 
acceptors and photolysis in their presence led to the inhibition of 
the succinate cytochrome c reductase system. Unfortunately, the 
extent of labelling by the new reagents was not given. 
The synthesis of azidoubiquinone analogues possessing 
photoactivatable groups on the quinone ring is a significant advance 
over the previous Q0c 10 NAPA analogue. However, some authors have 
noted that analogues with the azide moiety on the quinone ring 
photodecompose by internal rearrangement without generating nitrenes 
(Marinetti et al ., 1979; Germeraad, Weyler and Moore, 1974) . The 
details of the synthetic procedures for the azidoubiquinone analogues 
reported by Yu et al. (1982) have not yet been published. 
Figur e 5-2. Azidoubiquinone Photoaffinity Analogue 
Structure of Q0c1 oNAPA (from Yu and Yu, 1980b) 
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deriyatives (from Yu, Gu and 
Yu, 1982) 
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Photoaffinity Labelling of the Respiratory NADH Dehydrogenase 
The respiratory NADH dehydrogenase has been shown to catalyze 
the reduction of ubiquinone - 1 at high rates (Jaworowski et al., 
1981a) . Kinetic and inhibitor data indicate that the enzyme 
possesses a ubiquinone binding site (see Chapter 3) . The complete 
DNA sequence of the ndh gene and the deduced amino acid sequence of 
the enzyme has been determined (Young et al . , 1981; see Chapter 2) . 
The availability of the complete amino acid sequence for the enzyme 
provides a unique opportunity for defining its interaction with 
ubiquinone in molecular terms. 
I n the work described in this chapter a novel photoaffinity 
analogue of ubiquinone was used in an attempt to identify the 
ubiquinone binding site of the purified NADH:ubiquinone 
oxidoreductase . 
MATERIALS AND METHODS 
Chemica l s 
Ubiquinone-1 was supplied by F. Hoffman-La Roche and Co . , Basel 
and also by D. Magrath of this laboratory. The purity of the 
ub iquinone-1 was monitored by thin layer chromatography (TLC) and by 
ultraviolet absorption spectroscopy and mass spectrometry . Fluka 
supplied boron trifluoride diethyl etherate (laboratory reagent). 
[ l- 14c ] -3-aminopropanoic acid (54 .7 Ci/mole) was from New England 
Nuclear . Sodium borohydride and silica gel TLC plates (F
254
) were 
from Merck . Ethanol and methanol (Merck) were redistilled before use. 
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A number of chemicals were synthesized by Dr H.D. Campbell in 
this laboratory using published methods. These include: (a) BNPS -
skatole (2-(2-nitrophenylsulphenyl)-3-methyl-3-bromoindolenine) 
(Omenn, Fontana and Anfinsen, 1970; Fontana, 1972), (b) ANAP (N-4-
azido-2-nitrophenyl-S-alanine) (Jeng and Guillory, 1975; Guillory and 
Jeng, 1977), and (c) [ 14 c]-ANAP, which was synthesized by reacting 
[l-1 4c]-3-amino propanoic acid (50-100 µCi) with FNPA (4-fluoro-3-
nitrophenyl azide) as described previously (Guillory and Jeng, 1977). 
The optimal conditions for the cleavage reaction involving BNPS-
skatole were determined by Dr H.D. Campbell and were based upon the 
procedures reported by Omenn et al. (1970) and Fontana (1972). 
Spectrometry 
Proton magnetic resonance spectra were recorded by Dr D. Fenn 
using a JEOL FX-90Q Fourier nuclear magnetic resonance spectrometer 
at 30°C. Samples (-1 mg) were dissolved in CDC1
3 
(-0.5 mL) and 
chemical shifts are expressed relative to the internal standard 
tetramethylsilane (TMS). Typically, 100-500 pulses were 
accumulated. 
Electron impact (70 eV) and chemical ionization (NH3 ) mass 
spectra were recorded by Dr J.K. Macleod using a VG-micromass 7070F 
mass spectrometer fitted with a direct insertion probe. 
Visible and ultraviolet absorption spectra were recorded on a 
Cary 118 spectrophotometer. 
Liquid scintillation spectrometry was performed using a Packard 
Tri-carb 460 CD liquid scintillation spectrometer with a xylene -
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Triton X-100 based scintillant (33% v/v Triton X-100; ~67% v/v 
xylene; 0.5% (w/v) 2,5-diphenyloxazole). 
Reconstitution of Oxidase Activity 
Membrane preparations of the!· coli strains AN384 (ubi men) and 
AN387 were prepared as described previously (see Chapter 3; Wallace 
and Young, 1977b). AN384 and AN387 are isogenic strains prepared by 
Pl-transduction. 
The oxidases present in respiratory membranes were estimated by 
measuring the rate of oxygen uptake using a Clark type oxygen 
electrode (Wallace and Young, 1977b). The reaction mixture contained 
50 µL of membranes (-2 mg protein) and substrates (0.6 mM NADH, 20 mM 
succinate or 4 mM D-lactate) in a total volume of 2.5 mL STM buffer . 
Amino Acid Analysis 
Amino acid analyses were performed by Dr D.C. Shaw using a 
Beckman 120C amino acid analyzer. 
Synthesis of 2'-Hydroxyubiquinone-1 and 2'-Arylazidoubiquinone-1 (2'-
ANAP-Q-1) 
2'-Hydroxyubiquinone-1 was prepared from ubiquinone-1. In order 
to synthesize the 2'-hydroxyubiquinone-1 the following synthetic 
procedure was used: 8 mg of NaBH4 was added to 37 µmole ubiquinone-1 
in 400 µL of dried tetrahydrofuran (THF). Hydroboration of the 
sidechain double bond was then accomplished using diborane generated 
in situ by the addition of 64 µL boron trifluoride etherate plus 236 
µL THF. The mixture was then incubated at room temperature for 2 
hours protected from light. The resulting alkylborane was oxidized 
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with alkaline hydrogen peroxide to yield the quinol form of 2'-
hydroxyubiquinone-1 . This was done by the sequential addition of 
120 µL water (5 minutes incubation), 20 µL NaOH (30% w/v) and then 
20 µL of H202 (30% w/v) . The solution was then acidified with 75 µL 
of 2N H2so4 and the quinol was extracted with 3 x 1 mL CHC1
3
. The 
quinol was oxidized by the addition of Ag
2
0 (15 mg) to the CHC1
3 
extract . The mixture was then shaken for 3 hours protected from 
light and filtered through celite . The celite was washed with CHC1
3 
(~40 mL). The combined filtrates were rotary evaporated, dissolved 
in 1 mL CHC1 3 and then loaded onto 2 silica gel plates (20 cm x 20 cm 
x 0.25 mm) which were developed in CHC1 3 . The 2'-hydroxyubiquinone-1 
band (golden yellow, Rf ~o . 3) was eluted with ethanol. The yield 
was 30-50% . 
The 2'-ANAP-Q-1 was synthesized by DR H.D. Campbel l by coupling 
the 2'-hydroxyubiquinone-1 with ANAP using p- toluenesulphonyl 
chloride as a catalyst . [l- 14 c]-ANAP was also coupled with 2'-
hydroxyubiquinone-1 using the same method to yield [14c]-2' - ANAP-Q-l 
with a specific activity of 3 x 10 6 dpm/µmole . The overall scheme 
for the synthesis of the 2'-arylazidoubiquinone- 1 is shown in Figure 
5-3 . 
Covalent Radiochemical Labelling of Purified NADH:ubiquinone 
Oxidoreductase with [ 14 c]-2'-Arylazidoubiquinone - l 
The purified enzyme (5 . 8 mg protein m1-l) was extensively 
dialyzed against 5 mM potassium phosphate buffer, pH 7.5, 0.1% (w/v) 
cholate, 1 mM EDTA, 1 mM 2-mercaptoethanol and 20 µM FAD . 2 mL of 
the dialyzed enzyme was placed into a 3 mL volume stoppered quartz 
cuvette and after the addition of 15 µL of an ethanolic solution of 
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[1 4c]-2'-arylazidoubiquinone-l (61 mM, specific activity 3 x 106 
dpm/µmole) was irradiated at 4°C for 3 minutes as described below. 
The cuvette was held 20 cm from the ultraviolet light source (C-63 
mineralight, 302 nm wavelength; Ultra-Violet products, Inc.) on its 
side. During irradiation the cuvette was shaken slightly to mix . 
After addition of a furth~r 15 µL of [ 14 c]-2'-arylazidoubiquinone-l 
irradiation was continued for 3 minutes. Finally, a further 20 µL 
aliquot of [1 4c]-2'-arylazidoubiquinone-l was added and the cuvette 
irradiated for 6 minutes. Under these conditions the cuvette was 
maintained at 4°c and only a slight loss of NADH:ubiquinone-1 
oxidoreductase activity was recorded ()80% activity maintained) . 
After irradiation in the presence of [1 4 c]-2'-
arylazidoubiquinone-l the enzyme was precipitated and washed 3 times 
with acetone (Poulis et al., 1981) and the pellet was dried under 
vacuum. The [1 4 c]-2'-arylazidoubiquinone-l was soluble in acetone 
and free label was recovered in the acetone supernatant. The dried 
pellet was dissolved in 0.7 mL of 5 mM potassium phosphate buffer, pH 
7.5, containing 10% (w/v) SDS and 5 µL of 2-mercaptoethanol. The 
pellet did not readily dissolve at room temperature so it was placed 
in a boiling water bath for 10 minutes. 
The extent of covalent labelling was assessed by loading the 
sample onto a column (25 x 1.6 cm) of Sephacryl S-300 equilibrated 
with 5 mM potassium phosphate buffer, pH 7.5, containing 1 mM EDTA , 
2% (w/v) SDS and 0.1% (v/v) 2-mercaptoethanol. This gel filtration 
procedure has been shown to completely separate endogenous FAD, 
phospholipid and ubiquinone-8 from the enzyme polypeptide (Jaworowski 
et al., 1981b; Campbell, unpublished). 
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Separation and Characterization of the [ 14 c]-Labelled-Polypeptides 
produced by BNPS-skatole Cleavage at Trp Residues 
After cleavage of the [1 4 c]-labelled-polypeptide with BNPS-
skatole according to procedures reported by Omenn et al. (1970) and 
Fontana (1972), the peptide mixture was lyophilized and dissolved 1n 
sample buffer (Laemmli, 1970) for SDS-polyacrylamide gel 
electrophoresis (see Chapter 4). 
The cleaved peptide mixture in sample buffer was separated by 
SDS-polyacrylamide (12.5% w/v) slab gel electrophoresis. Four 
preparative slab gels were run and each of the bands (numbered 1 to 
6) shown in Figure 5-11 were cut out with a razor blade (see Results 
and Discussion). Each preparative gel was loaded with material 
equivalent to -1 mg of protein prior to cleavage. These preparative 
gels were not fixed in trichloroacetic acid before staining. 
Preparative gels were briefly stained (10 minutes) with Coomassie 
Blue at room temperature and destained as previously described 
(Chapter 4). The gel slices were eluted from the acrylamide gel by 
the addition of 2 mL of elution buffer (0.05 M NH4 Hco3 , 1.0% (w/v) 
SDS and 1.0% (v/v ) 2-mercaptoethanol) and incubated at 37°c for 24 
hours (Weber , Pringle and Osborn 1972). After 24 hours the buffer 
was removed and 2 mL of fresh buffer was added. After 48 hours the 
procedure was repeated. The elution procedure was demonstrated to be 
complete by acid hydrolysis of the eluted gel slices followed by 
amino acid analysis and liquid scintillation spectrometry. 
The eluted peptide samples were then extensively dialyzed (12 
hours) against four changes of 2 L buffer composed of 0.05 M NH
4
Hco
3 
and 0 . 1% (w/v) SDS . After dialysis the samples were placed in round 
bottomed flasks and freeze dried for 16 hours. The flocculent dried 
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material (still blue from the presence of dye) was dissolved in 3.2 
mL of distilled water. 1.4 mL was added to 10 mL of scintillation 
cocktail and its radioactivity determined. A further 1.4 mL was used 
for amino acid analysis and to accurately determine the protein 
concentration. 
Effect of added Ubiquinone-1 on the Extent of Labelling with [14c]-
2'-Arylazidoubiquinone-1 
With the aim of determining the effect of added ubiquinone-1 on 
the extent of labelling by [1 4c]-2'-arylazidoubiquinone-l two 
photoirradiation experiments were performed. One experiment was 
performed in the presence of added ubiquinone-1 and the other in its 
absence. The experimental procedure used was as follows: 300 µL of 
concentrated enzyme (7.9 mg m1-l protein) was added to a 0.5 mL 
volume quartz cuvette. 5 µL of a 10 mM ethanolic solution of [1 4c]-
2'-arylazidoubiquinone-l was added and irradiated for 20 minutes 
under conditions outlined in the preceding section. This procedure 
was repeated a further 3 times. In the case of the ubiquinone-1 
'protection' experiment 200 nmoles of ubiquinone-1 was added prior to 
irradiation (final concentration 0.6 mM >> K for ubiquinone-1). 
m 
The labelled protein was acetone precipitated 3 times with 2 mL 
acetone, desiccated under vacuum for 30 minutes and then dissolved in 
250 µL of 5 mM potassium phosphate buffer, pH 7.5, 5% (w/v) SDS, 1 mM 
EDTA and 0.1% (v/v) 2-rnercaptoethanol. The dissolved sample was then 
loaded onto a 5 mL volume Sephacryl-300 column equilibrated with 5 mM 
potassium phosphate buffer, pH 7.5, 2% (w/v) SDS, 1 mM EDTA, and 0.1% 
(v/v) 2-mercaptoethanol. 50 Fractions of -90 µL volume were 
collected and 25 µL of each fraction was subjected to liquid 
scintillation spectrometry. 
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RESULTS AND DISCUSSION 
Synthesis of a Novel Photoaffinity Analogue of Ubiquinone 
In order to be able to use the ANAP reporter group and to employ 
the strategy devised by Guillory and Chen (1977) for linking 
radiolabelled ANAP to NADH analogues it was necessary to introduce an 
esterifiable group into the ubiquinone sidechain. It was decided to 
attempt to synthesize 2'-hydroxyubiquinone-1. A hydroxyl group was 
introduced into the double bond of the isoprene sidechain of 
ubiquinone-1 by hydroboration followed by oxidation (see Figure 5-3 
and Materials and Methods ). 
Characterization of 2'-Hydroxyubiquinone-1 
Since the 2'-hydroxyubiquinone-1 was a new compound it was 
characterized in detail. As expected the purified 2'-
hydroxyubiquinone-1 was more hydrophilic than ubiquinone-1 as shown 
by its reduced Rf on TLC plates developed in CHC1
3 
(2'-
hydroxyubiquinone-1, Rf -0.3; ubiquinone-1, Rf ~o.8). 
The ultraviolet absorption spectra of the oxidized and NaBH
4 
reduced 2'-hydroxyubiquinone-1 were consistent with its benzoquinone 
ring structure (Figure 5-4). The A (279 nm) was slightly shifted max 
from the A of ubiquinone-1 (275 nm). The spectrum showed typical max 
borohydride reducibility (Crane and Barr, 1971) to yield the spectrum 
of the ubiquinol (A = 290nm). The ultraviolet absorption spectra max 
indicated that the ubiquinone ring structure and its substituents had 
been unaltered during the synthesis. The concentration of 2'-
hydroxyubiquinone-1 was determined using the difference spectra of 
the oxidized/reduced forms at 279 nm (6E = 12500 M-lcm-1 used as for 
ubiquinone-1; Crane and Barr , 1971). 
Figure 5-3. The Synthesis of 2 '-Arylazidoubiquinone-1 
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The ultraviolet absorption spectra were measured with a 46 µM 
solution of 2 '-hydroxyubiquinone-1 in absolute ethancl as 
described in the Materials and Methods. 
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The proton magnetic resonance spectrum of the compound was also 
consistent with its proposed structure (Figure 5-5). 2'-
Hydroxyubiquinone-1 4' ,5'-CH3 0.96 and 1.04 ppm (d); 5-CH3 , 2.06 
ppm (s); 1'-CH2 , 2.57 and 2.60 ppm (d), 2.65 ppm (s); 2'-CH, 3.46 ppm 
(m); 2,3-0CH3 , 3.99 and 4.00 ppm (d). The spectrum was 
indistinguishable from that of ubiquinone-1 and is consistent with 
the sidechain hydroxyl group being in the 2'-position. 
Mass spectra (electron impact) of the purified 2'-
hydroxyubiquinone-1 showed a prominent pair of peaks at m/e = 268 and 
270, attributed to the quinone and quinol forms (m and m+2, 
respectively) (Figure 5-6). The measured mass of the m/e = 268 peak 
in the high resolution mass spectrum of 2'-hydroxyubiquinone-1 was 
268.1306 (compared with 268.1311 calculated for c
14
0
5
H
20
). 
The fragmentation pattern is consistent with the assigned 
structure of 2'-hydroxyubiquinone-1. The spectrum has a ba se peak of 
196.1 (note also the peak at 197) which can be attributed to the 
benzylium species (Muraca, Whittick, Daves, Friis and Folkers, 1967). 
The presence of this species verifies that the compound is a 
benzoquinone (with ubiquinone ring substituents) and has a CH
2 
group 
at the l'-position in the side chain. 
Characterization of the Synthesized 2'-Arylazidoubiquinone-1 
The synthetic intermediates, 2'-hydroxyubiquinone-1 (2,3-
dimethoxy-5-methyl-6-(2'-hydroxy-3'-methylbutyl)-l,4-benzoquinone) 
and ANAP (3-(4-azido-2-nitroanilino) propanoic acid) which could be 
radiochemically labelled, were each synthesized and purified and then 
coupled via an esterification reaction. The product, named for 
simplicity 2'-arylazidoubiquinone-1 or 2'-ANAP-Q-1, was purified and 
Figure 5-5. Proton Magnetic Resonance Spectrum of 
2 -Hydroxyubiquinone-1 
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Approximately 1 mg of sample was dissolved in 0.5 mL CDCl 3 . 
Chemical shifts are expressed relative to the internal standard 
tetramethylsilane (TMS) (see M3terials and Methods for further 
details). 
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used to radiochemically label the purified NADH:ubiquinone 
oxidoreductase. The photoactivatable azidophenyl group is located 
the equivalent of 7 or 8 methylene units from the benzoquinone ring. 
The analogous derivative of ubiquinone, Q0c10 NAPA, reported by Yu and 
Yu (1980b; 1982) has the azidophenyl group located significantly more 
distant, being the equivalent of 15 methylene units from the 
benzoquinone ring. 
The structure of the 2'-arylazidoubiquinone-1 (see Figure 5-3) 
was verified by several independent techniques. 
The 4-azido-2-nitroanilino group was quantitated using the 450 
nm absorption peak (spectrum not shown), which is independent of the 
quinone absorption, as well as the 260 nm absorption peak after NaBH
4 
reduction, with a small correction for absorption by the quinol 
moiety (see Figure 5-7 for ultraviolet absorption spectra). The 
ubiquinone moiety was quantitated by measuring the absorbance change 
at A279 on NaBH4 reduction (Crane and Barr, 1971). This analysis 
showed that for 2'-arylazidoubiquinone-1, 1.0 mole of the 4-azido-2-
nitroanilino group is present per mole of ubiquinone. 
The chemical ionization mass spectrum of the 2'-
arylazidoubiquinone-1 showed prominent peaks at an m/e of 504 and 502 
(Figure 5-8) which are attributed to the quinol and quinone forms of 
the protonated ester (m+3 and m+l, respectively). The electron 
impact mass spectrum of 2'-arylazidoubiquinone-1 showed strong peaks 
at an m/e of 475 and 473 which are attributed to the quinol and 
quinone forms after the loss of two nitrogen atoms from the azido 
group. 
Figure 5-7. Ultraviolet Absorption Spectra of 2'-Arylazidoubiquinone-1 
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The ultraviolet absorption spectra were measured with a 22 µM 
solu t ion of 2 '-arylazidoubiquinone - 1 in absolute ethanol as 
described in the Materials and Methods . 
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Reconstitution of NADH, Succinate and D-Lactate Oxidase in ubi men 
Membranes by 2'-Arylazidoubiquinone-1 
Wallace and Young (1977b) characterized an E. coli strain 
(AN384) which is completely deficient in the synthesis of both 
ubiquinone and the menaquinones . 
The 2'-arylazidoubiquinone-1 photoaffinity analogue was tested 
to see if it could substitute for the natural ubiquinone homologue, 
ubiquinone-8, and restore the quinone-dependent NADH, succinate and 
D-lactate oxidases in AN384. It is clear from Table 5-1 that the 2'-
arylazidoubiquinone-1 can function in the three oxidase systems 
although with somewhat reduced efficiency compared with the 
ubiquinone homologues. 
Thus, the photoaffinity analogue appears to be substituting for 
ubiquinone in respiratory electron transport and potentially could be 
used to identify those components interacting with ubiquinone. In 
the present work it has been used specifically in relation to the 
respiratory NADH dehydrogenase. 
2'-Arylazidoubiquinone-1 as a Substrate of Purified NADH:ubiquinone 
Oxidoreductase 
The 2'-arylazidoubiquinone -1 analogue was shown to act as an 
electron acceptor for the purified NADH :ubiquinone oxidoreductase 
(Figure 5-9). However, the direct plot of activity verses substrate 
concentration does not exhibit hyperbolic kinetics . The nature of 
the plot suggests some form of substrate inhibition. The kinetics of 
the reaction were not further characterized . The highest rate 
recorded (2.8 units mL-1) was -30% of that for ubiquinone-1 (at 50 µM 
concentration). The assays were performed with an Aminco Chance dual 
Table 5-1. Restoration of Oxidase Activities in ubi men Membrane Vesicles by Ubiquinone Analogues 
Membrane 
vesicles 
AN384 
(ubiA menA) 
AN387 
Quinone 
added 
Q-3 
Q-1 
2'-ANAP-Q-1 
Nil 
Q-3 
Q-1 
2 '-ANAP-Q-1 
Nil 
NADH 
100 
71 
65 
4 
100 
64 
76 
76 
Oxidase (% Q-3) 
Succinate 
100 
93 
71 
4 
100 
104 
100 
96 
D-Lactate 
100 
100 
53 
8 
100 
75 
88 
81 
The oxidase assays were performed as described in the Materials and Methods . Rates are expressed as a percentage of the stimulated r ates with Q-3 added . The actual rates were as follows: AN384, 2290 , 207 and 112; AN387, 1036 , 340 and 47 ; ng atoms O rnin- 1rng- l protein for NADH, succinate and D-lactate oxidases , respectively. The ubiquinone analogues were added to give a final concentration of 20 µM . AN38 7 oxidase levels are equivalent t o wild type levels . 
Fi gur e 5-9 . Di r ect Plot fo r the Reduction of 2 '-Arylazidoubiquinone-1 
by Purified NADH :ubiqu inone Oxidoreductase 
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Assays were performed as described in the text and in the Materia ls 
and Methods (Chapter 3). 0.86 µg protein was added per assa y. 
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wavelength spectrophotometer. 2'-Arylazidoubiquinone -1 is more 
hydrophobic than ubiquinone-1 and assays were monitored by a change 
in absorbance at A of 340 nm minus the A at 395 nm to 
sample reference 
take into account any increase in turbidity during the reaction. 
Photolabelling of Purified NADH:ubiquinone Oxidoreductase 
As purified, the respiratory NADH:ubiquinone oxidoreductase 
possesses -1 mole of ubiquinone-8 per mole of enzyme subunit 
(Jaworowski et al., 1981b). The purified enzyme has a ubiquinone 
binding site which is accessible to ubiquinone-1 as shown by its low 
Km (see Chapter 3). Furthermore, experiments with ubi mutants have 
shown that the presence of ubiquinone-8 is not required to enable 
ubiquinone-1 to reconstitute the ubiquinone requiring oxidas es 
(Wallace and Young, 1977b). This indicates that ubiquinone-1 can 
interact directly with the catalytic site and does not interac t via 
tightly bound ubiquinone-8. This is also confirmed by the kinetic 
data for ubiquinone-1 (see Chapter 3). Thus, it was assumed that 
ubiquinone-1 derivatives such as [14c]-2'-arylazidoubiquinone-l would 
have access to the catalytic site for the purposes of photoaffinity 
labelling. 
[ 14c]-2'-arylazidoubiquinone-l was irradiated in the presence of 
purified enzyme as described in the Materials and Methods section . 
The [ 14c]-labelled protein was separated from unattached [ 14 c]-label 
by chomatography on a Sephacryl S-300 column. Two peaks of 
radioactivity were observed, the first of which was coincident with 
the protein peak (Figure 5-10). The second radioactive peak was 
attributed to labelled phospholipid or unreacted [14c]-2'-
arylazidoubiquinone-l. 
Figure 5-10 . 14 Sephacryl S-300 Chromatogram of [ CJ-Labelled 
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The conditions of chromatography are presented in the text and in 
the Materials and Methods . 
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The radioactive protein peak was pooled and concentrat ed by 
ultrafiltration (Amicon apparatus; PMlO membrane) until it was ~1 mL 
in volume. The labelled protein was precipitated with acetone and 
dried under vacuum . The extent of incorporation of label was 
typically 0 . 1-0.15 mole [ 14 c]-2'-arylazidoubiquinone-l per mole of 
protein (Mr 47200). This level of labelling is similar to that 
obtained using an azido analogue of NAD to label yeast alcohol 
dehydrogenase and azido derivatives of steroids to label steroid 
receptors (7% and 5-25%, respectively ; Chowdhry and Westheimer, 
1979). Moreover, aryl nitrenes react quite readily with water and 
the solvent reactions generally restrict insertion reaction yields to 
not more than 20-30% (Mueller, Hudson and Lee , 1982) . 
Cleavage of the [1 4c]-Labelled Polypeptide at Trp Residues by BNPS-
Skatole 
With the aim of establishing the predominant site of label 
attachment , the [ 14 c]-labelled polypeptide was cleaved at tryptophan 
residues using BNPS - skatole . The cleavage fragments produced were 
separated by preparative SDS-polyacrylamide gel electrophoresis, 
peptide staining bands were cut out and the peptides eluted from the 
gel slices and characterized. 
There are two tryptophan residues at positions 47 and 272 in the 
sequence of the enzyme . Cleavage at these points would theoretically 
lead to the production of three polypeptides: residues 2-47 (mol wt 
5000) , residues 48-272 (rnol wt 24500) and residues 273-434 (rnol wt 
17900) (see Chapter 2 for sequence). Partial cleavage would lead to 
the production of polypeptides composed of residues 2-272 (mol wt 
29400) and residues 48-434 (mol wt 42300). 
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Figure 5-11 shows an analytical gel of the BNPS-skatole cleavage 
fragments. The numbers illustrated in Figure 5-11 represent the six 
major peptide species produced. A densitometric trace (see Chapter 
3, Materials and Methods) of the cleavage products was performed 
(Figure 5-11). Using this procedure it was calculated that the six 
numbered peptides constituted -5 8% of the total protein loaded on the 
gel. The peptide bands designated 1 to 6 were processed as described 
in the Materials and Methods. The major peptide band nearest band 3 
was not processed since it was diffuse and appeared heterogeneous. 
The apparent Mr values for the cleavage peptides were 
determined by comparisons with proteins of known Mr. From the 
sizes of the cleavage products it was possible to assign fragments 1 
to 5 in terms of the amino acid sequence (Table 5-2). These 
assignments were verified by amino acid compositions (Table 5-3). 
It should be noted that band 6, the heavy band visible nearest 
the dye front, was also eluted and analysed. Since its amino acid 
composition did not fit any of the predicted total or partial Trp 
cleavage products it has not been definitely assigned and 
consequently is not included in Tables 5-2 and 5-3. 
The amino acid composition analysis, protein concentration 
analysis and liquid scintillation spectrometry enabled the extent 
(dpm/nmole peptide) and the stoichiometry (mole [1 4 c]-label/mole 
peptide) of labelling to be calculated (Table 5-4). The results 
suggest that there is some apparent loss of label (-55%) during 
cleavage, separation and elution of the peptides 3 and 5 (ie the sum 
of the dpm/nmole peptide values for bands 3 and 5 is -45% of that for 
the complete uncleaved polypeptide, band 1). The reason for this is 
Figure 5-11. SDS-Polyacrylamide Gel Electrophoresis and Densitometric Trace of [ 14c]-Labelled Peptides Produced by BNPS-Skatole Cleavage of [ 1 4 c]-Labelled-Protein 
Analytical SDS 
Polyacrylamide Gel 
Densitometric Trace 
top 
t 1 t t 
1 2 3 4 
3 
5 6 
I 0.2 ab, 5 
6 
dye front 
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The conditions of cleavage by BNPS-skatole and SDS-polyacrylamide gel electrophoresis are described in the text and in the Materials and Methods. 
Table 5-2 . Properties of Bands Isolated from [ 14 cJ-
2-Arylazidoubiquinone-l Labelled NADH : 
ubiquinone Oxidoreductase after Partial 
Cleavage at Trp Residues 
a Band-
1 
2 
3 
4 
5 
A . b ss i gnment-
2-434 
48 -434 
2-272 
48-272 
273-434 
Appa r ent 
C Mol Wt-
47000 
43000 
31000 
26500 
18000 
Calcula~ed 
Mol Wt-
47200 
42300 
29400 
24500 
17900 
a 
b 
Band assigned from SDS-polyacrylamide gel electrophoresis . 
Residue numbering . 
C 
d 
Determined by SDS-polyacrylamide gel electrophoresis . 
Calculated from sequence. 
Table 5-3. Amino Acid Compo sition of Peptides Isolated from ADH : ubiquinone Oxidor eductase Af ter Partial Cleavage at Trp Residues 
a Band -
(Residues) 
Amino l_Q_ 2 3 4 5 Acid ( 2-·4 34) (48-434) (2-272) (48-272) ( 273- 434 ) 
D 41 .8 (41) 41.3 (39) 26.8 (26) 25.6 (24) 14.4 (15) 
T 25.6 (26) 21.6 (22) 17.1 (18) 13.5 (14) 7.7 (8) 
s 21.6 (20) 20.3 (19) 12.0 (11) 10.8 (10) 7.8 (9) 
E 38.2 (37) 35.1 (35) 26.2 (26) 24.2 (24) 12.0 (11) p 15.0 (17) 10.9 (16) 8.5 (8) 8.3 (7) 6 .7 (9) 
G 43.1 ( 42) 36.9 (35) 26.8 (27) 21.0 (20) 14.1 (15) 
A 39.3 (39) 35.4 (36) 25.6 (26) 22.9 (23) 12.9 (13) 
v£ 23.8 (27) 21.8 (24) 17.6 (19) 15.6 (16) 7.6 (8) # 5.6 (14) 7.0 (13) 3.7 (5) 3.8 (4) 5.1 (9) 1£ 20.7 (26) 18.3 (23) 11.7 (14) 9.6 (11) 8.4 (12) 
L 48.1 (51) 43.1 (45) 33.2 (35) 27.2 (29) 15.5 (16) yd 10.1 (12) 9.6 (12) 5.9 (6) 5.7 (6) 4.6 (6) 
F 10.0 (11) 9.9 (11) 6.2 (6) 5.8 (6) 4.0 (5) 
H 16.8 (17) 8.9 (14) 10.6 (12) 8.8 (9) 5.1 (5) 
K 24.6 (25) 19.6 (18) 15.8 (18) 10.3 (11) 6.6 (7) Re 15.1 (22) 14. 2 (20) 8.8 (11) 7.1 (9) 6.8 (11) 
a Numbering of bands is as shown in Figure 5-11. Residue numbering 
-
(inclusive) is shown in brackets. Residue 1 (M) is not present in the purified enzyme. 
b Uncleaved enzyme . 
C Low values attributed to slow hydrolysis. 
-
d Low values attributed to oxidation. 
e Reason for low values unknown. -
Table 5-4. Localization of Labelling of the NADH:ubiquinone Oxidoreductase with [ 14 c]-2'-Arylazidoubiquinone-l 
Band Section of 
Polypeptide 
(Residue numbering) 
a dpm- nmole dpm mole [ 14 c]~ 
mole 
polypeptide 
a 
b 
C 
d 
1 
2 
3 
4 
5 
2-434 
48-434 
2-272 
48-272 
273-434 
eluted peptide 
264 
327 
329 
407 
531 
elutedb 
peptide-
0.66 
0.89 
2.7 
3.7 
9.1 
nmole 
peptide 
390 
370 
120 
110 
60 
dpm 
nmole of 
100 residues 
90 
95 
44 
49 
37 
The dpm values are averaged figures derived from two separate counts of 1 hour duration. 
o.13i 
0.12 
0.04 
0.04 
0.02 
These yields were calculated from the amino acid composition data using residues D, E, A and L (see Table 5-3). 
Calculated from the incorporation of radioactivity and the specific radioactivity of the [14c]-
2~arylazidoubiquinone-l. 
The pooled concentrated enzyme after gel filtration (Figure 5-10) in the presence of SDS had a mole [ 14cJ/mole polypeptide stoichiometry of 0.12. 
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unknown. Exposure of peptides to BNPS-skatole leads to the cleavag e 
of tryptophanyl peptide bonds CC-terminal position) and th e oxidation 
of the indole ring (Omenn et al., 1970). If tryptophan was heavily 
labelled it is possible that some loss of label could occur during 
the BNPS-skatole cleavage procedure but this explanation seems 
unlikely. 
As pointed out by Bayley and Knowles (1977) the exact nature of 
linkages formed to proteins by photolabile reagents has not been 
clarified. A few attempts to locate labelled amino acids have 
indicated that some of the linkages may be chemically labile since a 
considerable amount of radioactivity is lost during the analysis. 
For instance, significant losses (~40%) of nitrene-derived label have 
been shown to occur on treatment with cyanogen bromide (Fisher and 
Press, 1974). Fisher and Press (1974) ascertained that the loss of 
radioactive label represented a bound non-covalent label-lysine 
derivative. 
The BNPS-skatole cleavage allows comparison of the extent of 
labelling of three regions of the protein encompassing residues 2-42, 
48-272 and 273-434 (Table 5-4). The extent of labelling of the small 
N-terminal fragment is obtained by comparing bands 1 and 2 and also 
bands 3 and 4 and it seems clear that this segment carries less label 
than the other two bands. The middle region of the protein appears 
to be more highly labelled than the C-terminal segment. However , at 
present it is not possible to say whether th e labelling of these two 
fragments is highly localized or not. 
At this stage it was considered important to test whether excess 
ubiquinone-1 could specifically block labelling of the enzyme by the 
photoaffinity analogue. 
130. 
Attempts were made to assess the effect of the addition of 
ubiquinone-1 on the extent of labelling with [1 4 c]-2'-
arylazidoubiquinone-l. However, the extent of labelling 1n the 
presence of ubiquinone was in the same range as that obtained in its 
absence (-0.08-0.15 mole [ 14 c]/mole peptide). The fact that the 
presence of ubiquinone-1 did not markedly reduce the extent of 
labelling raised doubts as to the specificity of the labelling and 
further characterization of the positions of the label was not 
carried out. 
Jaworowski et al. (1981b) showed that pure preparations of the 
NADH:ubiquinone oxidoreductase contain 70% (w/w) lipid, predominantly 
phosphatidylethanolarnine. At present the sites of phospholipid 
binding on the enzyme are unknown. The added 2'-arylazidoubiquinone-
1 could well be locally concentrated in the phospholipid and 
photolysis may lead to covalent labelling of the lipid-binding sites 
as well as the specific ubiquinone active site. This may explain the 
lack of significant protection by ubiquinone-1 of the labelling by 
the photoaffinity analogue. 
SUMMARY 
A novel photoaffinity analogue of ubiquinone has been 
synthesized by coupling (using p-toluenesulphonylchoride) 3-(4-azido-
2-nitroanilino) propanoic acid to a ubiquinone-1 derivative 
containing a hydroxyl group on t he sidechain. This method may prove 
useful in linking other carboxylic acids containing a range of 
reporter groups to 2'-hydroxyubiquinone-1. This route becomes more 
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valuable when it is considered that [3H]-labelling of 2'-
hydroxyubiquinone-1 can be accomplished by the use of [ 3H]-NaBH
4 
in 
the 2'-hydroxyubiquinone-1 synthesis procedure . 
Using the readily available [l-1 4 c]-3-aminopropanoic acid (54 .7 
Ci/mole) as one of the starting materials a [1 4 c]-labelled 
preparation of 2'-arylazidoubiquinone-1 with high specific activity 
(3 x 10 6 dpm/µmole) was prepared with a high yield (~36% 
radiochemical yield). 
The 2'-arylazidoubiquinone photoaffinity analogue has been shown 
to be capable of acting as an electron acceptor with purified enzyme 
at levels approaching -30% of that for ubiquinone-1. The synthesized 
analogue has also been shown to be capable of restoring NADH, 
succinate and D-lactate oxidases in ubi ~ membrane vesicles, 
suggesting that it can substitute for ubiquinone-8 in the respiratory 
chain. In future the [ 14 c]-2'-arylazidoubiquinone-l may be usefully 
employed in probing other sections of the respiratory chain which 
utilize ubiquinone. 
After photolysis the [1 4c]-2'-arylazidoubiquinone-l was shown to 
be covalently attached (typically 0.1-0.15 mole label per mole 
polypeptide) to the purified enzyme. The enzyme was cleaved at 
tryptophan residues by BNPS-skatole. The labelled peptides produced 
were separated with high resolution by SDS-polyacrylamide gel 
electrophoresis, eluted from the gel and analyzed. Complete and 
partial cleavage peptides were isolated which encompassed the 
complete sequence. The peptides were identified by their migration 
upon SDS-polyacrylamide gel electrophoresis and their apparent 
molecular weights calculated. The assigned apparent molecular 
weights and sequence were verified by amino acid analysis. 
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The results suggested that the middle region of the protein 
appeared to be more heavily labelled than the C-terminal region which 
was more labelled than the N-terminal region. However, the 
interpretation of the labelling data was made more difficult because 
of a significant loss of label (-55%) during the cleavage, separation 
and elution of the peptides. Furthermore, photolysis experiments 
with and without ubiquinone-1 present showed that the presence of 
ubiquinone-1 did not lead to a decrease in the extent of labelling. 
The presence of relatively high levels of phospholipid on the enzyme 
may concentrate the photoaffinity reagent and lead to the labelling 
of phospholipid binding sites as well as residues in the region of 
the catalytic site. 
Chapter 6 
The Partial DNA Sequence of the Cloned Dld Gene 
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INTRODUCTION 
The membrane-bound D-lactate dehydrogenase of!· coli has been 
solubilized and purified to homogeneity (Kohn and Kaback, 1973; Futai 
1973). The enzyme possesses approximately 1 mole of FAD per mole of 
enzyme and has a reported molecular weight of 75000 ± 7% (Kohn and 
Kaback, 1973; Futai, 1973). Furthermore, the purified respiratory D-
lactate dehydrogenase has been shown to reconstitute the D-lactate 
oxidase and D-lactate-dependent active transport activities of 
membrane vesicles prepared from a dld mutant strain of E.coli ML 
308-222 (Short, Kaback and Kohn, 1974). 
Wallace and Young (1977b) showed that the D-lactate oxidase 
system required a quinone for activity (see Chapters 1 and 3 for 
further discussion). 
Young and Wallace (1976) isolated a strain of E.coli carrying a 
point mutation affecting the respiratory NADH dehydrogenase (ndh 
mutant; see Chapter 1 for further details). During attempts to clone 
the gene for the respiratory NADH dehydrogenase of!· coli from 
chromosomal DNA two hybrid plasmids were isolated (Young et al., 
1978). One of the plasmids, pIYl, derived from EcoRI digested 
chromosomal DNA was studied by Young and colleagues and shown to 
possess the gene coding for the NADH dehydrogenase (ibid.). Plasmid 
pIYl when transformed into an ndh mutant, IY12 (thi his ilv trp rpsL 
ndh), was shown not only to complement the growth of the ndh mutant 
strain on mannitol-minimal medium but also to amplify the NADH 
dehydrogenase to 8-10 times the normal level (Young et al., 1978). 
The other plasmid, pIY2, partially complemented the ndh mutant in 
terms of its ability to grow on mannitol-minimal medium but did not 
restore the NADH dehydrogenase levels in respiratory membranes . 
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Plasmid pIY2 was constructed of follows: HindIII was used to cl e ave 
a preparation of E.coli chromosomal DNA and the fragme nts produced 
were ligated into HindIII digested pGM706 (Hamer and Thomas, 1976). 
The ligated hybrid plasmids were transformed into an intermediate F+ 
strain and then transferred by F-mobilization to IY12 (F-,ndh rpsL). 
The cells were then selected for the complementation of ndh (Young et 
al., 1978). Electrophoresis of the HindIII digested pIY2 on an 
agarose gel indicated that it carries a 4.6 Mdal (-6.9 kb) DNA 
fragment. Young, Jaworowski and Paulis (1982) demonstrated that 
cells carrying pIY2 , in contrast to cells carrying the parent plasmid 
pGM706, overproduce the respiratory D-lactate dehydrogenase in the ir 
cell membranes by 15-20 fold with negligible activity appearing in 
the cytoplasm (ibid . ) . The pIY2 plasmid was further characterized by 
Santos, Kung , Young and Kaback (1982) . Santos et al. (1982) showed 
that pIY2 expressed the dld gene either in vivo with transformed 
rninicells or in vitro with a fractionated transcription/translation 
system . The product formed is specifically immunoprecipitated by y-
globulin prepared against the purified enzyme and comigrates with 
purified D- lactate dehydrogenase on SDS-polyacrylamide gels (ibid.). 
Therefore , it is clear that the plasmid pIY2 carries the structural 
gene coding for the respiratory D-lactate dehydrogenase of!· coli. 
It is believed that the considerable elevation of D-lactate oxidase 
which occurs in the ndh mutant carrying pIY2, provides an alternative 
route for the reoxidation of NADH and that this is responsible for 
the partial restoration of the growth of the ndh mutant (Young et 
al., 1982). 
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The cloning of the respiratory D-lactate dehydrogenase provides 
the opportunity to determine the primary sequence of the protein via 
DNA sequencing. Since the D-lactate oxidase is quinone-dependent 
(Wallace and Young, 1977b), and partially purified D-lactate 
dehydrogenase reduces ubiquinone-1 at high catalytic rates (I.G. 
Young, unpublished), it seems likely that the respiratory D-lactate 
dehydrogenase will also possess a ubiquinone binding site analogous 
to that of the respiratory NADH dehydrogenase . Furthermore, the dld 
protein also must possess an FAD binding site. The determination of 
the complete primary sequence of the dld protein would provide a 
basis for examining its evolutionary relationship with the ndh 
protein as well as with a number of soluble D-lactate dehydrogenases. 
It could also assist with the identification of the ubiquinone 
binding sites of the two respiratory dehydrogenases. For these 
reasons the determination of the DNA sequence of the dld gene was 
initiated . 
MATERIALS AND METHODS 
Many of the experimental procedures used in this chapter were 
described previously in the Materials and Methods section of Chapter 
2 . New procedures or significant variations are described below. 
Strains and Plasmids 
Strain IY36 is an E. coli Kl2 derivative defective in the ndh 
gene (Young and Wallace, 1976). Strain IY36 carries the plasmid 
pIY2 which contains an insert encoding the dld gene (Young et al., 
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1982). The pIY2 plasmid DNA was isolated as described in the 
Materials and Methods section of Chapter 2. 
E.coli JM103 has been described previously (Messing et al., 
1981) and has the following reported genotype: ~lacpro thi strA supE 
endA sbcBlS hsdR4 F'traD36 proAB laciq Z~MlS. JM103 was used as the 
recipient cell in transfections with Ml3mp8 (Messing and Vieira, 
1982; see Introduction). Recently, it has been reported (Focus Vol 5 
No . l, Mar 1983, Bethesda Research Laboratories, Inc. publication) 
that the strain JM103 has some notable drawbacks. These include: 
JM103 may not be hsdR4 (ie JM103 is not deficient in the Kl2 
restriction system as initially reported by Dr J. Messing) and JM103 
contains a cryptic Pl lysogen which may be responsible for observe d 
low efficiencies of transformation or Ml3 phage transfection with 
JM103 compared to other E.coli host strains. Neither of these 
drawbacks were a problem in the context of the present work. 
Ml3 Vectors for DNA Sequencing 
The Ml3 vector used was Ml3mp8. This is one of several new 
cloning vectors constructed by Messing and his colleagues (Messing et 
al ., 1981; Messing and Vieira, 1982). These vectors carry 
multipurpose cloning sites allowing a wide variety of different 
fragments to be cloned (Figures 6- 1 and 6-2). 
Two different universal primers were used for DNA sequencing of 
Ml3mp8 clones. These were the 26 bp double stranded primer of 
Anderson et al. (1980) and the 17-base synthetic primer described by 
Duckworth et al., (1981). The primers and their sites of priming are 
shown in Figure 6-3 . Both primers were kindly provided by Dr 
I.G . Young . 
Figure 6-1. A Genetic Map of Ml3mp7, Ml3mp8 and Ml3mp 9 
1 2 .3 4 5 6 7 8 9 10 11 12 13 14 
2 .3 4 5 SER PRO ASP PRO SER THR CYS ARG SER THR ASP PRO GLN ASN 6 7 8 
1 
THR 
M13mo7 ATG ACC 
MET ILE THR ASN 
ATG ATT ACG AAT TCC CCG GAT CCG TCG SER LE U AL A ACC TGC AGG TCG ACG GAT CCG GGG AAT TCA CTG GCC _, 
M13mp8 
M13mp9 
Eco RI BamHI Psi I 
Sal I 
Ace! 
Hine.II 
2 .3 4 5 6 7 
2 .3 4 5 6 ARG GLY SER VAL ASP LEU GLN 
THR MET ILE THR ASN SER 
ATG ACC ATG ATT ACG AAT TCC CGG GGA TCC GTC GAC CTG CAG 
Eco RI L_ ___ 3•m HI ~--
Smal 
XmaI 
I Pat I 
1 2 
THR MET 
ATG ACC ATG 
2 .3 
.3 4 PRO SER LEU 
ILE THR 
ATT ACG CCA AGC TTG 
Hindfil 
4 
ALA 
5 
Sall 
Ace! 
Hine II 
6 7 8 
ALA GLY ARG ARG 
GCT GCA GGT CGA CGG 
9 
ILE 
ATC 
Pat I L____j BamHI 
Sal I 
Ace! 
Hine II 
BamHI Eco RI 
Sall 
Accl 
Hine II 
8 9 10 11 
PRO SER LEU ALA 7 8 
LEU ALA 
CCA AGC TTG GCA CTG GCC 
L___J 
Hlndill Ho61tr 
10 11 
PRO GLY 5 6 7 8 
ASN SER LEU ALA 
CCC GGG AAT TCA CTG GCC 
L.._..__J 
EcoRI Ho,I!I 
Smar 
XmaI 
Map units are given in kb . The difference between the three 
molecules is given in detail by the nucleotide sequence of the 
pertinent region of the lacZ gene. The recognition sites for 
restriction endonucleases are labelled. The interruption of the 
wild-type amino acid sequence in Ml3mp2 by the inserted amino 
acid sequences is set up and numbered. The figure is taken from 
Messing and Vieira (1982). 
'------' 
Ho6.ll[ 
Figure 6-2. Cloning Guide to Ml3mp7 
Ml3 
Born HI G • GATC C 
GGATCC 
GAATTC 
Eco RIG t AATT C 
C T G C A G 
Pst I C TGCA JG 
Clonable Fragment 
Born HI G t GATC C 
Bgl II A•GATC T 
Bel I r•GATC A 
Sau 3A t 
Mbo I N GATC N 
Eco RI G i AATT C 
Eco RI* N • AATT N 
G-tailing any fragm ent ith C-tailing 
I Sal I 
II Ace I 
GTCGAC 
G i TCGA C Sa I I G t TCGA C 
Xho I Ci TCGA G 
GT l CG AC Ac c I GT t CG AC 
C I a I AT t CG AT 
Hpa II NC t CG GN 
Ta q I NT t CG AN 
any fragment ith lower efficiency 
e.g. Ba I I TGG + CCA 
Hae III NGG • CCN 
Hha I NNG CG •cNN 
+Bal 31+ 
sheared NNN NN NNN 
,so, 31 f 
The enzymes and their recognition sequences that are us e d for 
cleaving the vector are listed on the left side. The enzymes 
and treatments used to produce DNA fragments which may be 
cloned at each Ml3mp 7 site are listed on the right side. Cutting 
patterns are indicated by arrows and sticky ends are set apart from 
flanking nucleotides. The figure is taken from Messing et al ., (1981). 
Figure 6-3. Primers for Sequencing of Cloned DNA in Phage Ml3mp8 
5' (plus strand) Ml3MP8 TEMPLATE 3' 
I I CCAAGCTTGGCACTGGCCGTCGTTTTACAACGTCGTGACG,' 
HindIII 
PSP14 
PRIMER 
SYNTHETIC 
17-MER 
GTGACCGGCAGCAAAATGTTGCAGG 
T GA CC G G CA G CA A A AT G 5' 
C C 
TA 
G 5' 
The listed pSP14 primer is the complementary strand of the double-stranded primer described by Anderson 
et al., (1980). The 17-mer represents the synthetic single-stranded primer described by Duckworth 
et al., (1981). The HindIII site in the Ml3mp8 insert is shown (see Figure 6-1). 
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Sonication of Fragment 2-1 DNA, BamHI Linker Addition and Attemp ts t o 
Clone the Dld gene into pBR322 
2 µg of a preparation of fragme nt 2-1 (see Figure 6-4) in 50 µL 
of T10 E0 _1 buffer, pH 7 .5, was diluted to 1 mL in T10 E0
_
1
, 2.5 M 
NaCl, pH 7.5 buffer (Wilson and Thomas, 1974) and s on icated twice 
with 10 second bursts at o0 c. The DNA was e thanol precipitated, 
the pellet washed in 1 mL ethanol (0°c) and dissolved in 100 µL 
T10 E0 _1 , pH 7.5. The DNA sample was loaded into 4 lanes of an 
agarose gel (see Figure 6-5). The DNA was stained with ethidium 
bromide (0.5 µg mL-1) and a piece of the gel was cut out with a razor 
blade . The DNA within the slice encompassed the size range of 1.8 to 
4.0 kb. The slice was reset into another agarose gel and the DNA 
electrophoresed into 0.7 mL of hydroxylapatite and purified as 
described in the Materials and Methods section of Chapter 2. 
The purified DNA, approximately 0.7 µg, was 'filled-in' and 
labelled with [a-3 2P]dATP by the following procedure. To the 
purified DNA in a 50 µL solution composed of (60 mM Tris HCl, 8 mM 
MgC1 2 , 10 mM 2-mercaptoethanol, 0.2 mM of dGTP , dTTP and dGTP and 2µ1 
[a- 32P]dATP (10 mCi/mL; -3000 Ci/mmole)) was added 0.3 units of!· 
coli DNA polymerase I (Klenow fragment) and the solution incubated 
for 30 minutes at 22°c. 
BamHI linker DNA, d(C-G-G-G-A-T-C-C-C-G), was phosphorylated 
using T4 polynucleotide kinase and ligated to the 'filled-in' 
sonicated DNA samples using T4 DNA ligase (linker and enzymes were 
supplied by New England Biolabs, Inc . ). After the ligation of the 
DNA preparation it was digested with BarnHI restriction endonuclease 
(fragment 2-1 does not contain a BamHI site) and loaded onto a 5 mL 
Sephadex G-75 column equilibrated with 10 mM Tris HCl, 1 mM EDTA, 100 
mM NaCl, pH 7 . 5 buffer . Column fractions were subjected to liquid 
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scintillation spectrometry and were pooled taking care not to include 
linker DNA fractions . The pooled column fractions were ethanol 
precipitated and dissolved in T10 E0 . 1 buffer, pH 7.5. 
2 µL (0.5 µg) BamHI di gested pBR322 DNA and 3 µL of the 
sonicated DNA sample were mixed and additions were made to give a 
final buffer composition of (66 mM Tris HCl, pH 7.5, 60 mM MgC1 2 , 
50 µg m1-l BSA, 10 mM dithiothreitol, 1 mM rATP). The mixture was 
incubated for 5 minutes at 37°c, 2 µL T4 DNA ligase (200 uni ts ) was 
added and the incubation continued for 16 hours at 15°c. The DNA 
was transformed into strain IY12 as described in the Materials and 
Methods section of Chapter 2. 
Preparation of BamHI and Accl digested Ml3mp8 
To 50 µL Ml3mp8 (220 µg mL- 1) in an Eppendorf tube was added 37 
µL sterile distilled water, 10 µL sterile buffer (1.5 M NaCl, 60 mM 
Tris HCl, pH 7.9, 60 mM MgC1 2 , 1 mg mL-1 BSA) and 3 µL of BamHI 
endonuclease (15 units; New England, Biolabs, Inc.). The solutions 
were mixed and incubated for 1.5 hours at 37°c. The mixture was 
then vortexed (10 seconds) in the presence of 200 µL of neutralized 
phenol and the phases separated by centrifugation for 1 minute in an 
Eppendorf centrifuge. Residual phenol was removed from the aqueous 
phase by two extractions with 400 µL of diethyl ether. The DNA was 
ethanol precipitated by the addition of 0.1 volume of 5 M NaCl and 
2.5 volumes of ethanol. The solution was mixed and placed into a 
cardice-ethanol bath for 1 hour. The DNA was pelleted by 
centrifugation for 10 minutes in an Eppendorf centrifuge. The 
supernatant was removed and the pellet (not visible) was washed with 
1 mL of cold ethanol. The pellet was dried for 5 minutes in vacuo 
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and then dissolved in 100 µL T10 E0 . 1 buffer, pH 7 .5. 
The same procedure was used for the preparation of the Accl 
digested Ml3mp8 except that the digestion buffer added was composed 
of: 60 rnM NaCl, 60 mM Tris HCl, pH 7.5, 60 mM MgC1 2 , 60 mM 2-
mercaptoethanol, 1 mg mL-1 BSA. 
Endonuclease Digestion of Purified 2-1 Fragment with Sau3A or Hpall 
Plasmid pIY2 was digested with Hindlll endonuclease and the 
cloned fragment 2-1 was purified according to the procedures outlined 
in the Materials and Methods section in Chapter 2. 
To 50 µL of purified fragment 2-1 (3 µg), was added 5 µL buffer 
(500 mM NaCl, 60 mM Tris HCl, pH 7.5, 50 mM MgC1 2 , 1 mg mL-1 BSA) and 
1 µL (2 units) Sau3A endonuclease. The solutions were mixed and 
incubated at 37°c for 3 hours . After digestion the mixture was 
extracted with phenol and ether and then ethanol precipitated as 
described above . 
The same procedure was used for the preparation of the Hpall 
digested fragment 2- 1 except that the digestion buffer used was 
composed of: 60 rnM KCl , 100 mM Tris HCl , pH 7.4, 100 mM MgC1 2 , 10 
mM dithiothreitol , 1 mg mL- 1 BSA . 
Ligation of Digested Fragment 2-1 into Ml3mp8 
Fragments derived from the Sau3A or Hpall digestion of fragment 
2- 1 were cloned into BamHI and Accl digested preparations of Ml3mp8, 
respectively. The ligation procedure used was as follows: 1 µL (-100 
ng) digested Ml3mp8 was added to 1 µL (-SO ng) digested 
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fragment 2-1, this mixture was then added to a solution composed of 
(1 µL 1 M Tris HCl, pH 7.5, 1 µL 1 M MgC1 2 , 1 µL 1 mg m1-l BSA, 
1 . 5 µL 0.1 M dithiothreitol; 1.5 µL 10 mM rATP, 6 µL sterile 
distilled water). These solutions were mixed and then placed at 
37°c for 5 minutes. 2 µL of T4 DNA ligase (200 units) was added, 
mixed and placed at 15°c for 16 hours. After ligation, 5 µL of the 
mixture was used to transfect JM103 as described in the Materials and 
Methods section of Chapter 2. 
Computer Programs Used for the Storage and Manipulation o f DNA Gel 
Reading Data 
The computer programs used in this study have been described by 
Staden (1977;1980) . The files containing sequence data were stored 
on magnetic disks (Data cartridge RL02K-DC; Digital Equip . Corp., 
Maynard, Massachusetts). The computer used was a PDP 11/34 
(Digital) . The programs are all written in PDP FORTRAN using many 
small subroutines , some of which are common to all programs. The 
applications of the programs are listed below . 
BATIN: This program is used to enter new gel reading data on the 
disk and is used for the initial imput of data. Each gel reading is 
given a file name and is stored in an individual disk file. The 
program also writes to another file (file of file names) which 
contains the names of all the gel reading files it has written during 
each run. 
DBCOMP : This program is used to search for overlaps between 
sequences. It compares each gel reading file with each sequence file 
and then compares the gel reading files with each other . Any 
overlaps found (the operator defines the minimum length of overlap) 
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are sorted, their positions listed, printed and the complementary 
regions of the two overlapping sequences are displayed. 
DBCOMP is also valuable in that it can compare sequence data 
obtained with the known sequence of Ml3mp2 and pBR322 (which shares 
some sequence with pGM706) and hence can detect any extraneous 
sequences derived from either vector. 
DBUTIL : This program is used to establish and change the 
relationships between gel reading data . Relationships (ie which gels 
overlap with which) are set up and maintained in a special file which 
is called the database or file of relationships. It is this file 
that is used and, if necessary, updated by all the functions supplied 
by this program (Staden, 1980). 
The DBUTIL program has a number of functions which makes it 
particularly versatile. A number of important features are outlined 
below. 
(a) The enter function allows entry of a new gel reading into 
the database system after it has been scrutinized by the DBCOMP 
program. 
(b) The entry of gel reading data expands the database, the 
contents of which can be readily printed using the print function. 
Furthermore, the contents of any region of the database can be 
displayed. The display function readily shows the operator any 
problem areas in the lined up sequences. 
(c) The edit function allows the operator to edit any section 
sequence. 
of 
(d) The complement function allows the operator to complement 
and reverse all the gels covering any contiguous section of sequence . 
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(e) As the gel reading data entered increases, various contigs 
expand in length. A Join function allows overlapping contigs to be 
appropriately aligned and joined to make a larger composite contig. 
Ultimately the database will be composed of only one contig. 
Furthermore, the display function can be used to detect any regions 
which may require resequencing . 
Hence, the DBUTIL program offers a number of significant 
advantages over manual sequence data processing or the use of simple 
computer storage and retrieval systems. These advantages include: 
(a) progress can be rapidly monitored (functions; print display), (b) 
ambiguities can be readily detected and edited (function edit), (c) 
overlapping contigs can be expanded to ultimately form a continuous 
composite (functions; Join complement), and (d) the cumulative nature 
of the data collection process readily enables the operator to assess 
the reliability ( on each DNA strand) of any section of the sequence. 
RESULTS AND DISCUSSION 
The D-lactate dehydrogenase has a molecular weight of 
approximately 63000 (calculated from data presented in Santos et al., 
1982) . The coding region of the dld gene would therefore be expected 
to be approximately 1600-1800 bases long . The size of the cloned 
fragment carrying the dld gene is 6.9 kb and therefore is 
considerably larger than the estimated size of the dld gene. 
The standard approach would be to subclone fragments of the 6.9 
kb cloned insert so as to obtain the dld gene on a smaller piece of 
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DNA. This approach was attempted, while at the same time the random 
sequencing method was used to initiate the sequencing of the whole 
fragment. 
The sequencing approach used in this work involved the 
production of restriction fragments using enzymes with 4-base 
recognition sequences and the rand om cloning of these fragments into 
Ml3 vectors. This approach has been used extensively by Dr F. 
Sanger and his colleagues and has been found to be a convenient 
approach in rapidly obtaining sequence data (Sanger et al., 1980; 
1982). 
Isolation and Purification of the Cloned HindIII Fragment Containing 
the Dld gene 
The plasmid pIY2 was isolated from strain IY36 by the method of 
Clewell and Helinski (1969) (see Materials and Methods Chapter 2). 
Plasmid pIY2 was then digested with HindIII and the cloned 4.6 Mdal 
fragment (designated 2-1) purified by agarose gel electrophoresis and 
hydroxylapatite chromatography (see Figure 6-4). 
Attempts to Subclone the Dld Gene 
The strategy used was to shorten the 6.9 kb fragment by 
sonication, add linkers and to clone into pBR322 . 
The purified 6.9 kb was sonicated and the DNA fragments produced 
were size fractionated on a preparative agarose gel (Figure 6-5). 
DNA fragments encompassing the size range of 1.8 to 4.0 kb were 
purified by hydroxylapatite chromatography as described in the 
Materials and Methods section of Chapter 2 . 
Figure 6-4. Electrophoresis of Plasmid DNA and Purified Fragment 2-1 
on 0.8% (w/v) Agarose Gels 
kb 
• pairs 
23.1 
9.42 
6.56 
4.37 
2.32 
2.03 
1 2 34 
kb 
• pairs 
23.1 
9.42 
6.56 
- 4.37 
2.32 
2.03 
Samples : (1) and (4) HindIII restriction fragments of AcI857, 
(2) pIY2 digested with HindIII, and (3) Purified Fragment 2-1 
(-6.9kb). DNA was digested, subjected to electrophoresis and 
purified as described in the Materials and Methods of Chapter 2. 
Figure 6-5. Sonication and Size Fractionation of Fragment 2-1 on a 
0.8% (w/v) Agarose gel 
Recovered 
Sonicated 
DNA 
kb 
• pairs 
23.1 
9.42 
6.56 
4.37 -
2.32 
2.03 
Sonicated DNA 
A Hindlll f 
The sonicated DNA, size range 1.8 to 4.0 kb, was purified as described 
in the Materials and Methods section. 
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The purified fractionated DNA samples had their ends 'filled-in' 
using dNTPs, [a-3 2P]dATP, and Klenow polymerase enzyme. The 
'filled-in' DNA samples were ligated to phosphorylated BamHI linkers . 
Each sample was then digested with BamHI endonuclease and 
fractionated on a Sephadex G-75 column to remove free linker (Figure 
6-6). The first third of the peak fractions shown in Figure 6-6 were 
pooled and concentrated by ethanol precipit ation . The BamHI linker 
ligated DNA was ligated into the BamHI site of pBR322 and transformed 
into strain IY12 (ndh). Transformants were screened by firstly 
selecting on complete media (brain heart infusion agar, BHIA) plus 
ampicillin (Ap; 25 µg mL-1) . R Approximately 120 Ap transformants 
were replated onto BHIA plus tetracycline (Tc; 10 µg mL-1). Eight of 
s 
the 120 colonies were Tc , indicating that they contained inserts. 
It was necessary to see if any of these could compleme nt the ndh 
mutant so each of these colonies was replated onto mannitol-minimal 
plates (Materia ls and Methods section, Chapter 4). None gave 
convincing complementation. It may be that the failure to obtain a 
hybrid plasmid containing a functional dld gene was due to the 
relatively low numbers obtained. However, the complementation of the 
ndh mutants by the cloned dld gene would be dependent on the level of 
amplification of the D-lactate dehydrogenase and for some reason this 
may not be as high with the present plasmids as with pIY2. Dld 
mutants are available in the E.coli ML strain but growth of the 
parent ML strain on D-lactate is poor. Thus, a simple subcloning 
strategy by complementation was not available. Although subcloned 
fragments could be screened by coupled transcription/translation or 
measurement of D-lactate dehydrogenase in membrane preparations, it 
was decided to use a random sequencing approach until the N-terminus 
Figure 6-6 . Sephadex G-75 Column Chromatography of Sonicated 
Fragments of 2- 1 after BamHI Linker Addition 
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See text and the Materials and Methods section for further details. 
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of the dld coding region could be identified. The N-terminal 
sequence of the D-lactate dehydrogenase is currently being d e t e rmin e d 
by Drs H.D. Campbell and D.C. Shaw. 
Random Cloning of ~JA and ~II digested Fragments of 2-1 into 
Ml3mp8 
Double stranded (RF) Ml3mp8 was digested with the r e striction 
endonuclease BamHI and the purified fragment 2-1 cleaved with Sa u3A. 
The Sau3A fragments were ligated into the BamHI site of Ml3mp8. In 
parallel, another sample of Ml3mp8 was digested with AccI and the 
fragment 2-1 digested with HpaII. The HpaII generated fragme nts were 
ligated into the AccI site of the cleaved Ml3mp8 (see Figures 6-1 and 
6-2). After ligation, the recombinant phages were transfected into 
strain JM103 and the cells added to soft agar containing X-gal and 
IPTG and overlaid onto YT plates. The transfection involving Sau3A 
fragments gave -120 blue plaques and -170 white plaques. Each of the 
recombinant white plaques were 'picked' with sterile toothpicks and 
plaque-purified onto a fresh overlay. Batches of 40 plaques were 
then picked and grown up for template production. To examine 
whether the template production procedure had been successful, 
samples (5 ~L volume) were electrophoresed on a 0.8% (w/v) agarose 
gel (Figure 6-7). It can be seen from Figure 6-7 that the DNA 
template yields were variable. The Ml3 clones carrying random short 
fragments were screened for their suitability as sequence templates 
by carrying out the normal sequencing reaction with only one 
dideoxynucleotide. In this case the positions of thymines in the DNA 
sequence were determined and used as a basis for comparison of the 
various clones. This procedure is referred to as 'T-tracking' and an 
Figure 6-7. Electrophoresis of Recombinant Ml3mp8 DNA on a 0.8% 
(w/v) Agarose Gel 
5 µL of Ml3mp8 template samples were electrophoresed as described 
in the Materials and Methods (Chapter 2). 
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example is provided in Figure 6-8 . The variability in th e t empl a t e 
yields shown in Figure 6-7 was reflected in the int e ns i ty of the 'T-
track' sequencing reactions shown in Figure 6-8, Howev e r, in the 
sequencing reactions the amount of template used was va r i e d to 
compensate and hence this did not present a maJor difficulty. 
Furthermore, 'T-tracking' enables the size of the inserts to be 
determined by the recognition of the vector sequence (s e e Figure 
6-8). Clones carrying the same insert can be id e ntified and the 
suitability of clones for sequencing can be assessed. For example, 
the clone represented in lane 5 of Figure 6-8 appears to exhibit 
multiple banding and a high autoradiographic background and therefore 
would be rejected as a clone which is unsuitable for sequencing. 
A number of the Sau3A and Hpall generated clones were sequenced. 
In most cases the reaction mix was electrophoresed on a 'long' and 
'short' gel. Examples of sequence autoradiographs are shown in 
Figure 6-9. The autoradiographs presented in Figure 6-9 have been 
selected to highlight a number of characteristics of the sequencing 
gels. In Figure 6-9(a) it can be seen that the bands at the bottom 
of the gel are significantly less labelled than the bands in the 
upper region of the gel. This clone was sequenced using the 26 bp 
primer described by Anderson et al., (1980). When the 17-mer 
synthetic primer described by Duckworth et al. (1981) is used this 
difference is less pronounced, presumably due to greater label 
incorporation which makes reading of the gels in this region less 
difficult (see Figure 6-9, b,c and d) . The use of universal primers 
gave considerably better sequence data than that obtained previously 
with internal primers (see Chapter 2) . 
Some gels in Figure 6-9, especially those in the outer 'lanes' 
show a distortion of the bands which is attributed to heating effe cts 
Figure 6-8. 'T-Tracks' of Ml3mp8 clones Carrying Random Short 
Fragments Derived from Fragment 2-1 
1234567-8 
Ml3mp8 clones were prepared as described in the Materials and Methods 
section (Chapter 2). Each clone was used as a template in a 'T-lane' 
sequencing reaction. The vector sequence is illustrated by a 
vertical line. See text for further details. 
Figure 6-9. Autoradiographs of DNA Sequencing Gels: The 
Determination of the Sequence of Cloned Sau3A 
and HpaII Fragments 
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A C 
TC I_ AG 
11 
II 
. 
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(ie the bands are not horizontal but are at an angle) . This effect 
did not give rise to any difficulties in reading the gels. Some 
workers have used a thermostatic plate to overcome this problem 
(Garoff and Ansorge, 1981). 
The main factor affecting the reading of the autoradiographs was 
the resolution of bands in the upper part of the gel. It was 
generally not possible to obtain readings longer than 120 nucleotides 
from the short gels, the limitation being band sharpness. The band 
sharpness in autoradiographs is affected by the quality of the 
sequencing gel itself and the method used for autoradiography. An 
i~provement in the band sharpness with long gels was achieved by 
following the recommendation of Anderson (1981), ie using half 
strength TBE buffer. It has been suggested that the use of buffer 
gradient gels produces a more evenly-spaced band pattern and allows 
longer readings to be obtained (Amersham Research News, No . 27 Feb 
1983). As yet the buffer gradient system has not been assessed in 
this laboratory. 
Significant improvement in band resolution can also be obtained 
if the sequencing gels are dried before autoradiography (Sanger et 
al., 1982). Recently, it has also been demonstrated that the use of 
[a- 35 s]dATPaS instead of [a-3 2 P]dATP in DNA sequencing also gives a 
significant improvement in band sharpness (Gilson, Barrell, 
unpublished results cited in Amersham Research News, No. 27 Feb 
1983). 
Perhaps one of the maJor advances in the speed of carrying out 
the sequencing reaction comes with the development of the 
microcentrifuge technique (Davies, 1982). This method, devised by 
Sanger and his colleagues, supersedes the methods which extensively 
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use glass capillaries as reaction vessels (Sanger et al., 1980). In 
the method described by Davies (1982), all the steps in the 
sequencing procedure are done in microcentrifuge tubes and mixing is 
achieved by a quick centrifugation step which allows ten reactions to 
be handled at a time. As pointed out by Davies (1982) the procedure 
involving the use of glass capillaries has the maJor disadvantages of 
requiring considerable time for the manipulations involved and it is 
difficult to handle more than four complete reactions at a time. 
The Partial DNA Sequence of the Cloned Fragment 2-1 which contains 
the ]lg Gene 
Using the Staden (1980) computer program DBUTIL a DNA sequence 
database was constructed from the various gel readings. Sequence 
data was entered using the program BATIN and each reading was 
compared using DBCOMP (Staden, 1980) with the sequence of Ml3mp2 and 
pBR322 to eliminate any vector-derived clones. Gel readings were 
also compared with one another to detect any sequence overlaps. The 
construction of the database and the DNA sequence is shown in Figures 
6-10 and 6-11, respectively. Approximately 1030 bases of unique DNA 
sequence is presented in Figure 6-11. Moreover, a number of contigs 
have been sequenced twice giving total internal agreement (see Figure 
6-10 for DBUTIL printout). 
Unfortunately, a high percentage of the Sau3A and HpaII 
generated clones were relatively short (60-130 bp long). It has been 
observed previously that small fragments are more readily inserted 
into the vector Ml3mp2 (and presumably its derivatives) than large 
fragments (Sanger et al., 1980). The choice of other restriction 
endonucleases may have overcome this problem. Therefore, although 
Figure 6-10 . Processing of Sequence Data by Computer : Construction 
of a Sequence Database 
After the rela tionships between gel readings are established 
by DBCOMP a seq uence database i s constructed using DBUTIL . 
Examples of the procedures used a r e shown below. 
R DBSTRT 
INITIALIZE DATA BASE FILE 
PROJECT NAME= LDHLDH.DBl 
STOP - -
R DBUTIL 
DBUTIL 
PROJECT NAME= LDHLDH.DBl 
NUMBER OF GELS= 0 NUMBER OF CONTIGS = 0 
FOR 120 CHARACTER LINES TYPE Y 
SELECT OPTION BY NUMBER 
STOP=O,ENTER=l,PRINT=2,DISPLAY=3,JOIN=4,COMPLEMENT=5,EDIT=6 
OPTION NUMBER= 1 
ENTER 
NAME OF ARCHIVE= LDHOOl 
WORKING NAME FOR THIS GEL= LDHLDH . 001 
IF THIS GEL OVERLAPS TYPE Y 
A series of unrelated gel readings (ie no overlaps as shown 
by DBCOMP) are entered first then overlapping complementary 
or homologous gel readings are entered . 
11 
1: 
', 
1, 
When all entries are completed , sorted data is obtained as 
illus trated below . 
SELECT OPTION BY NUMBER 
STOP=0,ENTER=l,PRINT=2,DISPLAY=3,JOIN=4,COMPLEME T-5,EDIT=6 
OPTION NUMBER= 2 
NUMBER OF GELS= 18 NUMBER OF CONTIGS = 13 
TO SELECT CONTIGS TYPE Y 
FOR SORTED DATA TYPE Y 
LDH019 
LDH020 
LDH018 
LDH017 
LDH016 
LDH015 
LDH014 
LDH013 
LDH012 
LDHOll 
LDH009 
LDHOlO 
LDH005 
LDH006 
LDH003 
LDH004 
LDHOOl . 
LDH002 
987 
13 
17 
988 
12 
989 
11 
990 
10 
991 
9 
992 
8 
993 
7 
994 
6 
995 
5 
996 
4 
18 
997 
3 
14 
998 
2 
15 
999 
1 
16 
93 . 
1. 
1 . 
43 . 
1 . 
87. 
1 . 
114. 
1. 
111. 
1. 
72. 
1. 
128. 
1. 
58. 
1. 
23. 
1 
53. 
1. 
1. 
89. 
1. 
1. 
49. 
1 . 
1. 
115. 
1. 
1. 
0 
93 
93 
0 
43 
0 
87 
0 
114 
0 
111 
0 
72 
0 
128 
0 
58 
0 
23 
0 
53 
53 
0 
89 
86 
0 
49 
49 
0 
115 
115 
13 
0 
13 
12 
0 
11 
0 
10 
0 
9 
0 
8 
0 
7 
0 
6 
0 
5 
0 
4 
0 
4 
3 
0 
3 
2 
0 
2 
1 
0 
1 
17 
17 
0 
12 
0 
11 
0 
10 
0 
9 
0 
8 
0 
7 
0 
6 
0 
5 
0 
18 
18 
0 
14 
14 
0 
15 
15 
0 
16 
16 
0 
SELECT OPTION BY NUMBER 
STOP=0 , ENTER=l , PRINT=2,DISPLAY=3,JOIN=4,CnMPTEMvNT -5,~DI-=6 
OP TION NUMBER= 0 
I: 
The f irs t column lis t s the names of the archives (gel reading 
names ; eg LDEOOl) grouped into their respective contigs . The 
second co lumn lists the number s of the gel working names 
(numb ers 1-18 ; eg LDHLDH.001 ). The third and fourth columns 
list the length of DNA sequence covered on each sequen~e st r and . 
Columns five and six list the gel working names and shows which 
ge l readings are complementa r y or homol ogous and on which DA 
strand . 
One maj or advantage of t he DBUTii. program is that the oper ato r 
can readily assess the reliability of entered sequence data . 
This is done us ing the display op tion. Each gel reading 
sequence is automatically compared and a consensus sequence is 
listed . This is shown in the examples below. 
R DBUTIL 
DBUTIL 
PROJECT NAME= LDHLDH.DBl 
NUMBER OF GELS= 18 NUMBER OF CONTIGS = 13 
FOR 120 CHARACTER LINES TYPE Y 
SELECT OPTION BY NUMBER 
STOP=O,ENTER=l,PRINT=2,DISPLAY=3,JOIN=4,COMPLEMENT-5,EDIT=6 
OPTION NUMBER= 3 
NUMBER OF LEFT GEL THIS CONTIG = 1 
DEFINE REGION 
RELATIVE POSITION OF LEFT END= 
RELATIVE POSITION OF RIGHT END= 
10. 20. 30. 40. so. 60. 
1 GATCGCATCAAAGATGACGATGTGCGTCACGATGGTCGTCAC GC CCACGATTATGACTAT 
16 GATCGCATCAAAGATGACGATGTGCGTCACGATGGTCGTCACGCCCACGATTATGACTAT 
GATCGCATCAAAGATGACGATGTGCGTCACGATGGTCGTCACGCCCACGATTATGACTAT 
70. 80. 90. 100. 110. 120 . 
1 GTCCACCGCGTTCGTGATATTGAAGCCGAXACGCCCGCACGTTATAACGCCGATC 
16 GTCCACCGCGTTCGTGATATTGAAGCCGACACGCCCGCACGTTATAACGCCGATC 
GTCCACCGCGTTCGTGATATTGAAGCCGACACGCCCGCACGTTATAACGCCGATC 
SELECT OPTION BY NUMBER 
STOP=O,ENTER=l,PRINT=2,DISPLAY=3,JOIN=4,COMPLEMENT=5,EDIT=6 
OPTION NU.MEER= 3 
NUMBER OF LEFT GEL THIS CONTIG = 2 
DEFINE REGION 
RELATIVE POSITION OF LEFT END= 
RELATIVE POSITION OF RIGHT END= 
10. 20 . 30. 40. 50. 
2 GATCTCCATACACTTATCTCACAATATGGTTATGCCGCGCCTGGTGATC 
15 GATCTCAATACACTTATCTCACAATATGGTTATGCCGCGCCTGGTGATC 
GATCTCAATACACTTATCTCACAATATGGTTATGCCGCGCCTGGTGATC 
,, 
It 
11 
II 
I 
SELECT OPTIO BY NUMBER 
STOP=O, ENTER=l, PRI T=2, DISPLAY=3, JOIN=4 COr-1PLEMENT=5, EDIT=6 
OPTION NUMBER= 3 
NUMBER OF LEFT GEL THIS CONTIG = 3 
DEFINE REGION 
RELATIVE POSITION OF LEFT END= 
RELATIVE POSITION OF RIGHT END= 
10 . 20 . 30 . 40 . 50. 60. 
3 GATCGCGATGTCGTTATCATCAGCACCCTGCGTCTCGACAAGCTGCACGTTCTTGGCAAG 
14 GATCGCGATGTCGTTATCATCAGCACCCTGCGTCTCGACAAGCTGCACGTTCTTGGCAAG 
GATCGCGATGTCGTTATCATCAGCACCCTGCGTCTCGACAAGCTGCACGTTCTTGGCAAG 
70. 80 . 90 . 
3 GGCGAACAGGTGCTGGCCTATCCGGGCAC 
14 GGCGAACAGGTGCTGGCCTATCCGGG 
GGCGAACAGGTGCTGGCCTATCCGGGCAC 
100. 110. 
SELECT OPTION BY NUMBER 
STOP=O , ENTER=l,PRINT=2 ,DISPLAY=3,JOIN=4,COMPLEMENT=5,EDIT=6 
OPTION NUMBER= 3 
NUMBER OF LEFT GEL THIS CONTIG = 4 
DEFINE REGION 
RELATIVE POSITION OF LEFT END= 
RELATIVE POSITION OF RIGHT END= 
10. 20. 30. 40. so. 
4 GGCTGATTTCGCTATTCAGTCCGTACGCGCGAATAGACCCCTTTCATCTCCGG 
18 GGCTGATTTCGCTATTCAGTCCGTACGCGCGAATAGACCCCTTTCATCTCCGG 
GGCTGATTTCGCTATTCAGTCCGTACGCGCGAATAGACCCCTTTCATCTCCGG 
SELECT OPTION BY NUMBER 
STOP=O,ENTER=l,PRINT=2,DISPLAY=3,JOIN=4,COMPLEMENT=5,EDIT=6 
OPTION NUMBER= 3 
NUMBER OF LEFT GEL THIS CONTIG = 13 
DEFINE REGION 
RELATIVE POSITION OF LEFT END= 
RELATIVE POSITION OF RIGHT END= 
120. 
60. 
10. 20. 30. 40 . 50. 60. 
13 CCGGTGCATAACGTTTCAACTGCCCGTGACTTAACCAAACTGCTCATTGCCAGCAAACAA 
17 CCGGTGCATAACGTTTCAACTGCCCGTGACTTAACCAAACTGCTCATTGCCAGCAAACAA 
CCGGTGCATAACGTTTCAACTGCCCGTGACTTAACCAAACTGCTCATTGCCAGCAAACAA 
70. 80 . 90. 
13 TATCCGTTGATCGGGCAGTTAAGTACTACCGG 
17 TATCCGTTGATCGGGCAGTTAAGTACTACCGG 
TATCCGTTGATCGGGCAGTTAAGTACTACCGG 
100. 110 . 
SELECT OPTION BY NUMBER 
STOP=0,ENTER=l,PRINT=2,DISPLAY=3,JOIN=4,COMPLEMENT=5,EDIT=6 
OPTION NUMBER= 0 
120 . 
Figure 6-11. The Partial DNA Sequence of the Cloned Fragment 2-1 
which contains t he 12lsl Gene 
A consensus file was constructed from the dat a 
accumulated in the database . 
. R CONSEN 
CONSEN 
PROJECT NAME= LDHLDH.DBl 
NUMBER OF GELS= 18 NUMBER OF CONTIGS = 13 
NAME FOR CONSENSUS FILE= LDHCNl 
TO SELECT CONTIGS TYPE Y 
TO CALC ANOTHER CONSENSUS TYPE Y 
When the sequence is complete the database and the consensus 
sequence will be comprised of only one continuous contig. 
At present the database has 13 discontinuous contigs as is 
shown in Figure 6-10. The consensus sequence is listed below . 
. R SEQLST 
PLEASE TYPE NAME OF FILE 1 
LDHCNl 
FIRST SEQ NO= 
LAST SEQ NO= 
1 OR 2 STRANDED OUTPUT? TYPE NOW 
NUMBER OF GAPS BETWEEN LINES== 
FOR 120 LINE OUTPUT TYPE Y 
10 20 30 40 
<---LDHLDH .013-----> CCGGTGCP_TA ACGTTTCAAC 
70 80 90 100 
TGCTCATTGC CAGCAAACAA TATCCGTTGA TCGGGCAGTT 
130 140 150 160 
LDH.012--- -->CCGGTTT ATTATTGATA ACCGTACGCA 
190 200 210 220 
so 60 
TGCCCGTGAC TTli.ACCAAAC 
110 120 
AAGTACTACC CGG <---LDH 
170 180 
TCACCAGACA ATGGCC<---
230 240 
LDHLDH.011 ----->GATC ATCGTGTATA GGCGCATCGG TCATCGGCGG TATTTGTAAC 
250 260 270 280 290 300 
AACTCCGGCG GCCTCGCTGG TGCAACGTGG CCCGGCGTAT ACC<---LDH LDH.010---
310 320 330 340 350 360 
-- >CCGGATC GTTCTCGCGA TAGAACTTCT GCAACGTCTC CGGGTTCTGC CGCCGTGCCA 
370 380 390 400 410 420 
TGTTTAATCA GCTCTTTGAT TGCACGTGAT CGGAAACGGT GATGCCTTTA AAGCCCA<--
430 440 450 460 470 480 
-LDHLDH.00 9----->GAT CGCCACGCCA ATGAATGGCA TGGATGACAG CGACGTGAAG 
490 500 510 520 530 540 
CCCGACGCGG AGCCTTCGAT TCCCTTGCGG CGTTTTGGCG AACGATGAGA TTGCCAGCTG 
550 560 570 580 590 600 
TGTTGCTT<- --LDHLDH.0 08----- >GA TCCTGCATGG CGCGGATATC CTGACGGGTT 
610 620 630 640 650 660 
ACGGTGTTGA AAATCGCCCC AAC CTGACCG TTTTTTGATC <---LDHLDH 
. 007 - - ---> 
I! 670 680 690 700 710 720 
GATCGGCAAA GAGTGCGCGT TATTACTGGC GCCAGGGGTT TGATATTGGT ATTACCTGGC 
730 740 750 760 770 780 
ACTCAGATGA AGAAGGGGCA AAAGATACCG CGCGTGAGGT AGTTAGCCAC GGCGTACGTG 
I , 790 800 810 820 830 840 
Ii CGGAGATC< - --LDHLDH.0 06----->CC GGCAGATTTT CGAAGTTAGC CAGAATATGA 
:1 850 860 870 880 89 0 900 
I, CGGCGGATTT CGGTCAGCAC TTCCGG <--- LDHLDH.005 
----->GATC TATTCGAACC 
910 920 930 940 9SO 960 
ACCCGGATC <---LDHLDH. 004----->G GCTGATTTCG CTATTCAGTC CGTACGCGCG 
97 0 980 990 1000 1010 1020 
AATAGACCCC TTTCATCTCC GG <---LDHL DH.003---- - >GATCGCGA TGTCGTTATC 
1030 1040 1050 1060 1070 1080 
ATCAGCACCC TGCGTCTCGA CAAGCTGCAC GTTCTTGGCA AGGGCGAACA GGTGCTGGCC 
1090 1100 1110 1120 1130 1140 
TATCCGGGCA C<---LDHLD H.002----- >GATCTCAAT ACACTTATCT CACAATATGG 
1150 1160 1170 1180 1190 1200 
TTATGCC GCG CCTGGTGATC <---LDHLDH .001-----> GATCGCATCA AAGATGACGA 
1210 1220 1230 1240 1250 1260 
TGTGCGTCAC GATGGTCGTC ACGCCCACGA TTATGACTAT GTCCACCGCG TTCGTGATAT 
1270 1280 1290 5 15 25 
TGAAGCCGAC ACGCCCGCAC GTTATAACGC CGATC 
II 
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very convenient, the cloning of restriction fragments can result in a 
relatively high proportion of short clones. 
A solution to the problem of endonuclease generated short clones 
is to generate larger fragments by techniques such as shearing 
(Wilson and Thomas, 1974; Fuhrman, Deininger, LaPorte, Friedmann and 
Geiduschek, 1981) or DNase treatment (Anderson, 1981) followed by 
size fractionation. 
Time did not permit the application of these techniques to the 
present problem but further sequencing of the dld fragment has been 
carried out in this laboratory by Dr H.D. Campbell using cloned DNA 
generated by sonication. These fragments (approximately 500 bp in 
length) were made blunt ended and cloned into the SmaI site of 
Ml3mp9. This has proved to be a much more efficient sequencing 
strategy allowing gel readings of around 300-450 bases for each 
clone. 
SUMMARY 
The cloned =6.9 kb fragment (designated 2-1) which contains the 
dld gene was isolated and purified after HindIII digestion of pIY2. 
The fragment was sonicated to reduce its length to the size range of 
1.8 to 4.0 kb. BamHI linkers were added to the purified fragments 
and attempts were made to clone these fragments into the BamHI site 
of pBR322. However, difficulties were encountered in the attempt to 
obtain a recombinant plasmid capable of complementing the ndh mutant 
(ie growth on mannitol-minimal plates). 
The determination of the DNA sequence of the complete 2-1 
fragment which contains the dld gene was initiated. Sau3A and HpaII 
Ir 
I 
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restriction endonucleases were used to cleave fragment 2-1 and the 
generated fragments were randomly cloned into the BamHI and Accl 
sites of Ml3mp8 . The Ml3mp8 clones were isolated and a number were 
sequenced by the Sanger chain-terminating method using the 
' universal' 26 bp and 17-base primers described by Anderson et al. 
(1980) and Duckworth et al ., (1981). Approximately 1030 bases of 
unique DNA sequence was obtained . 
--
151. 
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